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Abstract
South Africa has a severe HIV (human immunodeficiency virus) burden and
the management of the disease is a priority, especially in the public health-
care sector. One element of managing the disease, is determining when to
initiate an HIV positive individual onto anti-retroviral therapy (ART), a
treatment that the patient will remain on for the remainder of their life-
time. For the majority of HIV positive individuals in the country, this
decision is governed by the results of a CD4 (cluster of differentiation 4)
test that is performed at set time intervals from the time that the patient
is diagnosed with HIV until the patient is initiated onto ART. A device
for CD4 measurement at the point of care (POC), the Alere PIMA, has
recently become commercially available. This has prompted a need to evalu-
ate whether CD4 testing at the POC (i.e. at the patient serving healthcare
facility) should be incorporated into the South African public healthcare
sector’s HIV diagnostic service provision model.
One challenge associated with the management of HIV in the country is the
relatively large percentage of patients that are lost to follow-up at various
points in the HIV treatment process. There is extensive evidence that
testing CD4 levels at the POC (rather than in a laboratory, as is the current
practice) reduces the percentage of patients that are lost to follow-up before
being initiated onto ART. Therefore, though POC CD4 testing is more
expensive than laboratory-based CD4 testing, the use of this technology in
South Africa should be investigated for its potential to positively influence
health outcomes.
In this research, a multi-objective location science model is used to generate
scenarios for the provision of CD4 testing capability. For each scenario,
CD4 testing provision at 3 279 ART initiation facilities is considered. For
each facility, either (i) a POC device is placed at the site; or (ii) the site’s
ii
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testing workload is referred to one of the 61 CD4 laboratories in the country.
To develop this model, the characteristics of eight basic facility location
models are compared to the attributes of the real-world problem in order to
select the most suitable one for application. The selected model’s objective,
assumptions and inputs are adjusted in order to adequately model the real-
world problem. The model is solved using the cross-entropy method for
multi-objective optimisation and the results are verified using a commercial
algorithm.
Nine scenarios are selected from the acquired Pareto set for detailed pre-
sentation. In addition, details on the status quo as well as a scenario where
POC testing is used as widely as possible are also presented. These scenar-
ios are selected to provide decision-makers with information on the range
of options that should be considered, from no or very limited use to wide-
spread use of POC testing. Arguably the most valuable contribution of
this research is to provide an indication of the optimal trade-off points
between an improved healthcare outcome due to POC CD4 testing and
increased healthcare spending on POC CD4 testing in the South African
public healthcare context. This research also contributes to the location
science literature and the metaheuristic literature.
iii
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Opsomming
Suid-Afrika gaan gebuk onder ‘n swaar MIV- (menslike-immuniteitsgebreks-
virus-)las en die bestuur van die siekte is ‘n prioriteit, veral in die openbare
gesondheidsorgsektor. Een element in die bestuur van die siekte is om te
bepaal wanneer ‘n MIV-positiewe individu met antiretrovirale- (ARV-)be-
handeling behoort te begin, waarop pasie¨nte dan vir die res van hul lewens
bly. Vir die meeste MIV-positiewe individue in die land word hierdie besluit
bepaal deur die uitslae van ‘n CD4- (cluster of differentiation 4-)toets wat
met vasgestelde tussenposes uitgevoer word vandat die pasie¨nt met MIV
gediagnoseer word totdat hy of sy met ARV-behandeling begin. ‘n Toestel
vir CD4-meting by die punt van sorg (“POC”), die Alere PIMA, is on-
langs kommersieel beskikbaar gestel. Dit het ‘n behoefte laat ontstaan om
te bepaal of CD4-toetsing by die POC (met ander woorde, by die gesond-
heidsorgfasiliteit waar die pasie¨nt bedien word) by die MIV-diagnostiese
diensleweringsmodel van die Suid-Afrikaanse openbare gesondheidsorgsek-
tor ingesluit behoort te word.
Een uitdaging met betrekking tot MIV-bestuur in die land is die betreklik
groot persentasie pasie¨nte wat verlore gaan vir nasorg in die verskillende
stadiums van die MIV-behandelingsproses. Heelwat bewyse dui daarop dat
die toetsing van CD4-vlakke by die POC (eerder as in ‘n laboratorium, soos
wat tans die praktyk is) die persentasie pasie¨nte wat verlore gaan vir nasorg
voordat hulle met ARV-behandeling kan begin, verminder. Daarom, hoewel
CD4-toetsing by die POC duurder is as toetsing in ‘n laboratorium, behoort
die gebruik van hierdie tegnologie in Suid-Afrika ondersoek te word.
In hierdie studie is ‘n meerdoelige liggingswetenskapmodel gebruik om sce-
nario’s vir die voorsiening van CD4-toetsvermoe¨ te skep. Vir elke scenario
word CD4-toetsvermoe¨ by 3 279 ARV-inisiasie fasiliteite oorweeg. Vir elke
fasiliteit word toetsvermoe¨ verskaf deur (i) die plasing van POC-toestelle by
iv
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die fasiliteit, of (ii) verwysing vir laboratoriumgebaseerde toetsing by een
van die 61 CD4-laboratoriums in die land. Die kenmerke van agt basiese
fasiliteitsliggingsmodelle is met die kenmerke van die werklike probleem
vergelyk om die mees geskikte model vir toepassing op die werklike prob-
leem te bepaal. Die doelwitte, aannames en insette van die gekose model
is daarna aangepas om die werklike probleem voldoende te modelleer. Die
model is opgelos met behulp van die kruis-entropie-metode vir meerdoelige
optimering, waarna die resultate deur middel van ‘n kommersie¨le algoritme
bevestig is.
Nege scenario’s uit die verworwe Pareto-stel word uitvoerig aangebied. Daar-
benewens beskryf die studieresultate die besonderhede van die status quo
sowel as ‘n scenario waar POC-toetsing so wyd moontlik gebruik word. Hi-
erdie scenario’s word aangebied om besluitnemers van inligting te voorsien
oor die verskeidenheid moontlikhede wat oorweeg kan word, wat wissel van
geen of baie beperkte tot wydverspreide gebruik van POC-toetsing. Die
mees beduidende bydrae van hierdie navorsing is stellig dat dit ‘n aanduid-
ing bied van die optimale kompromie tussen ‘n verbeterde gesondheidsorg-
uitkoms weens CD4-toetsing by die POC, en verhoogde gesondheidsorgbeste-
ding aan CD4-toetsing by die POC, in die konteks van Suid-Afrikaanse
openbare gesondheidsorg. Die navorsing dra ook by tot die ligingsweten-
skapliteratuur sowel as tot die metaheuristiekliteratuur.
v
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dij value
ni The number of additional patients that would have
been initiated on to ART at site i if POC testing
had been used at that site
P The number of facilities to locate
qj The cost of performing the CD4 tests assigned to
the laboratory at site j
ri The cost of performing the POC tests assigned to
ART initiation site i
S The maximum acceptable service distance between
a facility and the demand node it serves
vi The number of CD4 tests requested by ART ini-
tiation site i
wj The total CD4 testing volume assigned to the lab-
oratory at site j
xj A decision variable indicating whether a facility is
to be located at a candidate site j
yij A decision variable indicating whether demand
node i is served by a facility at node j
zi A decision variable indicating whether the demand
at facility i is covered or not
xvii
Stellenbosch University  https://scholar.sun.ac.za
Nomenclature
Subscripts
i Index of demand nodes
j Index of facility sites
Terminology
10 Point Plan The South African Department of Health’s set
of priorities released in response to the country’s
MTSF for the period 2009 to 2014
Cepheid GeneXpert device A point of care testing device used to perform the
GeneXpert MTB/RIF test
GeneXpert MTB/RIF test A point of care test for the diagnosis of TB
Heuristic A search procedure generally designed to solve a
specific optimisation problem efficiently
Maputo Declaration A declaration on laboratory service provision drawn
up in 2008
Metaheuristic A search procedure that may incorporate several
heuristics, used for solving optimisation problems
Odds ratio A statistical measure expressing how strongly the
absence or presence of one factor is associated with
the absence or presence of another factor
Pareto set A collection of optimal solutions to a multi-objective
optimisation problem
Alere PIMA A point of care diagnostic device for CD4 mea-
surement
Sero-discordant couples Couples where one partner is HIV positive and the
other partner is HIV negative
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Chapter 1
Introduction
In this chapter, the research problem is defined through a brief summary of the most
relevant aspects of the literature study. The research objectives and methodology are
described and the structure of the report is laid out.
1.1 Background
A new point-of-care (POC) device for human immunodeficiency virus (HIV) diagnostic
testing, the Alere PIMA device for CD4 (cluster of differentiation 4) measurement,
has recently become commercially available. This has prompted a need to re-evaluate
the delivery of diagnostic services in the South African public healthcare sector to
determine:
1. Whether this point-of-care CD4 testing device should be used; and
2. How the current diagnostic service delivery model should be adjusted to incorpo-
rate the use of this device (if it is to be used).
1.2 Problem definition
South Africa has a severe HIV burden and the management of the disease in the country
is a priority, especially in the public healthcare sector. HIV affects the immune system
cells, especially the CD4+ T lymphocytes. Over a period of time, HIV infection reduces
CD4 levels, weakening the immune system and putting the body at risk of death due
to cancer or other infections (Boyle et al., 2012).
1
Stellenbosch University  https://scholar.sun.ac.za
1.2 Problem definition
One element of managing the disease, is managing the process through which HIV
positive individuals are initiated onto anti-retroviral therapy (ART). Though ART is
not a cure for HIV, it slows the progression from HIV to AIDS (acquired immunod-
eficiency syndrome) (Boyle et al., 2012) and is currently the best medical treatment
available to HIV positive individuals. Once a patient has been initiated onto ART,
they continue receiving this treatment for the remainder of their lifetime. Providing
ART to an individual is costly and it is therefore necessary to carefully manage the
initiation of patients onto this treatment.
The initiation onto ART is governed by a decision tree with two main criteria:
1. If an HIV positive person belongs to a target group (at present, target groups in
South Africa include people with tuberculosis (TB) and pregnant women), this
person is automatically eligible to be initiated onto ART; or
2. If an HIV positive person does not belong to one of the target groups, they are
only initiated onto ART once their CD4 count falls below a set threshold.
Thus, for all HIV positive individuals that do not form part of one of the target groups,
initiation onto ART is governed by the results of a CD4+ T lymphocytes cell count
(henceforth referred to as a “CD4 test”). HIV positive patients whose CD4 count is
above the ART initiation threshold continue receiving a CD4 test at a set interval until
their CD4 cell count falls below the threshold value and they are initiated onto ART.
At present, blood samples for CD4 testing are drawn at clinics, hospitals and other
healthcare facilities and collected for testing at laboratories. Once the testing is com-
pleted, the results are communicated back to the healthcare facility and then back to
the patient. In this model, testing is conducted at a site that is physically removed from
the healthcare facility and there is a delay between when the patient comes in to have
their blood drawn for testing and when the results are available to be communicated
back to the patient.
A specific challenge in the management of HIV positive patients, especially in the
South African public healthcare sector, is patients that are lost to follow-up. Patients
for whom a blood sample for CD4 testing was drawn at a specific healthcare facility that
do not return to this healthcare facility once the results of their CD4 test are available,
are an example of individuals that are deemed lost to follow-up. These individuals may
have a CD4 cell count that falls below the threshold for ART initiation, yet, because
2
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they do not return to the healthcare facility once their CD4 test results are available,
they are not initiated onto ART.
One hypothesis is that eliminating the delay between when a sample is taken and
when a result is available will reduce the number of patients that are lost to follow-
up. This hypothesis is the key motivation for considering the use of POC diagnostic
devices for CD4 testing. POC devices are placed within the healthcare facility where
the patient’s sample is taken, thus POC testing is different to traditonal laboratory-
based testing because the testing takes place at the healthcare facility itself rather than
at a remote site. POC devices are designed to conduct testing in a short time frame to
enable the patient to wait at the healthcare facility for their results to become available.
At present, the Alere PIMA is the only commercially available POC CD4 device
that is ready for implementation.
POC CD4 testing is more expensive than traditional laboratory-based CD4 testing,
yet, it has been shown to have a positive impact on patient health by reducing the
number of patients that are lost to follow-up before ART initiation (Wynberg et al.,
2014). For this reason, there is a need to evaluate different scenarios for the use of
POC CD4 testing in South Africa. The scenarios that should be evaluated range from
a model that relies completely on laboratory-based CD4 testing, to one that relies
completely on POC CD4 testing. In addition, a range of hybrid scenarios that lie
between these two extremes should also be evaluated.
Location science (an application of Operations Research) can be used to build and
evaluate scenarios for the placement of this device at clinics and hospitals in the country.
Scenarios can be evaluated by quantifying the likely impact (both financial and in terms
of patient health) of using the Alere PIMA device for POC CD4 measurement at public
healthcare facilities and of making adjustments to the South African diagnostic service
delivery model to incorporate the use of this device. The outputs from this modelling
can inform the decision-making of public healthcare managers in South Africa that are
concerned with:
1. Managing public healthcare funds in such a way that the country achieves good
HIV-specific healthcare outcomes (such as ensuring that a large portion of the
number of eligible individuals are initiated onto ART); and
3
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2. Managing diagnostic service delivery (including HIV-related diagnostics such as
CD4 testing).
Concepts such as the current model for diagnostic service delivery in South Africa,
POC testing, the ART initiation pathway, CD4 testing and the Alere PIMA device
that were briefly referred to in this section, are discussed in detail in Chapter 2.
1.3 Aim and objectives
1.3.1 Aim
The aim of this study is to apply Operations Research to solve a location science
problem related to HIV diagnostic service provision within the South African public
healthcare sector.
1.3.2 Objectives
1. Investigate the status quo of (i) diagnostic CD4 testing in South Africa; and (ii)
POC CD4 testing in general in order to build an understanding of the character-
istics of the real-world problem that is to be solved;
2. Identify the different mathematical formulations that are used in location science;
3. Categorise the mathematical formulations that have been identified according to
the characteristics of the real-world problem;
4. Determine what will be used as the mathematical basis for the formulation (and
by implication whether the model will have a single or multiple objectives), and
determine which factors will be taken into consideration during optimisation;
5. Mathematically formulate the real-world problem;
6. Solve the real-world problem using an appropriate method, for example an exact
method (if possible), a metaheuristic or simulation; and
7. Interpret the results in terms of their implication for HIV diagnostic service pro-
vision in the South African public healthcare sector.
4
Stellenbosch University  https://scholar.sun.ac.za
1.4 Research design
1.4 Research design
The research design is comprised of the following elements:
1. Unit of analysis: conceptual or non-empirical problem;
2. Meta-analytic questions (in analysing existing mathematical formulations of lo-
cation science problems);
3. Interviews (in gathering expert opinions on the factors to include in the model
and to set as the objective(s)); and
4. Application of Operations Research by means of a case study.
1.5 Research methodology
The research methodology followed comprised of the following main phases:
1. A literature study, which covered the following:
(a) The current state of the SA public healthcare sector, including the expen-
diture on healthcare delivery and the strategic development goals for the
sector;
(b) The current model for diagnostic service delivery within the SA public
healthcare sector;
(c) The nature of POC CD4 testing as well as its likely impact on healthcare
outcomes;
(d) Possible changes to the SA public healthcare diagnostic service delivery
model that can be investigated;
(e) Industries where location science is applied;
(f) Examples of the application of location science to healthcare; and
(g) Existing mathematical formulations for location science.
2. Classification of existing mathematical formulations for location science according
to their suitability for application to the real-world problem.
5
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3. Case study: application of location science to an optimisation problem in the SA
public healthcare diagnostic sector. The case study included:
(a) Information gathering on the real-world problem from subject matter ex-
perts;
(b) Input data gathering and analysis;
(c) Mathematical formulation of the real-world problem;
(d) Validation of the mathematical formulation using subject matter experts;
(e) Application of a solution algorithm or metaheuristic;
(f) Verification of the correct application of an algorithm or metaheuristic as
well as of the quality of the results generated; and
(g) Recommendations for diagnostic service delivery in the SA publich health-
care sector based on the results obtained.
1.6 Structure of the report
Chapter 2 provides a comprehensive overview of the real-world problem by (i) giving
an overview of the South African healthcare sector; (ii) providing background on the
diagnostic service delivery model employed in the SA public healthcare sector; (iii)
describing the role of CD4 testing in the HIV treatment process; (iv) providing infor-
mation on POC CD4 testing and its likely impact on healthcare outcomes; and (v)
defining the possible changes to the current diagnostic service delivery model that are
to be investigated in this thesis.
Chapter 3 provides a brief introduction to the field of Operations Research and
the need for Operations Research in healthcare before proceeding to a more detailed
discussion of location science and the types of models used in location science. The
chapter concludes with examples of general applications of location science as well as
healthcare-specific applications of location science. The purpose of this chapter is to
motivate that Operations Research in general and location science in particular offer
appropriate approaches to solving the real-world problem.
Chapter 4 is concerned with determining the most appropriate location science
model for application to the real-world problem. The chapter introduces eight basic
6
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location science models and then analyses the suitability of each of these models based
on criteria such as the model objective, assumptions, inputs and outputs.
Chapter 5 presents the modelling of the real-world problem. The chapter provides
detailed information on the input data analysis, the mathematical formulation as well
as the solution methodology. The validation of the mathematical formulation as well
as the verification of the solution methodology are also discussed in this chapter.
The results of the modelling as well as the implication for diagnostic healthcare
service delivery are discussed in Chapter 6.
Chapter 7 summarises the research findings.
1.7 Conclusion: Introduction
This chapter introduced the research by summarising the real-world problem and set-
ting out the research methodology as well as the structure of the report. Chapter 2
describes the real-world problem in more detail, starting with a description of the South
African healthcare sector before providing details on diagnostic service delivery in the
country.
7
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The real-world problem
The project was introduced in Chapter 1. The research problem as well as the aim
and objectives of the study were defined, the research design and methodology were
described and the structure of this thesis was summarised.
This chapter provides the background to the project by exploring each of the fol-
lowing topics:
1. The current state of the South African healthcare sector;
2. The current model of diagnostic service delivery within the South African public
healthcare sector; and
3. The status quo of POC CD4 testing and its likely impact on healthcare service
delivery.
2.1 The South African healthcare sector
It should be noted that there is wealth of literature available, on the state of the South
African healthcare sector, healthcare spending both in South Africa and elsewhere in
the world, HIV and TB in South Africa and HIV and TB in general. The aim of this
chapter is not to attempt to provide a complete review of all of the literature available,
but rather to give an overview in order to provide the reader with sufficient background
on the context of the problem being investigated.
8
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2.1.1 The status quo: SA healthcare sector
The South African healthcare service is divided into a public sector and a private
sector. The public healthcare sector is based on the principle of universal care and the
sector provides free basic healthcare for all citizens who cannot afford private healthcare
(Human, 2010). A 2010 study estimated that the public sector served approximately
80% (Human, 2010) of the population, a 2009 study placed this figure above 85%
(Chopra et al., 2009) while in a 2013 statement the minister of health, Dr Aaron
Motsoaledi, estimated this figure at 84% (South African Press Agency, 2013).
The public healthcare system is primarliy accessed through clinics and public hos-
pitals and the standard of care varies (Human, 2010). It is widely recognised that the
public healthcare system does not provide the same level of care as the private health-
care system. According to Human (2010) “reducing the great disparity between quality
of care in the public and private sectors is one of South Africa’s greatest challenges”.
This study fits exclusively within the public healthcare domain. Though literature
calls for greater integration, or at the least, greater co-operation between the public
and the private sectors (Mayosi et al., 2012), these two sectors are, to a large extent,
operating independently of one another at this point in time.
Literature divides the development of the South African healthcare sector since
1994 into two periods. The period before 2009 is marked by the government’s policies
of AIDS denialism and by a lack of co-operation between the scientific and clinical
communities and the government officials of the time. The period since 2009 is char-
acterised by a new partnership between the scientific community and the government,
leading to the wide-scale implementation of ART and an increased focus on bringing
the TB epidemic under control (Mayosi et al., 2012).
2.1.2 Performance in terms of the millenium development goals
The millenium development goals (MDGs) are a set of eight developmental goals that
were formulated during the United Nations’ Millenium Summit in 2000. All of the 189
states that were members of the United Nations at the time agreed to strive to achieve
these goals by 2015. Achievement in terms of MDGs numbers 4, 5 and 6 can be used
as a measure to assess the performance of the healthcare system:
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1. MDG 4 states that infant mortality should be reduced by two thirds between
1990 and 2015. In the period between 1994 and 2008, the country’s performance
in terms of this goal deteriorated (Chopra et al., 2009). Since 2009, the country’s
performance has improved (Mayosi et al., 2012);
2. MDG 5 states that the number of maternal deaths per 100 000 live births should
be reduced by 75% between 1990 and 2015. The country’s performance with
regards to this metric was essentially static for the period 1994 to 2008 (Chopra
et al., 2009). Data on the performance since 2009 is contradictory, however Mayosi
et al. (2012) conclude that there might have been a slight improvement during
this period; and
3. MDG 6 sets targets for combating HIV/AIDS, malaria, TB and other diseases.
For both the period 1994 to 2008 (Chopra et al., 2009) and the period 2009 to
2012 (Mayosi et al., 2012), the Lancet’s review (a series of six articles reviewing
the state of the South African healthcare sector that are widely cited in literature)
concludes that South Africa has made insufficient progress in terms of achieving
this goal.
2.1.3 Healthcare spending
According to World Bank data (World Bank, 2013b), South African healthcare spend-
ing as a percentage of gross domestic product (GDP) is the highest in Africa over the
period for which data is available (an average of 8.4% between 1995 and 2011). Figure
2.1 compares South African healthcare as a percentage of GDP with that of the rest
of sub-Saharan Africa. Chopra et al. (2009) estimate that between 55% and 60% of
healthcare spending is in the private sector. World Bank data, summarised in Figure
2.2, shows that the percentage of the South African healthcare budget spent on public
healthcare has increased significantly from 39.9 % in 2006 to 47.7 % in 2011 (World
Bank, 2013b).
Public healthcare spending is dominated by tertiary hospitals with thirty percent
of the total public healthcare budget spent on super-tertiary hospitals located in Cape
Town, Johannesburg and Durban (Chopra et al., 2009). Specific programmes that
target HIV/AIDS are taking up an increasing proportion of the healthcare budget. In
the 2009 budget speech, the then minister of finance, Trevor Manuel, estimated that “if
10
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Figure 2.1: South African versus average sub-Saharan African (SSA) healthcare spend-
ing as a percentage of gross domestic product (GDP). (Data source: World Bank
(2013a).)
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Figure 2.2: South African versus average sub-Saharan African (SSA) public healthcare
spending as a percentage of total healthcare spending. (Data source: World Bank
(2013c).)
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the government health budget continues at its current level, 47% of it would be required
to provide first-line and second-line ART (anti-retroviral therapy) for all eligible South
Africans in 2014” (Mooney & Gilson, 2009).
Literature contains contradicting opinions on the sufficiency of healthcare funding.
Ruff et al. (2011) argue that, especially in comparison to our African peers, the avail-
able healthcare funding in South Africa is adequate. The authors refer to inefficiencies
in management and low productivity as the central problems that are preventing the
country from extracting adequate value from the funding that is being put into the pub-
lic healthcare system. In contrast to this, in an article that forms part of The Lancet’s
2009 review of the South African healthcare sector Abdool Karim et al. (2009) argue
that increased funding is necessary to rebuild physical healthcare infrastructure that
has been damaged by a sustained period of neglect. The article states that “the extent
to which the South African healthcare service is dysfunctional is generally underesti-
mated” and suggests that increased spending on healthcare infrastructure would assist
in adressing this problem. Several of the articles that form part of the Lancet’s 2009
review describe a paradox of persistently poor health outcomes in spite of the rela-
tively high healthcare spending in the country (Chopra et al., 2009). In its 2010/2011
– 2012/2013 framework document, the Department of Health (DoH) appears to agree
with the Lancet review’s observations when it states that the country’s healthcare out-
comes are not always commensurate with its GDP ranking (Department of Health,
2010).
2.1.4 Strategic goals and objectives
South Africa’s Medium Term Strategic Framework (MTSF) for the electoral mandate
period 2009 – 2014 was formally accepted by Cabinet in January 2010 (Department of
Health, 2010). This framework set the high-level developmental strategy for the country
as a whole and was intended to guide planning and the allocation of resources in all
government departments (The Presidency: Republic of South Africa, 2009). The MTSF
was drawn up in line with the country’s long-term goal of achieving the MDGs (The
Presidency: Republic of South Africa, 2009). The MTSF contains 20 key outcomes
which are to be achieved by the healthcare sector (Department of Health, 2010):
1. Increased life expectancy at birth;
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2. Reduced child mortality
3. Decreased maternal mortality ratio;
4. Managing HIV prevalence;
5. Reduced HIV incidence;
6. Expanded PMTCT programme;
7. Improved TB case finding;
8. Improved TB outcomes;
9. Improved access to ART for HIV-TB co-infected patients;
10. Decreased prevalence of multi-drug-resistant tuberculosis;
11. Revitalisation of Primary Health Care (PHC);
12. Improved physical infrastructure for healthcare delivery;
13. Improved patient care and satisfaction;
14. Accreditation of health facilities for quality;
15. Enhanced operational management of health facilities;
16. Improved access to human resources for health;
17. Improved healthcare financing;
18. Strengthened Health Information Systems (HIS);
19. Improved health services for the youth; and
20. Expanded access to home based care and community health workers.
In response to the MTSF, the DoH released a set of priorities commonly referred to
as the “10 Point Plan” (Health Systems Trust, 2010). These priorities were drawn up
in line with the country’s MTSF and aim to assist the country in achieving the MDGs
(Department of Health, 2010):
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1. Provision of strategic leadership and creation of a social contract for better health
outcomes;
2. Implementation of a National Health Insurance (NHI) plan;
3. Improving quality of health services;
4. Overhauling the healthcare system and improving its management;
5. Improving human resources planning, development and management;
6. Revitalisation of physical infrastructure;
7. Accelerated implementation of the HIV and AIDS and sexually transmitted in-
fections National Strategic Plan 2007 – 2011 and increased focus on TB and other
communicable diseases;
8. Mass mobilisation for better health for the population;
9. Review of the drug policy; and
10. Strengthening research and development.
Appendix A contains a table that describes the key activities to be executed to
achieve each of the priorities in the 10 Point Plan and indicates how these priorities and
activities align to the twenty healthcare outcomes listed in the MTSF. The appendix
also contains details on the quantified 2009 performance as well as the 2014 target for
each of the twenty MTSF healthcare outcomes.
The National Strategic Plan (NSP) on HIV, sexually transmitted diseases (STDs)
and TB 2012 – 2016 was drawn up by the South African National AIDS Council. The
NSP is intended to determine the strategic direction for the national, provincial, district
and community-level response to HIV, STDs and TB and it is aligned to the MTSF
(South African National AIDS Council, 2012). The NSP sets out the following four
strategic objectives:
1. Addressing social and structural barriers to HIV, STD and TB prevention, care
and impact;
2. Preventing new HIV, STD and TB infections;
14
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3. Sustaining health and wellness; and
4. Increasing the protection of human rights and improving access to justice.
2.1.5 HIV / AIDS in South Africa
South Africa has an estimated 6.1 million HIV positive individuals living in the country
(UNAIDS, 2013). This accounts for approximately 17.9% of the estimated 34 million
HIV positive individuals in the world (UNAIDS, 2011). There is consensus in literature
that this is the largest number of HIV positive individuals living in any one country
in the world. The country’s HIV epidemic has stabilised in recent years with data
indicating that the spread of the disease is starting to plateau (South African National
AIDS Council, 2012). The number of new infections per year decreased with 22%
between 2001 and 2009 (UNAIDS, 2011). Despite this, the country still has the largest
number of new infections per annum in the world (UNAIDS, 2011).
South Africa has the largest number of individuals that are co-infected with HIV
and TB in the world (UNAIDS, 2011) and TB is the leading cause of death for HIV
positive individuals in the country (UNAIDS, 2013). UNAIDS (2013) estimates that
330 000 of the 520 000 new TB cases diagnosed in South Africa in 2011 were co-infected
individuals. TB was declared a national emergency in the country in 2004 and South
Africa currently has the third largest TB burden in the world (South African National
AIDS Council, 2012). The high multi-drug resistant tuberculosis (MDR-TB) and exten-
sively drug resistant tuberculosis (XDR-TB) caseload has further complicated efforts to
combat the disease (UNAIDS, 2013). South Africa has adopted an integrated strategy
for the management of TB and HIV aimed at preventing HIV positive individuals from
developing TB (UNAIDS, 2013). An estimated 31% of co-infected individuals were
receiving treatment for both TB and HIV and an estimated 102 000 co-infected indi-
viduals were receiving ART in 2012 (UNAIDS, 2013). The number of deaths attributed
to TB in co-infected individuals in the country has decreased from 99 000 in 2004 to
88 000 in 2012 (UNAIDS, 2013).
There is no known cure for HIV, however, worldwide, ART is the preferred method
of treatment for people with HIV. HIV positive individuals who receive ART have a
lower likelihood of becoming ill or dying from AIDS, developing TB, and transmitting
both HIV and TB (UNAIDS, 2013). The positive impact of ART on health is illustrated
15
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by the 11.3 year increase in life expectancy in KwaZulu-Natal between 2003 (when ART
scale-up began) and 2011 (UNAIDS, 2013).
South Africa has the largest ART programme in the world. An estimated 1.8 million
people were receiving ART in April 2011 (Mayosi et al., 2012), by December 2012 the
minister of health estimated that the figure had increased to 1.9 million people (Mot-
soaledi, 2012) while UNAIDS (2013) estimated the 2012 figure at 2.01 million people.
To place the scale of the South African ART programme in perspective, India has the
second largest ART programme in the world with an estimated 570 000 individuals
receiving treatment (UNAIDS, 2013). According to the World Health Organisation
(WHO) 2010 guidelines, 81% of the approximately 2.5 million people who were eligi-
ble for ART in 2012 were receiving the treatment. The WHO published a new set of
guidelines for ART eligibility in 2013, under these guidelines, the number of eligible
individuals in the country increases to 5.1 million people (UNAIDS, 2013). At the time
of writing this thesis, South Africa was not complying with these new guidelines. It
is evident that it would require significant financial resources to essentially double the
number of individuals receiving ART. Table 2.1 lists the 20 biggest ART programmes
in the world and states the estimated ART coverage based on WHO 2010 guidelines.
The annual number of AIDS-related deaths in the country has reduced by 21%
between 2001 and 2010 (UNAIDS, 2011). In the 2011 World AIDS day report, UNAIDS
(2011) predicted that the substantial increase in the number of people receiving ART
between 2009 and 2010 in South Africa would most likely result in a significant reduction
in the number of new infections in the country. The organisation estimated that, at
the current levels of healthcare spending, the number of new infections will stabilise at
approximately 500 000 per year (UNAIDS, 2011).
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Table 2.1: Size and estimated coverage of the twenty biggest ART programmes in the
world (Data source: UNAIDS (2014)).
Country People on People needing Estimated ART
ART 1 ART 2 coverage 2,3
South Africa 2 150 881 2 695 092 80%
India 604 987 NA 50%
Kenya 604 027 827 624 73%
Zimbabwe 565 675 716 375 79%
Nigeria 491 021 1 537 092 32%
Zambia 480 925 605 416 79%
Uganda 438 542 681 587 64%
United Republic of Tanzania 432 293 710 095 61%
Malawi 405 131 584 394 69%
Brazil 313 175 NA NA
Mozambique 309 851 688 620 45%
Ethiopia 288 137 478 875 61%
Thailand 239 090 NA 76%
Botswana 212 083 211 946 95%
China 126 448 NA NA
Russian Federation 125 623 NA NA
Cameroon 122 783 275 662 45%
Namibia 116 687 129 221 90%
Rwanda 114 618 132 045 87%
Coˆte d’Ivoire 110 370 226 509 49%
[1] Based on Global AIDS Response Progress Reporting data.
[2] Based on national Spectrum files.
[3] Based on WHO 2010 Guidelines.
Abbreviations: NA, not available.
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2.2 Diagnostic service delivery in South Africa
Accurate diagnostic testing is essential for clinical diagnosis, monitoring of infectu-
ous diseases and directing public healthcare policy (Petti et al., 2006). In developed
countries, the majority of clinical decisions are based on the outcomes of diagnostic
laboratory tests and the appropriate use of laboratory medicine is increasingly being
recognised as a strategy for assisting countries in achieving the MDGs (Elbireer et al.,
2011). Nkengasong (2010) states that improving clinical and public health laboratories
is a key component of health systems strengthening.
2.2.1 The current service delivery model
Diagnostic service provision in the country exists in both the private sector and the pub-
lic sector. Within the public healthcare sector, diagnostic testing capabilities are pro-
vided exclusively by the National Health Laboratory Service (NHLS) (National Health
Laboratory Service Website, 2014). In addition to routine and specialist diagnostic
pathology testing facilities in all of the nine provinces, the NHLS contains four spe-
cialist units: (i) the National Institute for Communicable Diseases; (ii) the National
Institute for Occupational Health; (iii) the National Cancer Registry; and (iv) the
South African Vaccine Producers (National Health Laboratory Service Website, 2014).
The NHLS employs a tiered system of service provision where small primary and
district laboratories offer basic testing capabilities and selected sites in larger metropoli-
tan areas and academic hospitals offer more specialist testing capabilities (in addition to
the basic testing capabilities). This tiered system is aligned to the Maputo Declaration
on laboratory service provision that recommends that a tiered, integrated laboratory
network provides the best model for diagnostic service provision in resoure-limited set-
tings (Maputo Conference, 2008). The Maputo Declaration recommends four levels of
testing facilities:
1. Level I – Primary laboratories;
2. Level II – District laboratories;
3. Level III – Regional or Provincial laboratories; and
4. Level IV – National or Reference laboratories.
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Figure 2.3: The distribution of NHLS laboratories.
The NHLS operates in excess of 300 laboratories in the country, according to the cri-
teria defined in the Maputo Declaration, eight of these can be classified as Level IV
National or Reference laboratories (National Health Laboratory Service Website, 2014).
A 2006 study of diagnostic testing capablity in sub-Saharan Africa makes a generalised
statement that access to laboratory testing facilities is severly limited, but moderates
this statement by remarking that capabilities of laboratories vary widely accross the
region (Petti et al., 2006). Though access to laboratory testing in many sub-Saharan
African countries may be severly limited, it is clear that this cannot be said to apply
to South Africa. However, though the number of laboratories in the country may be
sufficient, it is less clear whether the equity of distribution of laboratory facilities is sat-
isfactory. When viewing the geographical distribution of laboratory facilities depicted
in Figure 2.3, these appear to be densely situated in some parts of the country and
sparsely situated in others.
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The NHLS relies on a well-developed transport network, generally operated by
couriers and porters that are employed by the NHLS, to transport diagnostic specimens
from clinics and hospital wards to local laboratories. All specimens are received and
registered on the NHLS Laboratory Information System at the local laboratory before
being referred on to other laboratories for more specialised testing, as required. The
NHLS also offers private pathology providers in the country a referral service for tests
that are not requested frequently or are expensive to provide.
The South African Minister of Health was one of seven African Ministers of Health
that signed the African Society for Laboratory Medicine’s 2012 Ministerial Call for
Action to Strengthen Laboratory Services in Africa (International Conference of the
African Society for Laboratory Medicine, 2012). The Call for Action acknowledges the
Maputo Declaration, it places emphasis on the importance of ensuring that there is a
sufficiently large, professional, quality laboratory workforce and declares a commitment
towards developing harmonised policies to govern the quality of diagnostic products and
medical devices in Africa (International Conference of the African Society for Labora-
tory Medicine, 2012).
South Africa also provides support for laboratory services elsewhere in Africa. An
example of this is the South African National Accreditation System that is used to
accredit certain laboratories outside of the country’s borders (Olmsted et al., 2010).
Another example is the NHLS’ National Institute for Communicable Diseases that,
in collaboration with the WHO and PEPFAR (President’s Emergency Plan for AIDS
Relief), established the African Center for Integrated Laboratory Training (ACILT)
(Nkengasong et al., 2010). ACILT provides training to laboratory personnel from ac-
cross Africa and ACILT training staff perform follow-up visits to provide additional
support (Nkengasong et al., 2010).
2.2.2 Point of care testing
Ehrmeyer & Laessig (2007) summarised the many definitions of point of care (POC)
testing as follows: “patient specimens assayed at or near the patient with the assump-
tion that test results will be available instantly or in a very short timeframe to assist
caregivers with immediate diagnosis and / or clinical intervention”. POC is a relatively
new development in diagnostic testing that shifts the point of analysis from a labora-
tory environment, that is typically situated at some distance from the patient, to the
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point of care (i.e. to the patient’s bedside or to the clinic consultation room). In the
South African context, POC testing devices have also been situated at primary and
district laboratories as a means of decentralising analytical capabilities and bringing
these closer to the patient. The characteristic of POC testing are discussed in more
detail in the next subsection.
The following POC tests are relevant within the management of the TB and HIV
epidemics in South Africa:
1. The Cepheid GeneXpert MTB/RIF test for the diagnosis of TB. This test is
currently being used as part of South Africa’s diagnostic service delivery model.
It is discussed in more detail in Subsection 2.2.2.2;
2. Rapid / simple tests for the diagnosis of HIV. These tests are also currently being
used as part of the country’s diagnostic service delivery model and are discussed
in more detail in Subsection 2.2.2.3;
3. CD4 measurement for the measurement of HIV. A POC CD4 test has recently
become commercially available, it is the purpose of this study to recommend
whether this device should be used in South Africa and, if it is to be used, how it
should be integrated with the existing diagnostic service delivery model. This is
introduced in Subsection 2.2.2.4 and discussed in more detail in Section 2.3; and
4. HIV Viral load monitoring. Viral load monitoring forms part of the management
process for patients that are on ART. POC viral load testing technology is not
currently available, although it is expected that such technology will become
available in the future. Ths is referred to briefly in Subsection 2.2.2.4.
2.2.2.1 Charateristics of POC
POC testing varies widely in terms of the complexity of the analysis. For example,
many rapid HIV tests rely solely on the reaction that occurs when a drop of blood is
placed on a test strip. In contrast to this, the GeneXpert device that is used widely
throughout South Africa for TB analysis, involves a full polymerase chain reaction
(PCR) analysis that takes place within the bench-top analyser. In spite of the varying
complexity of the analysis, a key characteristic of a POC test is that the operator
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should require no or minimal scientific training in order to execute the test accurately
(Anderson et al., 2011).
Another key characteristic is that the reagents and consumables required for the
test need to be able to withstand a wide range of temperatures and have a long shelf
life, this sets POC apart from typical laboratory tests where the monitoring and control
of reagents and their storage conditions is a necessary component of quality control.
Anderson et al. (2011) suggest a shelf life exceeding at least six months at ambient
conditions (where ambient conditions can vary from more than 40◦C to below 0◦C). The
ability of the test itself to be performed outside of a temperature-controlled environment
is also important (Anderson et al., 2011).
There is consensus in literature that POC testing should be “rapid”. There is no
exact definition for the time-frame that constitutes rapid testing, and POC testing time
varies from a few minutes (e.g. in the case of HIV diagnosis) to a few hours (e.g. in
the case of GeneXpert MTB/RIF for TB). However, there is consensus that the testing
should occur while the patient waits, so that, even in cases where it is not possible to
initiate treatment immediately, the patient leaves the clinical encounter with certainty
regarding their diagnosis and with a clear idea of the way forward (Pai et al., 2012).
2.2.2.2 Existing POC testing in South Africa: TB diagnosis
Pai et al. (2012) describes POC testing as a particularly powerful tool for the manage-
ment and control of infectious diseases. In South Africa, rapid testing for HIV diagnosis
and GeneXpert MTB/RIF for TB diagnosis have been implemented on a large scale in
recent years.
In 2010, the WHO endorsed the use of the GeneXpert MTB/RIF test for patients
who are suspected of having either MDR-TB or being co-infected with HIV and TB, this
description encompasses the majority of suspected TB patients in South Africa (Meyer-
Rath et al., 2012). At this point in time, the most common method of testing for TB
was through a combination of smear microscopy and culture. The smear microscopy
technique is more than 125 years old and is unable to detect drug-resistance (Van Rie
et al., 2010), it also has a poor ability to detect TB in HIV positive individuals1. Culture
for the detection of TB is the so-called “gold standard” of testing, however the test has
1Getahun et al. (2007) cites 15 different publications to give a range of between 24% and 61% of
HIV positive TB patients testing smear negative.
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a turnaround time of between two and six weeks and requires a biosafety level1 two or
three facility, which cannot be easily provided in remote settings (Van Rie et al., 2010).
Long turnaround time is a particular concern in the diagnosis of MDR-TB, with a study
conducted prior to the implementation of Cepheid GeneXpert technology finding that
33% of MDR-TB patients passed away and 16% could not be traced by the time that
the laboratory-confirmed MDR-TB diagnosis (based on culture) was available (Heller
et al., 2010).
In March 2011, the DoH announced a nationwide implementation of the Cepheid
GeneXpert device to replace smear microscopy. The goal was to improve the accuracy
of TB detection and to ensure that drug resistant TB cases are detected early so that
appropriate treatment can be initiated timeously (Mayosi et al., 2012). The imple-
mentation was to be achieved in a two to three year timeframe (Meyer-Rath et al.,
2012).
As of 2012, South Africa has the largest Cepheid GeneXpert MTB/RIF testing
programme in the world (Mayosi et al., 2012) with 37% of global Cepheid GeneXpert
instrument sales and 53% of global Cepheid GeneXpert cartridge sales being attributed
to the country (Health Systems Trust, 2013). By March 2013, South Africa had more
than 290 Cepheid GeneXpert devices being operated in more than 140 centres and
almost 1.2 million tests had been performed (UNAIDS, 2013).
In a study that aimed to quantify the likely impact and cost of the Cepheid Gen-
eXpert implementation in South Africa, Meyer-Rath et al. (2012) estimated that, once
the implementation of the device had been completed, an additional 30% to 37% of
TB cases would be diagnosed per year (this would include an estimated additional 69%
to 71% of MDR-TB cases). Furthermore, the study found that 81% of patients would
be diagnosed after their first visit (versus 46% before the Cepheid GeneXpert imple-
mentation). The study estimated that the cost of TB diagnosis alone would increase
by 55% while the total treatment cost per TB case would increase by 8% (Meyer-Rath
et al., 2012). In South Africa’s 2013 budget estimate, the National Treasury credits the
1A facility’s biosafety level classification is determined based on a wide range of factors, including
(i) attributes of the physical infrastructure such as the ventilation system, access control and the
availability of emergency infrastructure such as eye wash stations; (ii) the level of training of the
personnel as well as the type of supervision that is present in the facility; and (iii) the standard
operating procedures that govern safety aspects such as the handling of sharp materials, the transport
of specimens and materials, and the decontamination of work surfaces.
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implementation of the Cepheid GeneXpert technology with strengthening the country’s
TB subprogramme and allocates an additional R338 million to cover the higher testing
costs associated with the Cepheid GeneXpert (National Treasury, 2013).
At present, the Cepheid GeneXpert is being implemented in laboratories (includ-
ing those located at district hospitals) throughout the country. Lessells et al. (2013)
describes the design of a study to compare the impact on the timely initiation of appro-
priate TB treatment when the Cepheid GeneXpert is located in the primary healthcare
clinic itself rather than centrally at a district hospital. This study is currently under
way.
2.2.2.3 Existing POC testing in South Africa: HIV diagnosis
POC testing for the diagnosis of HIV is widely used in South Africa and around the
world. In 2010, the South African DoH introduced a voluntary HIV counselling and
testing initiative with the aim of expanding its ART programme. Twelve million people
were tested during a twelve month period (Glencross et al., 2012).
There are a large number of companies that produce and supply assays for the detec-
tion of HIV antibody. The WHO states that of the 29 assays that have been evaluated
in recent years, 19 were so-called “simple” or “rapid” tests that do not require any
equipment other than the consumables and reagents used (World Health Organisation,
2014). In its latest report on the operational characteristics of HIV rapid diagnostic
tests, the World Health Organisation (2013b) evaluated eight assays, with a testing
time that varied between two minutes and 17 minutes for a single specimen. Plate
(2007) reviewed the implementation of POC for HIV diagnosis in 11 African countries,
as part of the review 15 rapid assays were evaluated. The study defines rapid HIV
tests as tests that provide results within 30 minutes and require minimal equipment
and training. Eight of the 15 assays that were evaluated were based on the lateral flow
principle, these assays do not require any reagents other than that contained in the
test device itself and none of these test devices require refrigeration. Wu & Zaman
(2012) agree that rapid tests that are based on the lateral flow principle are the most
ready-to-use, the study also defines rapid tests as assays that provide results within 30
minutes and require minimal or no reagents or equipment. Due to the high sensitivity
and high specificity achieved by rapid HIV assays, these tests are included alongside
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other laboratory-based tests for HIV diagnosis as gold standard technologies (Wu &
Zaman, 2012).
In a review of low-cost diagnostics tools, Wu & Zaman (2012) credit rapid HIV
tests with significantly increasing both (i) the number of individuals that are tested for
HIV; and (ii) the number of HIV positive individuals that receive their results before
being lost to follow-up. Anderson et al. (2011) describe the positive effect that rapid
POC tests for HIV diagnosis has had on healthcare provision, especially in remote
areas where timely availability of HIV results have: (i) assisted in the prevention of
mother-to-child transmission (PMTCT); (ii) improved the uptake of voluntary testing;
and (iii) reduced the loss of patients to follow-up.
2.2.2.4 The next step in POC testing: CD4 measurement
As discussed in Subsection 1.1, a device for POC CD4 testing, the Alere PIMA has
recently become commercially available. Evidence suggests that the use of POC CD4
testing for governing the initiation onto ART can improve healthcare outcomes by
reducing the number of patients that are lost to follow-up (Wynberg et al., 2014).
Consequently, there is a need to evaluate whether this device should be used as part of
diagnostic service provision in South Africa’s public healthcare sector. This is the real-
world problem being investigated in this thesis. This real-world problem is discussed
in detail in the following section.
2.3 The real-world problem: Should POC CD4 testing be
implemented in South Africa
Section 1.2 briefly described the ART initiation pathway, the role of CD4 testing in
this process and the concept of loss to follow-up. These concepts are now discussed in
more detail.
2.3.1 The role of CD4 testing in the ART initiation pathway
CD4 testing is used as the mechanism that governs ART initiation for the majority of
HIV positive patients in South Africa. The exception is target groups that are initiated
onto ART as soon as HIV is diagnosed. Target groups include pregnant women, patients
with TB and sero-discordant couples .
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Figure 1: ART initiation decision tree.
1
Figure 2.4: ART initiation decision tree.
Figure 2.4 depicts the process from HIV diagnosis to the initiation of ART. As
shown, patients that do not form part of target groups for immediate ART initia-
tion have their CD4 count tested after they are diagnosed as being HIV positive. If
their CD4 count falls below the threshold value, they are initiated onto ART. If their
CD4 cell count falls above the threshold value, their CD4 cell count is tested at a set
time interval until it falls below the threshold value and they are initiated onto ART.
Currently, WHO regulations stipulate an ART initiation threshold of 500 cells/mm³
(World Health Organisation, 2013a). As stated in Subsection 2.1.5, South Africa is still
operating according to the previous WHO recommended threshold of 350 cells/mm³.
In South Africa, the set interval for CD4 testing prior to ART initiation is six months
for individuals with a CD4 count of less than 500 cells/mm³ and twelve months for
individuals with a CD4 count of more than 500 cells/mm³ (Lessells et al., 2011).
Though it is not necessary for determining their eligibility for ART, patients that
form part of the target groups for immediate ART initiation also receive a CD4 test
following a positive HIV diagnosis. Thus, any person that tests HIV positive, should
have a CD4 test performed following this diagnosis.
After ART initiation, patients receive both CD4 tests and HIV viral load tests at
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set intervals as part of the monitoring process for patients on ART. At present, HIV
viral load testing is not available as a POC test, as such, it falls outside the scope of
this study. CD4 testing as part of the monitoring process for patients receiving ART
also falls outside the scope of this discussion, as it is not expected that implementing
POC at this point will have any impact on loss to follow-up, the primary driver of
improved health outcomes being investigated in this study. However, if POC CD4
testing capability is provided at a site, it is reasonable to assume that healthcare workers
at this site will use the POC device for all CD4 tests performed at this site. As such,
the volumes of CD4 tests that are performed as part of ART monitoring at each site
must be included in the scope of this study.
According to the Maputo declaration, CD4 testing should be offered at all Level II,
Level III and Level IV laboratories (Maputo Conference, 2008).
2.3.2 Loss to follow-up and the expected impact of CD4 testing
The concept of loss to follow-up was briefly described in Section 1.2 and referred to
again in Subsections 2.2.2.3 and 2.2.2.4. Within the context of HIV care, the term
“loss to follow-up”, is used to refer to HIV positive patients that no longer come to
a healthcare facility to receive monitoring or treatment for this disease. There are a
number of points in the HIV care pathway where patients can be lost to follow-up. The
term “lost to programme” includes both patients that have been lost to follow-up as
well as patients that have passed away during any given stage of the care pathway.
2.3.2.1 Loss to follow-up in the HIV care pathway
Mugglin et al. (2012) conducted a systematic review of 29 studies from sub-Saharan
Africa in order to estimate the losses at various stages prior to initiation onto ART.
Figure 2.5 depicts the pathway from HIV diagnosis to initiation onto ART and indicates
where losses occur.
The left section of Figure 2.5 shows the stage from HIV diagnosis to CD4 testing.
As mentioned in Subsection 2.3.1 any patient that has tested positive for HIV (e.g.
through a rapid test for HIV diagnosis) should have a CD4 test performed, regardless
of whether this patient forms part of one of the target groups for ART initiation.
However, in a meta-analysis of studies covering the period from HIV diagnosis to ART
initiation, Mugglin et al. (2012) estimate that only 72% of patients that test positive
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Figure 2.5: Routes from HIV diagnosis to ART initiation (Mugglin et al., 2012).
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for HIV have their CD4 count measured (“CD4 test sample taken” in Figure 2.5). The
figure shows that a portion of HIV positive patients that do not receive a CD4 cell
count are clinically staged, this clinical staging is not a part of the standardised pre-
ART care pathway and it is unclear whether these patients eventually start ART. The
remainder of the patients who do not receive a CD4 test at this point are considered
lost to the programme. (As stated in Subsection 2.3.2 “Lost to programme” includes
patients that are lost to follow-up as well as patients that have passed away.)
The study classified a CD4 count as being completed (“CD4 test completed” in
Figure 2.5) if the CD4 count was performed within a set time frame after HIV diagnosis
and the patient was informed of the CD4 result. Few of the studies reviewed by Mugglin
et al. (2012) measured the percentage of patients that received the result of their CD4
test. In a study conducted at a large HIV/AIDS clinic in South Africa between January
2008 and February 2009, Larson et al. (2010) found that 65% of patients who had a
sample taken for CD4 testing did not complete this testing within 12 weeks of testing
positive for HIV.
The middle section of Figure 2.5 depicts stage two, assessment of eligibility for ART.
Through meta-analyses, Mugglin et al. (2012) found that 40% of patients that tested
positive for HIV were eligible for ART initiation at this stage.
The right section of Figure 2.5 depicts stage three, from eligibility assessment to
the start of ART. As shown in the figure and discussed previously in this section,
patients that are not yet eligible for ART should be enrolled into pre-ART care (where
they will continue receiving a CD4 test at set time intervals until they are eligible for
ART initiation). Patients that do not enter pre-ART care are considered lost to the
programme. Though it falls outside the bounds of the Mugglin et al. (2012) study, it
is important to note that patients that are enrolled in pre-ART care may stop coming
for CD4 tests and become lost to follow-up prior to ART initiation.
Through meta-analysis, Mugglin et al. (2012) found that 63% of patients that are
eligible for ART are successfully initiated onto treatment. As shown in Figure 2.5, the
remainder of these patients are either waiting for ART or are lost to the programme.
The “waiting for ART” step is not part of the official pre-ART care pathway although
studies show that some of these patients are eventually initiated onto ART.
Though it falls outside of both the scope of this thesis and the scope of the study
conducted by Mugglin et al. (2012), it is important to note that not all of the patients
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that are initiated onto ART continue with this treatment until death, these patients
are categorised as lost to follow-up after initiation of ART.
In summary, Mugglin et al. (2012) found that in total 13% of ART eligible patients
and 57% of ART ineligible patients were lost to follow-up before the initiation of ART.
As mentioned in Subsection 2.3.2.1, the 57% does not include the number of patients
that were enrolled in pre-ART care but were later lost to follow-up before being initiated
onto ART.
2.3.2.2 The expected impact of POC CD4 testing on loss to follow-up
In recent years, several publications (including Anderson et al. (2011), Zachariah et al.
(2011) and Boyle et al. (2012)) have argued that POC CD4 testing has the potential
to reduce the loss to follow-up in the HIV care pathway. POC CD4 testing could be
conducted immediately after rapid HIV diagnosis so that a newly diagnosed patient
would know on the same day of treatment whether they are eligible for ART. With
the exception of patients who choose not to have a CD4 test conducted after testing
positive for HIV, such an approach could potentially ensure that all newly diagnosed
HIV positive patients have their ART eligibility determined after diagnosis (the end of
stage two in Figure 2.5). Even in cases where CD4 testing is not conducted on the same
day as HIV diagnosis, POC CD4 testing should eliminate the loss to follow-up between
having a CD4 test conducted and receiving the CD4 result. (This loss was estimated
by Larson et al. (2010) and is discussed in Subsection 2.3.2.1.) Finally, it is reasonable
to assume that POC CD4 testing would have an impact on the loss to follow-up rate
of patients enrolled in pre-ART care.
Zachariah et al. (2011) give the following reasons for an urgent need for POC CD4
testing in low income contries:
1. To assess eligibility for ART;
2. To start ART earlier;
3. To improve PMTCT uptake (this is not applicable in South Africa as pregnant
women form part of the target group that are initiated onto ART regardless of
CD4 count);
4. To simplify ART (initiation) at the primary care level;
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5. To enhance task shifting (i.e. to ensure that ART initiation can be conducted at
remote healthcare facilities). This has limited applicability to South Africa where
ART initiation is already conducted at remote healthcare facilities; and
6. To reduce early attrition from programmes (this refers to the loss to follow-up
prior to ART initiation).
Following the commercial availability of POC CD4 testing capabilities, a number of
studies have measured the impact of POC CD4 testing on loss to follow-up. Wynberg
et al. (2014) conducted a systematic review of 15 studies (published between 2011 and
2013) and found that:
1. POC CD4 testing increased the percentage of HIV positive patients that proceed
to have a CD4 test;
2. POC CD4 testing increased the percentage of patients that received the result of
their CD4 test;
3. POC CD4 testing reduced the time between HIV diagnosis and CD4 testing;
4. POC CD4 testing reduced the time from CD4 testing to receiving the test result;
and
5. There is mixed evidence for increased ART initiation due to POC CD4 with two
South African studies finding that patients were respectively three times more
likely and six times more likely to initiate and a third South African study finding
that there was no difference in the likelihood of eligible patients initiating ART.
The expected impact of POC CD4 testing on the pre-ART initiation loss to follow-
up rate is quantified in Subsection 5.1.8.
2.3.3 CD4 testing methods
This section begins with a description of laboratory-based CD4 testing technology
before providing an overview of the emerging field of POC CD4 testing technology.
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2.3.3.1 Laboratory-based CD4 testing
CD4 testing is traditionally laboratory based. The current gold standard technology
for CD4 measurement is flow cytometry (Wu & Zaman, 2012). By 2008, the simplified
single platform PanLeucogated CD4 methodology was being used in 52 NHLS labora-
tories in South Africa (Glencross et al., 2008) and it is the predicate methodology used
by the NHLS (Glencross et al., 2012). This methodology makes use of flow cytome-
try devices such as the BD FACSCalibur and the BD FACSCount to perform CD4
testing. This method forms the reference standard against which POC CD4 testing in
South Africa should be evaluated.
2.3.3.2 POC CD4 testing technology
Both Anderson et al. (2011) and Zachariah et al. (2011) stated that reliable, cost-
effective, and time-effective POC CD4 testing was not yet widely available. Anderson
et al. (2011) made specific mention of the limited commercial release of the Alere
PIMA analyser and its disposable test cartridges as a start to meeting the need for
POC CD4 testing technology. A year later, Wu & Zaman (2012) conducted a review of
mechanisms for diagnosing and monitoring HIV in low-resource settings and found that
a number of technologies, including the Alere PIMA had recently become available. In
the same year, Boyle et al. (2012) conducted a review of emerging technologies for CD4
testing and identified nine existing or emerging POC CD4 test technologies, including
the Alere PIMA. Table 2.2 is taken from Boyle et al. (2012) and summarises the
identified POC CD4 technologies and their specifications.
As shown, the PointCareNOW, CyFlow® miniPOC and Alere PIMA are the
only POC CD4 technologies that are being marketed for which the instrument has al-
ready been developed. Of these three existing commercially available POC CD4 testing
methods, the Alere PIMA is the only one that does not make use of flow cytometry
(Boyle et al., 2012). The PointCareNOW requires specialist skills (phlebotomy) to
take a venous sample in order to provide a sufficient amount of blood for the test. It is
essential that adequate quality control measures are in place to ensure that specimen
preparation, equipment and reagents are functional, especially in POC settings where
testing is performed outside of the controls that are associated with a traditional labora-
tory environment. Boyle et al. (2012) mention only the Alere PIMA as incorporating
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quality control indicators for these three aspects.
When evaluating the characteristics of the PointCareNOW, the CyFlow® miniPOC
and the Alere PIMA as summarised in Table 2.2 against the desired characteristics for
a POC CD4 device as summarised in Table 2.3, it becomes evident that none of these
devices posess all of the desired characteristics. However, though the Alere PIMA
does not comply with all of the requirements set out, the fact that it uses a capillary
blood sample, is based on simple technology and has quality control procedures in
place, makes it the technology that is most ready for implementation in low-resource
settings. This is why the Alere PIMA CD4 testing technology was selected for use in
this study.
Table 2.3: Interpretation of WHO ASSURED criteria for POC CD4 technology.
Wu & Zaman (2012) interpretation
of ASSURED criteria for POC CD4
testing in low-resource settings
Desirable characteristics for a POC
CD4 test for low-income countries
as defined by Zachariah et al. (2011)
Affordable
Less than USŁ500 per testing device.
Less than USŁ10 per test. Between USŁ1 and USŁ2 per test.
Sensitive and specific
Lower limit of CD4+ detection 350 cell-
s/mm³.
The test should be robust and reliable so
that repeat testing is not required.
User-friendly
The device should be easy to use. The test should be simple to use. (Dip
stick or lateral flow technology is prefer-
able.)
No more than one to two days of training
should be required.
Use non-venous blood so that specialist
skills (such as phlebotomy) are not re-
quired for sample collection.
Results should be easy to read.
Rapid and robust
Less than 90 minutes testing time. Testing time should be short (preferrably
10 minutes).
Continued on next page
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Wu & Zaman (2012) interpretation
of ASSURED criteria for POC CD4
testing in low-resource settings
Desirable characteristics for a POC
CD4 test for low-income countries
as defined by Zachariah et al. (2011)
Reagent / kit shelf life of more than one
year at room temperature.
The test kits and consumable should have
a shelf life of at least fifteen months and
should ideally be able to withstand tem-
peratures of up to 40◦C.
A minimal amount of consumables should
be required.
A high throughput is required.
Equipment-free
A compact, battery powered device. If possible, no electronic instrumentation
should be required.
Data analysis to be conducted on-site.
Easy sample handling.
No cold chain required for reagents or
kits.
The test kits and consumable should not
require a cold chain.
Easy disposal of all waste that is gener-
ated.
It should be easy to dispose of all waste
safely.
Deliverable to end-users
The device should be portable and pre-
ferrably hand-held.
It must be possible to adapt the test to
a quality assurance programme that can
ensure that tests are functioning properly
and results are reliable.
The performance of the Alere PIMA CD4 test has been evaluated in studies by
Mwau et al. (2013), Glencross et al. (2012), Manabe et al. (2012), Sukapirom et al.
(2011) and Mtapuri-Zinyowera et al. (2010). All of these studies compared the per-
formance of the Alere PIMA to that of gold standard laboratory-based CD4 testing.
The findings differed across the various studies, with some studies classifying the Alere
PIMA’s performance as satisfactory and other studies recommending that the tech-
nology should be refined or further quality control mechanisms should be incorporated
before the device will be ready for use in the field. The most important findings are
summarised below:
1. Manabe et al. (2012) found that CD4 cell counts were negatively biased at higher
absolute numbers and noted that this will limit the test’s usefulness as a moni-
toring device for patients on ART. Sukapirom et al. (2011) also found the CD4
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cell count obtained by the Alere PIMA to be lower than that obtained by the
gold standard technology and agrees with Manabe et al. (2012) that this occurs
more often in samples with a higher absolute CD4 count. Sukapirom et al. (2011)
did not find this negative bias to be statistically significant. Mwau et al. (2013)
also found the CD4 cell counts to be lower than those measured by the laboratory
gold standard, but this finding was not limited to higher absolute CD4 cell counts.
Glencross et al. (2012) found positive bias during rural clinic field studies, but
noted that, with additional support from the manufacturer, this bias was reduced
during a subsequent inner-city clinic field study;
2. Mwau et al. (2013) found the precision of the Alere PIMA to be unaccept-
able and the repeatability of the test to be less than the rate reported by other
evaluations of the technology and recommended that the technology should be
further refined to address these problems. Sukapirom et al. (2011) found the Alere
PIMA to give “highly precise and reproducible results”. Glencross et al. (2012)
concluded that the variable precision of the Alere PIMA test during various
stages of the study could be attributed to variable capillary sampling techniques
and recommended that adherence to the specified capillary sampling technique at
the POC is of paramount importance. The authors noted that the development
of a capillary sampling quality control method by Alere was being awaited. Mwau
et al. (2013), Manabe et al. (2012) and Mtapuri-Zinyowera et al. (2010) found
that using the Alere PIMA with either venous blood samples or finger pricks
(capillary sampling) yielded satsifactorily similar results;
3. Mtapuri-Zinyowera et al. (2010) found that there was no significant difference
in the results obtained when the test was performed by a laboratory technician
versus when it was performed by a nurse; and
4. Sukapirom et al. (2011) noted the fact that the test can only provide the absolute
CD4+ T-lymphocyte count rather than the frequency of the CD4+ T-lymphocyte
count as a limitation and noted that it would be good if the technology can be
expanded to include this capability in the future.
As is evident from the discussion on the performance evaluation studies being con-
ducted on the Alere PIMA above, the device is currently being evaluated in pro-
36
Stellenbosch University  https://scholar.sun.ac.za
2.3 The real-world problem: Should POC CD4 testing be implemented in
South Africa
gramme settings. As such, data gathering on the cost of using the device is on-going.
Larson et al. (2012) developed a standardised methodology for estimating the cost per
test for POC CD4 testing from the provider’s perspective so that data from differ-
ent studies can be compared accurately. As mentioned in Section 1.2, studies in South
Africa have found that POC CD4 testing is more expensive than traditional laboratory-
based testing. The difference in the cost per test for laboratory-based CD4 testing and
POC CD4 testing is quantified in Subsection 5.1.4.
2.3.4 Possible changes to the current service delivery model that are
to be investigated
South Africa has more than 7 000 DoH public healthcare facilities, including hospitals,
clinics and community healthcare centres, where services are provided to patients. ART
initiation services are available at approximately 3 600 of these sites.
The country has more than 300 public healthcare laboratories (NHLS laboratories)
that are responsible for providing diagnostic testing services to the patient-serving DoH
facilities, 61 of these NHLS laboratories offer CD4 testing.
The purpose of this study is to investigate whether POC CD4 testing should be used
in South Africa and how it should be incorporated into the diagnostic service provision
model (if it is to be used). In order to answer this question, it is necessary to investigate
the financial impact and the health impact of a number of different scenarios – these
scenarios should include a scenario where no POC CD4 testing is used, a scenario
where no laboratory-based CD4 testing is used as well as a number of scenarios where
a combination of POC CD4 testing and laboratory-based testing is used. For each
scenario, the following decisions must be made:
1. For each of the ART initiation facilities, a decision must be made to either provide
POC CD4 testing capability at the healthcare facility itself, or not; and
2. For each ART initiation site where POC testing capability will not be provided,
it is necessary to determine to which of the existing CD4 laboratories the facility
should refer its CD4 samples.
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2.4 Conclusion: The real-world problem
This chapter described the real-world problem by providing background on the current
state of healthcare delivery in South Africa as well as the medium-term goals and
objectives for public healthcare in the country. The current diagnostic service delivery
model was discussed, with emphasis placed on the current role of POC testing in HIV
and TB treatment. Finally, the Alere PIMA device for CD4 testing was introduced
and the possible changes to the diagnostic service delivery model that are to be explored
in this study were defined.
The following chapter will discuss the role of Operations Research in supporting
decision-making within healthcare and will introduce the field of location science.
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Operations Research and location
science in healthcare
The real-world problem was introduced in Chapter 2 through a description of the state
of healthcare in South Africa, including the diagnostic service delivery model.
This chapter describes the role of Operations Research in supporting decision-
making within the healthcare sector and introduces the field of location science and
its application to healthcare.
3.1 Operations Research and healthcare
3.1.1 Operations Research
The science of Operations Research is a well-established field, academically as well as
in industry. Here, the field is briefly introduced through a definition of Operations
Research as well as a description of the most important concepts that are necessary for
understanding the remainder of this document.
The field of Operations Research can be traced back to early attempts to incorpo-
rate scientific methods into the management of organisations. The name Operations
Research was first used during the Second World War when mathematical modelling
and optimisation techniques were employed in the management of military services.
During the post-war industrial boom, the same types of questions that had been an-
swered in a military context arose in industry, and the field of Operations Research
grew as new applications were developed (Hillier & Lieberman, 2010).
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Winston (2004) gives the following definition for Operations Research: “Operations
Research (often referred to as management science) is simply a scientific approach to
decision-making that seeks to best design and operate a system, usually under condi-
tions requiring the allocation of scarce resources.” Winston (2004) describes a system
as an organisation of interdependent components that work together to establish a
common goal. The scientific approach to decision-making usually entails the use of one
or more mathematical models (Winston, 2004).
The mathematical models used have three key components: (i) the objective func-
tion(s); (ii) the decision variable(s); and (iii) the constraint(s). Optimisation is the
process of searching for the value(s) of each of the decision variables that simulta-
neously satisfy all of the given constraints and optimise (maximise or minimise) the
value(s) of the objective function(s) (Winston, 2004).
The mathematical models used in Operations Research can be classified according
to various criteria. Some of the most commonly used classifications that are relevant
to subsequent discussions in this document are (Winston, 2004):
1. Static vs. Dynamic: In static models, the values of coefficients and constants in
the objective function and constraint equations are assumed to remain fixed over
time. In dynamic models, these values do not remain constant over time;
2. Deterministic vs. Stochastic: In deterministic models, the values of coefficients
and constants in the objective function and constraint equations are assumed to
be known with certainty. In stochastic models, these values are represented by
statistical or empirical distributions because they are not known with certainty;
3. Continuous vs. Discrete: In continuous models, decision variables may assume
any (non-integer) value, in discrete models, decision variables may only assume
set (usually integer) values; and
4. Single-objective vs. Multi-objective: Multi-objective optimisation models contain
two or more conflicting objectives. For this reason, no single, optimal solution to
a multi-objective optimisation model exists. Rather, the optimal solution set is
a collection of solutions known as a Pareto set. A solution is a member of the
Pareto set if it is not possible to improve the performance of the solution in terms
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of any one of the objectives without decreasing its performance in terms of at
least one of the other objectives.
The process of optimising (solving) a mathematical model may require a large
amount of computational effort. The development of different solution methods for
mathematical models represents an independent research field within Operations Re-
search. At present, three main solution methods exist:
1. Exact Algorithms: An exact algorithm is a defined search procedure that guar-
antees that the solution that is generated is the optimum answer to the problem.
The use of an exact algorithm can become infeasible due to the computational
effort required for certain mathematically complex problems. Exact algorithms
can not be applied to problems with more than one objective function;
2. Heuristics: Heuristics are most often developed with the purpose of solving a
specific problem efficiently. Like exact algorithms, heuristics also define a search
procedure, however, unlike exact algorithms, there is no guarantee that the an-
swer that is generated is in fact the optimum answer to the problem (Hillier &
Lieberman, 2010); and
3. Metaheuristics: A metaheuristic is a more high-level search procedure that may
incorporate the use of heuristics. A metaheuristic incorporates feedback proce-
dures that enables it to search through the potential solutions in an attempt to
generate solutions that are closer to optimal as it goes along. In contrast to heuris-
tics that are generally developed with the purpose of solving a specific problem
type, metaheurstics can be used to solve a wider variety of problems. As with
heuristics, there is no guarantee that the final solution that is proposed is the
optimum solution to the problem. Metaheuristics are useful in solving problems
that are too computationally burdensome to be solved by exact algorithms as
well as problems with more than one objective function.
Computational complexity theory is concerned with quantifying the complexity of solv-
ing any given problem. The concept of polynomial time is one of the methods that are
used to quantify computational complexity. The term “NP-hard” will be used later in
this chapter, the following brief descriptions of complexity classifications are given in
order to provide a sufficient understanding of the term “NP-hard”:
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1. A problem can be classified as P (i.e. as being of polynomial time) if it can be
solved (by a theoretical computer, called a Turing machine) in a time that does
not exceed a polynomial expression that has been defined in terms of the problem
size;
2. A problem is classified as NP if it can be verified on a non-deterministic Turing
machine in polynomial time. From this definition it follows that all problems
that are classified as P can also be classified as NP. However it is unclear whether
the inverse is true. This question (whether NP = P) is considered to be one of
the most important questions that currently exist in mathematics (Anthonissen,
2007);
3. Cook (1971) proved the existence of subset of NP problems called NP-complete
problems. A problem (call the problem Ψ) can be classified as NP-complete if
any NP problem can be reduced to Ψ by a Turing machine in polynomial time;
and
4. A problem is classified as NP-hard if it is at least as computationally complex
as the most complex NP problems. More formally, a problem (call the problem
Ω) can be classified as NP-hard if there exists an NP-complete problem that can
be reduced to Ω by a Turing machine in polynomial time (Anthonissen, 2007).
NP-complete problems are a subset of NP-hard problems. NP-complete problems
include all problems that can be classified as both NP and NP-hard. The set of
NP-hard problems also contains problems that can not be classified as NP.
The relationship between the various classifications described here is illustrated in Fig-
ure 3.1. The diagram on the left represents the relationship if it were to be proven that
P 6= NP, while the diagram on the right illustrates the case if it were to be proven that
P = NP.
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NP-complete
NP
P
NP-hard
If P 6= NP If P = NP
NP-hard
P = NP = NP-Complete
Figure 3.1: Relationship between P, NP, NP-complete and NP-hard. (Diagram con-
ceptualised by Benham Esfahbod.)
3.2 The need for Operations Research in healthcare
Simon Fraser University’s Complex Systems Modelling Group (2010) states that, world-
wide, there is an increasingly popular view that conventional approaches to the design of
healthcare systems are failing. This growing realisation is attributed to the increased
pressure that healthcare providers are facing as they attempt to continue providing
quality services while maintaining control over escalating costs. The book describes
the questions facing the healthcare sector as extremely complex and states that, in the
majority of cases, it is not sufficient to rely on intuition to answer a given question. The
Complex Systems Modelling Group (CSMG) describes an increased use of modelling
as a method of either (i) developing evidence-based answers to the complex questions
facing healthcare decision-makers; or (ii) characterising a problem and exploring dif-
ferent ways to resolve it in order to help steer healthcare decision-makers in the right
direction.
Reid et al. (2005) confirm the CSMG’s assertion when it describes “a growing
realization within the healthcare community of the critical role information and com-
munications technologies, systems engineering tools, and related organisational innova-
tions must play in addressing the interrelated quality and productivity crises facing the
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healthcare system”. This book describes the contrast between the instrumental role
that engineering plays in the development of medical technologies and the support of
medical research and the very limited application of engineering techniques to the design
and management of the healthcare delivery system. It describes the complex nature of
healthcare delivery systems (involving interrelated systems of distributed, specialised
personnel, multiple information and material flows, specialised care facilities, financial
resources, etc.) as well as the similarities between these complexities and those found
in other systems where systems thinking and industrial engineering techniques have
successfully been applied to improve operations. Reid et al. (2005) summarises the
problem as follows: “In short, the principles, tools, and research from engineering dis-
ciplines associated with the analysis, design, and control of complex systems (Systems
Engineering, Industrial Engineering, Operations Research, Human-factors Engineer-
ing, Financial Engineering/Risk Analysis, Materials/Microelectromechanical Systems
Engineering, etc.) – disciplines that have helped improve, and sometimes transform,
many manufacturing and other services industries – are largely unknown in the clinical
operations of healthcare delivery.”
Brandeau et al. (2004) group the decisions facing healthcare policy makers and
planners into two broad categories: (i) healthcare planning and organising; and (ii)
healthcare delivery. Healthcare planning and organising is defined as encompassing
high-level decision-making and includes decisions on the economics and structure of
healthcare systems while healthcare delivery encompasses lower-level decision-making
that is mainly concerned with the management of healthcare operations and with clin-
ical practice. This structure is depicted in Figure 3.2.
This study fits within the “Operations management for healthcare delivery” do-
main. The operations management problems that arise within healthcare are similar
to traditional operations management problems and include the following:
1. Strategic planning problems (e.g. design of services);
2. Design of the healthcare supply chain;
3. Facility planning and design;
4. Equipment evaluation and selection; etc.
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Healthcare plan-
ning and organising
Healthcare delivery
Healthcare system economics:
 Healthcare budget and
funding mechanisms;
 Prioritisation and costing of
services;
 Etc.
Operations management:
 Supply chain design;
 Facility location and layout;
 Workforce planning and
scheduling;
 Etc.
Healthcare system structure:
 Public vs. private service
provision;
 Primary vs. tertiary
healthcare provision;
 Public resource allocation;
 Etc.
Clinical management:
 Identification of health risks
and diagnosing disease;
 Determining disease
prevention and treatment
plans for individuals and
patients;
 Etc.
General public policy decisions:
 Plans for mitigation of
environmental-, lifestyle-, and
infectious disease risks;
 Management of national
vaccine and pharmaceutical
supplies;
 Etc.
Healthcare management decision categories
Figure 3.2: Categories of healthcare management decision-making.
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According to the description of the real-world problem in the preceding chapters,
there is a need to develop scenarios for incorporating POC testing into the existing
diagnostic service provision model by determining (i) which hospitals and clinics to
place POC CD4 devices at; and (ii) which CD4 testing laboratories the remaining
hospital and clinic sites should refer their work to. From this description, it is evident
that the field of location science (which fits within the Operations Research domain)
should be explored as a possible approach to solving the real-world problem.
3.3 Location science
In a review of location science research, Hale & Moberg (2003) give the following
description for facility location problems: “Facility location problems investigate where
to physically locate a set of facilities (resources) so as to minimise the cost of satisfying
some set of demands (customers) subject to some set of constraints.” ReVelle & Eiselt
(2005) describe four components that characterise a location problem:
1. Customers (it is assumed that these customers are already located at specific
points or on specific routes);
2. Facilities that need to be located;
3. A space wherein customers are located and facilities are to be located; and
4. A metric that indicates distances or travel times between customers and facilities.
When reviewing the list of decisions (described in Subsection 2.3.4) that need to be
made to solve the real-world problem under investigation, against the definition given
by Hale & Moberg (2003) and the key components defined by ReVelle & Eiselt (2005),
it becomes apparent that location science could be a suitable approach for solving the
real-world problem. When fitting the real-world problem to the given definition for
location science:
1. The facilities to be located would be the allocation of POC CD4 testing capability
to an ART initiation site or the allocation of an ART initiaiton site to an existing
CD4 laboratory; and
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2. The customers or set of demands that need to be satisfied would be the number of
CD4 test requests generated at each patient-serving healthcare facility (hospital,
clinic, etc.).
When assessing the real-world problem against the four key components of a location
problem:
1. The customers (the patient-serving healthcare facilities) are located at specific
points;
2. There are a set of facilities (CD4 testing capability) that need to be located;
3. A defined space exists wherein customers are located and facilities need to be
located (the existing public healthcare hospitals, clinics, community healthcare
centres and CD4 laboratories in the country); and
4. Either the distance or the travel time between each of the customer and facility
nodes in the country can be calculated.
Location science is a well-established research area within the field of Operations
Research and several researchers have published textbooks and articles that provide
detailed accounts of the field and its applications. It is impossible to summarise the
literature here, rather, the aim is to provide a general overview of the field of location
science, its development, research gaps that currently exist, industries that location
science have been applied to and the use of location science in healthcare-related prob-
lems.
3.3.1 A brief overview of the field of location science
Hale & Moberg (2003) state that location science as an area of analytical study can be
traced back to the early seventeenth century when Pierre de Fermat, Battista Cava-
lierri and Evagelistica Torricelli all independently proposed the basic Euclidian spatial
median problem (also known as the Weber problem). ReVelle & Eiselt (2005) credit
Torricelli with the first literature on a location problem. Owen & Daskin (1998) argue
that the formal study of location theory began in 1909 when Alfred Weber studied the
positioning of a single warehouse in such a way that the total distance between the
warehouse and its customers would be minimised (this is the Weber problem referred
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to by both Hale & Moberg (2003) and ReVelle & Eiselt (2005)). In the period between
the early 1900s and the 1960s, the research focus remained on locating a single facility
within a two-dimensional field (ReVelle & Eiselt, 2005). From the 1960s onward, the
research focus widened to include problems that considered the location of several fa-
cilities and this lead to increased research interest in the field (Owen & Daskin, 1998).
Hale & Moberg (2003) describe near linear growth in the annual number of location
science study publications between the 1960s and the 2000s.
Current et al. (2002) attribute the sustained interest in location science to the
following five factors:
1. Location decisions are made at all levels of human organisation – ranging from
individuals and households, through commercial organisations and up to interna-
tional governing agencies;
2. Location decisions are most often strategic in nature as they typically require
significant financial resources and have a long lifetime. In the public sector, loca-
tion decisions significantly impact the ability to deliver services to the population
whilst in the private sector, location decisions typically impact a company’s abil-
ity to compete in a given market place;
3. Location decisions often have a wide-scale impact on economic, social, environ-
mental and health factors, amongst others;
4. Location problems are typically difficult to solve (with a large number of classic
model types being classified as NP-hard); and
5. Location problems tend to be application-specific with the objectives, the con-
straints and the variables (the structural form) being determined by the specific
problem being investigated.
Earlier, reference was made to the large volume of location science literature that
has been produced. However, both ReVelle & Eiselt (2005) and Current et al. (2002)
state that, though there is a wealth of literature available on different models (math-
ematical formulations) for location science problems as well as on efficient solution
techniques for these models, there is a significant shortage of literature that describes
the practical application of location science to real-world problems. When one recalls
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the application-specific nature of location science problems described by Current et al.
(2002), it becomes apparent that this lack of literature on location science applications
to real-world problems represents a meaningful research gap.
ReVelle & Eiselt (2005) attribute the shortage of application literature to the diffi-
culties associated with fitting complex, strategic, real-world problems that often involve
multiple objectives to the theoretical models (mathematical formulations) that have
been developed. The authors suggest either developing more comprehensive models
that can deal with these complexities holistically or developing models that consist of
a number of subproblems and using extensive sensitivity analysis to analyse and syn-
thesise the subsets of results that are obtained. ReVelle & Eiselt (2005) also suggest
that integrating Geographic Information Systems (GIS) with location science so that
multiple decision-makers can work with an input interface and see the results from in-
put modifications to the model graphically displayed, may increase the use of location
science in real-world applications.
Location science is studied in a large variety of academic disciplines including Op-
erations Research, Industrial Engineering, Civil Engineering, Geography, Urban Plan-
ning and Supply Chain Management (Hale & Moberg (2003), Dimopoulou & Giannikos
(2007)).
3.3.2 Location science model types
Literature contains different opinions on what the basic location science model types
are, however, the following eight basic model types for networks are most commonly
defined:
1. The set covering problem – ReVelle & Eiselt (2005), Hale & Moberg (2003) and
Current et al. (2002);
2. The maximum (or maximal) covering location problem – ReVelle & Eiselt (2005),
Hale & Moberg (2003) and Current et al. (2002);
3. The P-center problem – ReVelle & Eiselt (2005), Hale & Moberg (2003) and
Current et al. (2002);
4. The P-median problem – ReVelle & Eiselt (2005), Hale & Moberg (2003) and
Current et al. (2002);
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5. The uncapacitated facility location problem (including fixed charge location prob-
lems) – ReVelle & Eiselt (2005) and Current et al. (2002);
6. The maxisum location problem Current et al. (2002) (referred to as the “undesir-
able facility location problem” and defined as an extension of the basic problem
structures by ReVelle & Eiselt (2005));
7. The P-dispersion problem – Current et al. (2002); and
8. The hub location problem – Current et al. (2002) (defined as an extension to the
basic problem structures by ReVelle & Eiselt (2005)).
(Note: the “P” used in the names of the basic location science model types should not
be confused with the “P” used in the classification of complexity.)
Daskin & Dean (2004) state that the majority of facility location models are derived
from only three of the basic models listed above: (i) the location set covering model;
(ii) the maximal covering model; and (iii) the P-median model. In addition to the two
examples included in the list above, ReVelle & Eiselt (2005) define the following seven
extensions to the basic problem structures:
1. Cent-Dians and Medi-Centers;
2. Balancing objectives;
3. Hierarchical siting problems;
4. Hub location problems;
5. Competitive location problems;
6. Combined siting and routing; and
7. Capture problems.
The eight basic model types will be discussed in more detail in Chapter 4 and the
standard mathematical notation for each model will be given. The seven extensions to
the basic model structures will not be discussed in any further detail, the interested
reader is referred to ReVelle & Eiselt (2005) for a detailed discussion of these.
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3.3.3 Applications of location science
Location science is applied to a wide range of problem types. Various authors have
reviewed the literature on real-world applications of location science: Current et al.
(2002) compiled an overview of general applications; Ho (2008) reviewed applications
where traditional Operations Research modelling techniques were integrated with the
“analytical hierarchy approach” method; Melo et al. (2009) provided an overview of
applications to supply chain optimisation; Farahani et al. (2012) reviewed covering
problems; and Boloori Arabani & Farahani (2012) considered only dynamic models.
Some of the examples given by each of these authors are summarised in Table 3.1.
Table 3.1: Examples of applications of location science.
Application Citation[1]
Advertising medium selection Kwak et al. (2005)[1]
Agriculture harvesting measure selection Guo and He (1999)[1]
Air craft alert site location Bell et al. (2011)[3]
Airline hubs O’Kelly (1987)[2]
Airports Saatcioglu (1982)[2]
Apparel sizing Tryfos (1986)[2]
Archaeological settlement analysis Bell and Church (1985)[2]
Auto emission testing stations Swersey and Thakur (1995)[2]
Automotive supply chain Fleischmann et al. (2006)[4]
Bank account location Cornuejols et al. (1977)[2]
Bank branch location Alexandris and Giannikos (2010)[3]
Bloodbank Price and Turcotte (1986)[2]
Brewery depots Gelders et al. (1987)[2]
Bus garages Maze et al. (1981)[2]
Bus stops Gleason (1975)[2]
Chemicals supply chain Jayaraman and Ross (2003)[4]
Chip manufacturing Cho and Sarrafzadeh (1994)[2]
Coal handling facilities Osleeb and Ratick (1983)[2]
Computer service centers Ghosh and Craig (1986)[2]
Customer data collection method selection Badri (2001)[1]
Damper placement Kincaid and Berger (1993)[2]
Database management Pirkul (1986)[2]
Daycare centers Holmes et al. (1972)[2]
Electric power generating plants Cohon et al. (1980)[2]
Electronics industries Gebennini et al. (2009)[5]
Emergency equipment for oil spills Belardo et al. (1984)[2]
Emergency medical services ReVelle et al. (1977)[2]
Environment land use pattern selection Malczewski et al. (1997)[1]
Continued on next page
51
Stellenbosch University  https://scholar.sun.ac.za
3.3 Location science
Continued from previous page
Application Citation[1]
Essential air services Flynn and Ratick (1988)[2]
Evacuation management (dynamic model) Mamada et al. (2005)[5]
Fast-food restaurants Min (1987)[2]
Fire station systems (dynamic model) Yang et al. (2007)[5]
Fire stations Schilling et al. (1980)[2]
Flexible manufacturing system tool selection Daskin et al. (1990)[2]
Food supply chain Avittathur et al. (2005)[4]
Forest harvesting sites Hodgson et al. (1987)[2]
Forestry supply chain Vila et al. (2006)[4]
Franchise outlets Pirkul et al. (1987)[2]
Government internet access technology selection Malladi and Min (2005)[1]
Grain subterminals Hilger et al. (1977)[2]
Hardware supply chain Laval et al. (2005)[4]
Hazardous waste disposal sites ReVelle et al. (1991)[2]
Healthcare IT-based project selection Kwak and Lee (2002)[1]
Higher education faculty course assignment Ozdemir and Gasimov (2004)[1]
Ingot size selection Vasko et al. (1988)[2]
Landfill industries (dynamic model) Melachrinoudis et al. (1995)[5]
Logistics subcontractor selection Lee and Hsu (2004)[1]
Logistics supplier selection Ghodsypour and O’Brien (1998)[1]
Manufacturing/distribution system (dynamic model) Melachrinoudis and Min (2000)[5]
Manufacturing maintenance strategy selection Bertolini and Bevilacqua (2006)[1]
Manufacturing material handling device selection Braglia et al. (2001)[1]
Manufacturing sub-component selection Akgunduz et al. (2002)[1]
Meat industries Schu¨tz et al. (2008) [5]
Medical diagnosis Reggia et al. (1983)[2]
Metallurgical grade assignment Vasko et al. (1989)[2]
Military nuclear fuel cycle selection Kim et al. (1999)[1]
Military ship selection Crary et al. (2002)[1]
Military supply chain Farahani and Asgari (2007)[4]
Oil industries (dynamic model) Mokhtarian (2011)[5]
Paper recycling supply chain Pati et al. (2008)[4]
Police patrol area design Curtin et al. (2010)[3]
Political party platform Ginsberg et al. (1987)[2]
Product positioning in feature space Gavish et al. (1983)[2]
Product procurement and standardisation Watson (1996)[2]
Production lot sizing Van Oudheusden and Singh (1988)[2]
Public library policies (dynamic model) Koontz et al. (2009)[5]
Public swimming pools Goodchild and Booth (1980)[2]
Railroad sidings Higgins et al. (1997)[2]
Rain gauges Hogan (1990)[2]
RFID network design for asset tracking in healthcare Oztekin et al. (2010)[3]
Continued on next page
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Application Citation[1]
Rural healthworkers Bennett et al. (1982)[2]
Sand supply chain Liste and Dekker (2005)[4]
Satellite homing stations Helme and Magnanti (1989)[2]
Satellite orbits Drezner (1988)[2]
Schools (dynamic model) Antunes and Peeters (2001)[5]
Social service centers Patel (1979)[2]
Solar power system design Birge and Malyshko (1985)[2]
Solid waste collection Marks and Liebman (1971)[2]
Telecommunication switching centers Hakimi (1965)[2]
Truck terminals Love et al. (1985)[2]
Transportation (dynamic model) Bozkaya et al. (2010)[5]
Vehicle inspection stations Hodgson et al. (1996)[2]
Vehicle routing Bramel and Simchi-Levi (1995)[2]
Warehouses Kuehn and Hamburger (1963)[2]
Wi-Fi equipment location Lee and Murray (2010)[3]
[1] Citations are as given by Ho (2008)
[2] Citations are as given by Current et al. (2002)
[3] Citations are as given by Farahani et al. (2012)
[4] Citations are as given by Melo et al. (2009)
[5] Citations are as given by Boloori Arabani & Farahani (2012)
These citations have not been included in the references of this document as they were not
directly referenced in the writing of this thesis.
In the next section, this discussion is continued with a more detailed focus on the
application of location science specifically to healthcare-related problems.
3.3.4 Location science and healthcare
Daskin & Dean (2004) classify healthcare and related location literature into three
broad categories:
1. Accessibility models: Accessibility models use static inputs (e.g. the demand at
a node, the travel time between nodes, and the cost of establishing a facility are
often assumed to be fixed and to remain constant over a time period) to determine
the optimal placement of healthcare facilities. Due to the static inputs that
are used, accessibility models are frequently applications or limited extensions of
the basic location science model types defined in Subsection 3.3.2. Accessibility
models also include hierarchical models where different levels of service provision
(e.g. primary healthcare clinics, district hospitals and tertiary hospitals) are to
be located in a tiered network. Lastly, though Daskin & Dean (2004) state that
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the vast majority of healthcare location science models are discrete, there are also
some examples of continuous accessibility models in literature;
2. Adaptability models: Adaptability models attempt to locate facilities under con-
ditions of uncertainty regarding the future (e.g. the demand that will be present
at each node at some point in the future may be unknown). These models often
make use of scenario analysis in order to make a recommendation on the best way
forward. Under conditions of uncertainty, the recommended (“best”) solution is
not necessarily the optimal solution for a particular scenario, rather, it is the so-
lution that fares best across all of the scenarios. (The term “regret” refers to the
difference between the performance of the optimal solution and the performance
of the recommended solution for any one scenario.) In scenario planning, certain
decisions (e.g. the placement of healthcare facilities) need to be made before it is
known which scenario will eventually come into being, whilst other decisions (e.g.
the assignment of medical staff to the healthcare facilities) can be made after the
true scenario is revealed. Scenario planning typically makes use of the following
three performance measures: optimising the expected performance, minimising
the worst case performance and minimising the worst case regret; and
3. Availability models. Availability models are concerned with short-term uncer-
tainty regarding the operating conditions of a system. (For example, an ambu-
lance may have no emergencies occuring in the area which it is assigned to for an
extended period of time and then have two emergencies occuring which it needs
to respond to simultaneously.) There are two approaches to dealing with this
short-term uncertainty:
(a) Deterministic: Models are set up in such a way that demand nodes are
covered multiple times (whenever possible). For example, in cases where
multiple optimal solutions exist, the solution that maximises the system-wide
multiple coverage is selected, or, in cases where multiple optimal solutions
do not exist, a constraint may be added that requires that each demand
node be covered at least twice, etc.;
(b) Stochastic (probabilistic): Models make use of queueing theory, Bernoulli
trials, etc. to account for the uncertainty that is present in the model.
Table 3.2 summarises examples of the application of location science to healthcare
problems.
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Table 3.2: Examples of applications of location science to healthcare.
Application Description Citation
Accesibility models
Healthcare facilities
(Chongju Metropolitan
Area, Korea)
A multi-objective equity-efficiency trade-off model
that incorporates various basic model types, includ-
ing the two-parameter production-constrained grav-
ity model, is developed. The Monte Carlo inte-
ger programming technique is combined with the
augmented Lagrangian algorithm to solve the case
study.
Cho (1998)
Healthcare facilities,
hierarchical placement
(Rio de Janeiro, Brazil)
A three-level successively inclusive hierarchichal
model is applied to the case study (which is focused
on maternal and perinatal facilities). Several re-
laxations and heuristics for solving the problem are
developed and tested.
Galvao et al.
(2002)
Emergency medical ser-
vices locations (Theo-
retical development of
modeling and solution
methodology)
A maximal covering location model is expanded to
include three objectives. Two solution approaches
are tested: lexicographic linear programming; and
fuzzy goal programming.
Araz et al. (2007)
Healthcare facilities,
hierarchical placement
(South India)
Three maximum cover type models and three P-
median type models are implemented on case study
data and compared. A new mathematical model,
specifically designed to locate the maximum num-
ber of sustainable facilities is developed and applied
to a case study.
Smith et al.
(2009)
Long-term care facilities
locations (Chuncheong
Provinces, Korea)
A customised mathematical model is developed for
use in siting long-term care facilities (typically for
the elderly). A customised solution heuristics is de-
veloped and tested on a case study.
Kim & Kim
(2010)
Healthcare facilities
(Malaysia)
The capacitated maximal covering location problem
is applied to a case study. A new solution algorithm
(based on the genetic algorithm) is proposed and
applied.
Shariff et al.
(2012)
Healthcare facilities (ur-
ban sub-districts, China)
An extension of the cost-based P-median location-
allocation model is applied to the case study (which
is focussed on non-communicable disease prevention
and control units). The efficiency of non-inferior
solutions is evaluated based on their relative cost
and service.
Guo et al. (2013)
Continued on next page
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Application Description Citation
Healthcare facilities
(Guadalajara and
Cuenca Provinces,
Spain)
A customised multi-objective mathematical formu-
lation (with distance as one objective and cost as the
other) is developed for the case study (which looks
at facilities that provide 24-hour care) and solved
using a harmony search algorithm.
Landa-Torres
et al. (2013)
Adaptibility models
Road network design
for improved access
to healthcare facili-
ties (Suhum District,
Ghana)
A new mathematical model (the maximal covering
network improvement problem) is formulated and
applied to a case study. Several different scenarios
are modelled and the results are compared.
Murawski &
Church (2009)
Healthcare facility lo-
cations and road net-
work design for improved
access (Nouna district,
Burkina Faso)
The budget facility location-network design problem
is modeled as a mixed integer programme and ap-
plied to a real-world problem. Several different sce-
narios are modelled and the results are compared.
Cocking et al.
(2012)
Emergency blood sup-
ply scheduling (Beijing,
China)
A multi-period location-allocation model is applied
to the case study and a heuristic algorithm (based
on Lagrangian relaxation) is developed and applied
to the case study.
Sha & Huang
(2012)
Healthcare facilities (Il-
lam Province, Iran)
The budget-constrained dynamic uncapacitated fa-
cility location-network design problem is developed
and applied to a case study. Two heuristics are pro-
posed for solving the problem.
Ghaderi & Jabal-
ameli (2013)
Reduction and consol-
idation of healthcare
facilities (Peloponnese
Province, Greece)
An iterative three-step process incorporating data
envelopment analysis and integer programming
location-allocation models is applied to evaluate sce-
narios in a case study.
Mitropoulos et al.
(2013)
Availability models
Real-time emergency
medical services re-
allocation (Montreal,
Canada)
A dynamic reallocation model and a parallel Tabu
search heuristic to calculate reallocation scenarios
before they are required is developed and applied to
a case study.
Gendreau et al.
(2001)
Emergency medical ser-
vices locations (Theoret-
ical model was developed
and applied to a classical
reference problem)
Stochastic elements are incorporated separately into
each stage of a two-stage model in the form of prob-
abilities in the contraint equations.
Beraldi et al.
(2004)
Continued on next page
56
Stellenbosch University  https://scholar.sun.ac.za
3.3 Location science
Continued from previous page
Application Description Citation
Emergency medical ser-
vices locations (Riyadh,
Saudi Arabia)
The maximal covering location problem is expanded
to incorporate stochastic elements and applied to a
case study. Goal programming is used to accommo-
date more than one objective.
Alsalloum &
Rand (2006)
Emergency medical ser-
vices locations (Theo-
retical development of
modeling and solution
methodology)
The capacitated facility location problem is ex-
panded to incorporate stochastic elements (when
emergencies will occur and the travel time to emer-
gencies). A two-stage stochastic model is devel-
oped that incorporates probabilities in the con-
straint equations. An exact solution method and
three heuristics for solving the model are developed
and tested.
Beraldi & Bruni
(2009)
Emergency medical ser-
vices locations (Ground
and air ambulances, New
Mexico, USA)
Extensions of both the location set covering prob-
lem and the maximal covering location problem are
applied to a case study and solved using a greedy
heuristic.
Erdemir et al.
(2010)
Real-time emergency
medical services re-
allocation (Athens,
Greece)
A new two-step model is developed that incorpo-
rates the hypercube model and a location model.
The new model is applied to a case study and solved.
Geroliminis et al.
(2011)
Emergency medical ser-
vices locations (Theo-
retical development of
modeling and solution
methodology)
Uncertainty regarding where emergencies will occur
is addressed by setting the objective to minimise
the expected maximum distance to emergencies. A
solution method that is based on simulation is de-
veloped. The problem is continuous, on the plane.
Canbolat & von
Massow (2011)
Emergency medical
services locations (Rural
outskirts of Tehran,
Iran)
The linear location set covering problem is extended
to form the linear reliability-based model. This
model is applied to a case study in a rural setting.
Shariat-
Mohaymany
et al. (2012)
Emergency medical ser-
vices locations (South
East Wales, UK)
A new mathematical formulation (the maximal ex-
pected survival location model for heterogeneous pa-
tients) is developed, applied to a case study and
solved using a genetic algorithm.
Knight et al.
(2012)
Real-time emergency
medical services re-
allocation (Vienna,
Austria)
A customised mathematical model is developed
specifically for the problem and applied to the case
study. The problem is solved using approximate dy-
namic programming.
Schmid (2012)
Real-time emergency
medical services re-
allocation (Waterloo,
Canada)
A two-step stochastic model that aims to minimise
the number of reallocations whilst maintaining an
acceptable service level is developed and applied to
a case study.
Naoum-Sawaya &
Elhedhli (2013)
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3.4 Conclusion: Operations Research and location science
in healthcare
This chapter provided a brief introduction to Operations Research in general and to the
field of location science in particular. The need for Operations Research in healthcare
was identified and examples of both general and healthcare-specific applications of
location science were given.
The following chapter will present the standardised mathematical formulations of
location science problems before identifying the most suited formulation for application
to the real-world problem.
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Mathematical models for location
science applications
The previous chapter placed this study in context by providing background on (i) the
role of Operations Research in healthcare; and (ii) location science and its application
to healthcare.
In this chapter, the mathematical models that are typically used in location sci-
ence, both in general applications as well as in healthcare-specific applications, are
described in more detail and analysed. The discussion then moves on to the selection
and adaptation of the base model for application to the real-world problem.
4.1 Mathematical formulations for general location sci-
ence applications
Eight basic location science model types were introduced in Chapter 3. Literature
contains several different criteria for categorising location science models. This section
starts with a discussion of some of the proposed methods for classifying mathematical
models before proceeding to a detailed discussion of each of the eight basic model types.
4.1.1 Classification of location models
The purpose of starting with a summary of various methods for classifying models is to
make the reader more attuned to the subtle elements that differentiate models before
presenting the eight basic models.
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4.1.1.1 Classification according to objective
Several authors have suggested classifying the different types of location models ac-
cording to their objective. Owen & Daskin (1998), Church (1999) and Hale & Moberg
(2003) suggest defining four categories based on the overarching goal that the mathe-
matical model seeks to achieve. Generally, the authors differed on the definition of the
various categories. The three approaches that were proposed are summarised here.
Owen & Daskin (1998) proposed the following four categories:
1. Median problems – place a fixed number of facilities in a manner that minimises
the average distance from any customer to its closest facility;
2. Covering problems – place facilities in such a way that all (the minimum required
number of facilities to place is calculated as part of the model) or most (only a
fixed number of facilities can be placed) of the demand in the system is covered
within a specified distance;
3. Center problems – place a fixed number of facilities in a manner that minimises
the maximum distance between the customer that is located furthest away from
the facility to which it has been assigned; and
4. Other problem formulations.
Church (1999) agreed with Owen & Daskin (1998) on the definition of the first and
second category only:
1. Median models – see description given in Owen & Daskin (1998) list;
2. Covering models – see description given in Owen & Daskin (1998) list;
3. Capacitated facility models – there is a limit on the number of customers that
each faclity can serve; and
4. Competition models – location decisions can be adjusted (over predefined time
frames) in response to the location decisions made by competitors.
The categories proposed by Hale & Moberg (2003) overlap with those that have
been defined thus far:
1. Minisum – equivalent to the “median” category defined by both Owen & Daskin
(1998) and Church (1999);
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2. Minimax – equivalent to the “center problems” category defined by Owen &
Daskin (1998);
3. Set covering – a subset of the “covering” category proposed by both Owen &
Daskin (1998) and Church (1999). All demand in the model must be covered
within a specified distance, thus the number of facilities to locate are determined
as part of the solution; and
4. Maximal covering – also a subset of the “covering” category proposed by both
Owen & Daskin (1998) and Church (1999). All demand in the model does not
necessarily need to be covered. The number of facilities to locate are specified
and the goal is to cover as much demand as possible within a specified distance.
Both Current et al. (2002) and ReVelle & Eiselt (2005) proposed more general
approaches whereby models are classified based on their consideration of distance or
their type of objective.
Current et al. (2002) defined the following three ways in which distance is considered
in a location model’s mathematical formulation:
1. Maximum distance (described as an “equity” objective) – encompasses the “cov-
ering problems” and the “center problems” defined by Owen & Daskin (1998);
2. P-dispersion problem – facilities are placed in such a way that the minimum
distance between any pair of newly sited facilities is maximised; and
3. Total or average distance (described as an “efficiency” objective) – includes the
“median” category defined by both Owen & Daskin (1998) and Church (1999)
and the “capacitated facility models” category defined by Church (1999).
ReVelle & Eiselt (2005) essentially define the same three categories, but use different
terminology:
1. Pull objectives – equivalent to the “maximum distance” category defined by Cur-
rent et al. (2002);
2. Push objectives – equivalent to the “P-dispersion” category defined by Current
et al. (2002); and
3. Balancing objectives (achieving equity) – equivalent to the “total or average dis-
tance” category defined by Current et al. (2002).
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4.1.1.2 Classification according to other criteria
In addition to suggesting classifications based on the model objective (Subsection
4.1.1.1) both Hale & Moberg (2003) and ReVelle & Eiselt (2005) proposed alterna-
tive classification criteria. These proposals are summarised here.
Both groups of authors suggested using the space of location decisions to classify
models into the following three categories:
1. Continuous – new facilities can be located anywhere within the space that is being
modelled;
2. Discrete – new facilities can only be located at a number of predefined candidate
sites; and
3. Network – new facilities can only be located on the arcs or nodes of a defined
network.
ReVelle & Eiselt (2005) suggested a system for classifying models according to the
number of facilities that are to be located. The following categories were defined:
1. One facility to locate; or
2. P facilities to locate, where:
(a) P is given; or
(b) P is not given (“free entry”). In instances where P is not given, P is either:
i. Restricted by a budget; or
ii. Determined endogenously through the objectives of the model.
Finally, ReVelle & Eiselt (2005) made two more suggestions: (i) a distinction could
be made between models that allow customers a choice regarding the facility that
they use (user attracting) versus those that allocate customers to facilities (delivery
systems); and (ii) it is appropriate to distinguish between location science models that
are developed for the public sector and those that are developed for the private sector.
4.1.2 Basic model types
The eight basic facility location models are described in detail in the following section.
For each model, the key assumptions, the required model inputs and the model outputs
are defined before the mathematical formulation is given.
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4.1.2.1 Set covering problem
The set covering problem makes use of an indicator variable that indicates whether the
demand at a specific node can be covered by a facility at a specific location based on
the distance between the demand node and the facility. Two commonly used variations
of the problem exist:
1. The standard set covering model that seeks to minimise the total cost of locating
the selected facilities; and
2. The location set covering model that aims to minimise the total number of facil-
ities that are located.
The location set covering model is typically applied when the operating costs (that
are determined by the number of facilities that are located) are more dominant than
the fixed cost of locating a facility (that is assumed to be approximately equal for all
facilities (Daskin & Dean, 2004)).
The assumptions in this model are:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are unlimited;
4. The demand nodes are unweighted;
5. The coverage distance can either be standardised across the model, or, additional
restrictions on the set of facilities that can cover the demand at any particular
node can be applied. (Additional restrictions would typically include factors such
as the ease of travel from a demand node to a particular candidate location.);
6. All of the demand must be covered; and
7. The objective of both the standard set covering model and the location set cov-
ering model were described in the introductory paragraph above.
The inputs required by this model are:
1. The list of demand sites;
2. The list of potential facility sites;
63
Stellenbosch University  https://scholar.sun.ac.za
4.1 Mathematical formulations for general location science applications
3. The coverage distance (the indicator variable); and
4. Either the operating cost of a facility (for the standardised set covering model)
or, the fixed location cost of a new facility (for the location set covering model).
The model generates the following outputs:
1. The number of facilities to locate;
2. The location of each facility; and
3. The facility responsible for serving each demand node.
Mathematical notation: Standard set covering model (Farahani et al., 2012).
Let
I: set of demand nodes, I = {1, 2, . . . , i, . . . , I}
J: set of facility sites, J ∈ {1, 2, . . . , j, . . . , J}
fj : the fixed cost of locating a facility at site j
S: the maximum acceptable service distance
aij : a binary parameter, aij = 1 if the distance from candidate site j
to the demand node i is not greater than S.
Decision variable
xj =
1 if a facility is to be located at candidate site j0 otherwise.
The task now becomes to minimise
J∑
j=1
cjxj (4.1)
subject to
J∑
j=1
aijxj ≥ 1 i ∈ I, (4.2)
xj ∈ {0, 1} j ∈ J.
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Mathematical notation: Location set covering model (Daskin & Dean, 2004).
In the location set covering model, the objective function is to minimise
J∑
j=1
xj , (4.3)
the constraints in (4.2) apply.
According to Daskin & Dean (2004), a typical difficulty that results from applying
the standard set covering model is that the cost of covering all of the demand is often
prohibitive. Similarly, when the location set covering model is applied, the number of
facilities that need to be located in order to cover all of the demand is often too large.
4.1.2.2 Maximal covering model
The maximal covering location model differs from the set covering model in that it
does not necessarily cover all of the demand in the system. It is often used to locate
service facilities (such as parks, hospital and schools) and is particularly useful in cases
where the budget is insufficcient to cover all of the demand in the network (Davari
et al., 2011). The model incorporates data on the demand at each node in order to
prioritise the nodes that generate the largest demand. Like the set covering model, the
maximal covering model incorporates the concept of coverage distance that dictates the
maximum distance between a demand site and the facility that is assigned to serve it.
This model is based on the following assumptions:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are unlimited;
4. The demand nodes are weighted;
5. The coverage distance is fixed;
6. All of the demand is not necessarily covered; and
7. The objective is to maximise the total amount of demand that is covered.
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The model requires the following inputs:
1. The list of demand sites;
2. The demand at each site;
3. The list of potential facility sites;
4. The coverage distance (the indicator variable); and
5. The number of facilities to locate.
The outputs generated by the model are:
1. The location of each facility; and
2. The facility responsible for serving the demand nodes that are covered.
Mathematical notation: (Daskin & Dean, 2004).
The definitions for i, j, fj , S, aij and xj are taken from the mathematical notation
for the standard set covering problem given in Subsection 4.1.2.1.
Let
hi: demand at node i
P : the number of facilities to locate.
The decision variable is
zi =
1 if demand node i is covered0 otherwise.
The objective is now to maximise
I∑
i=1
hizi (4.4)
subject to
zi −
J∑
j=1
aijxj ≤ 0 i ∈ I, (4.5)
J∑
j=1
xj = P , (4.6)
xj ∈ {0, 1} j ∈ J,
zi ∈ {0, 1} i ∈ I.
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4.1.2.3 P-center model
The P-center model is similar to the set covering model in that it requires that all
of the demand be covered. It is similar to the maximal covering model in that the
total number of facilities that are to be located is fixed as part of the constraints. The
P-center model manages to cover all of the demand with a fixed number of facilites by
relaxing the service standard (i.e. the coverage distance of each facility).
The assumptions of the P-center model are:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are unlimited;
4. The demand nodes are unweighted;
5. The coverage distance is not fixed;
6. All of the demand must be covered; and
7. The goal is to relax the coverage distance only as much as is required to cover all
of the demand with the given number of facilities.
The following inputs are required by the model:
1. The list of demand sites;
2. The list of potential facility sites;
3. The number of facilities to locate; and
4. The inter-site travel distances.
The outputs generated by the model are:
1. The coverage distance that was achieved;
2. The location of each facility; and
3. The facility responsible for serving each demand node.
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Mathematical notation: (Owen & Daskin, 1998).
The definitions for the variables i, j and P are taken from the mathematical no-
tation for the standard set covering problem and the maximal covering problem given
previously.
Let
D: the maximum distance between a demand node and the closest
facility
dij : the distance between demand node i and potential facility site j.
The problem contains two decision variables, the definition for xj was given in the
mathematical notation of the standard set covering problem, the other decision variable
is
yij =
1 if demand node i is served by a facility at node j0 otherwise.
The objective is to minimise
D (4.7)
subject to
J∑
j=1
xj = P , (4.8)
J∑
j=1
yij = 1 i ∈ I, (4.9)
yij − xj ≤ 0 i ∈ I, j ∈ J, (4.10)
D ≥
J∑
j=1
dijyij i ∈ I, (4.11)
xj ∈ {0, 1} j ∈ J,
yij ∈ {0, 1} i ∈ I, j ∈ J.
4.1.2.4 P-median model
The P-median model is similar to the P-center model in that it also locates a fixed
number of facilities in such a way that all of the demand in the model is covered.
However, like the maximal covering model, it also takes the demand at each node into
consideration. In addition, the P-median model takes the travel distance between each
demand node and each candidate facility location into consideration.
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The P-median model assumes that:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are unlimited;
4. The demand nodes are weighted;
5. The coverage distance is not fixed;
6. All of the demand must be covered; and
7. The objective is to minimise the total demand-weighted travel distance between
each demand node and the facility to which it is assigned.
The inputs required by the P-median model are:
1. The list of demand sites;
2. The demand at each site;
3. The list of potential facility sites;
4. The number of facilities to locate; and
5. The inter-site travel distances.
The model generates the following outputs:
1. The location of each facility; and
2. The facility responsible for serving each demand node.
Mathematical notation: (Owen & Daskin, 1998).
The definitions for the variables i, j, hi, dij and P as well as for the decision variables
xj and yij are taken from the mathematical notation for the standard set covering
problem, the maximal covering problem and the P-center model given in Subsections
4.1.2.1 to 4.1.2.3.
The objective is to minimise
I∑
i=1
J∑
j=1
hidijyij (4.12)
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subject to
J∑
j=1
xj = P , (4.13)
J∑
j=1
yij = 1 i ∈ I, (4.14)
yij − xj ≤ 0 i ∈ I, j ∈ J, (4.15)
xj ∈ {0, 1} j ∈ J,
yij ∈ {0, 1} i ∈ I, j ∈ J.
4.1.2.5 The fixed charge location model
The fixed charge location problem differs from the P-median problem in only two ways:
(i) the number of facilities that are to be located are not fixed; and (ii) the objective
function is adapted to include the total cost of locating all of the selected facilities. The
model is commonly formulated in one of two ways:
1. The capacitated fixed charge location model assumes that each facility can serve
a limited demand; and
2. The uncapacitated fixed charge location model assumes that each facility can
serve an unlimited demand.
The assumptions in this model are:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are either limited (capacitated model) or unlimited (unca-
pacitated model);
4. The demand nodes are weighted;
5. The coverage distance is not fixed;
6. All of the demand must be covered; and
7. The objective is to minimise the total combined travel cost and fixed facility
location cost.
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The model requires the following inputs:
1. The list of demand sites;
2. The demand at each site;
3. The list of potential facility sites;
4. The fixed cost of locating a new facility;
5. The inter-site travel distances; and
6. The maximum capacity of each facility (only applicable to the capacitated model).
The outputs generated by the model are:
1. The number of facilities to locate;
2. The location of each facility; and
3. The facility responsible for serving each demand node.
Mathematical notation: Capacitated fixed charge location model (Current et al.,
2002).
The definitions for the variables i, j, fj , hi, and dij are taken from the mathematical
notation for the standard set covering problem, the maximal covering problem and the
P-center model given previously.
Let
Cj : the capacity of a facility at candidate site j
ω: the transport cost per unit demand and per unit distance.
The decision variables xj and yij were defined in Subsections 4.1.2.1 and 4.1.2.3.
The objective now becomes to minimise
J∑
j=1
fjxj + ω
I∑
i=1
J∑
j=1
hidijyij (4.16)
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subject to
J∑
j=1
yij = 1 i ∈ I, (4.17)
yij − xj ≤ 0 i ∈ I, j ∈ J, (4.18)
J∑
j=1
hiyij − Cjxj ≤ 0 i ∈ I, (4.19)
xj ∈ {0, 1} j ∈ J,
yij ∈ {0, 1} i ∈ I, j ∈ J.
Mathematical notation: Uncapacitated fixed charge location model (ReVelle &
Eiselt, 2005).
The mathematical notation for the uncapacitated fixed charge location model is
identical to the notation for the capacitated fixed charge location model given above,
except that constraint (4.19) is omitted.
4.1.2.6 The undesirable facility location (maxisum) model
The maxisum model differs from the P-median in only one way: the model is concerned
with locating undesirable facilities (e.g. prisons or solid waste repositories), therefore
the model seeks to maximise (rather than minimise) the total demand-weighted travel
distance in the model (Current et al., 2002).
This model is based on the following assumptions:
1. Facilities can only be located on the nodes of the network;
2. The demand is located at the nodes of the network;
3. The facility capacities are unlimited;
4. The demand nodes are weighted;
5. The coverage distance is not fixed;
6. All of the demand must be covered; and
7. The objective is to maximise the total demand-weighted travel distance between
each demand node and the facility to which it is assigned.
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The inputs required by the model are:
1. The list of demand sites;
2. The demand at each site;
3. The list of potential facility sites;
4. The number of facilities to locate; and
5. The inter-site travel distances.
The outputs generated by the maxisum model are:
1. The location of each facility; and
2. The facility responsible for serving each demand node.
Mathematical notation: (Farahani & Masoud, 2009).
The definitions for the variables i, j, hi, P and dij as well as the for the decision
variables xj and yij are taken from the mathematical notation for the standard set
covering problem, the maximal covering problem, and the P-center model given in
Subsections 4.1.2.1 to 4.1.2.3.
The objective is to maximise
I∑
i=1
J∑
j=1
hidijyij (4.20)
subject to
J∑
j=1
yij = 1 i ∈ I, (4.21)
J∑
j=1
xj = P , (4.22)
yij − xj ≤ 0 i ∈ I, j ∈ J, (4.23)
xj ∈ {0, 1} j ∈ J,
yij ∈ {0, 1} i ∈ I, j ∈ J.
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4.1.2.7 The P-dispersion problem
The P-dispersion problem differs from the problems described thus far in two ways:
(i) it is not concerned with the distance between the demand sites and the facilities,
rather, it is concerned exclusively with the distance between each of the newly sited
facilities; and (ii) the model is not concerned with siting facilities in order to serve a
defined demand that exists within the network, it is merely concerned with siting new
facilities. Similar to the maxisum model, the P-dispersion model attempts to maximise
distance rather than to minimise it.
The P-dispersion model assumes that:
1. Facilities can only be located on the nodes of the network;
2. No demand nodes are defined in the network;
3. The facility capacities are irrelevant (and can therefore be viewed as unlimited);
4. No coverage distance exists as there are no demand nodes to cover; and
5. The objective is to site new facilities that are as dispersed as possible in the
available space.
The following inputs to the model are required:
1. The number of facilities to locate; and
2. The inter-site travel distances.
The model output is:
1. The location of each facility.
Mathematical notation: (Farahani & Masoud, 2009).
The defnitions for the variables i, j, P and dij are taken from the mathematical
notation for the standard set covering problem, the maximal covering problem, and the
P-center model given in Subsections 4.1.2.1 to 4.1.2.3.
Let
E: the minimum distance between facilities
M : a very large number, larger than the maximum dij value.
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The definition for the decision variable xj was given previously in the mathematical
notation of the standard set covering problem.
The objective is to maximise
E (4.24)
subject to
J∑
j=1
xj = P , (4.25)
E ≤ dij + (M − dij) (1− xi) + (M − dij) (1− xj) i ∈ I, i<j, (4.26)
xj ∈ {0, 1} j ∈ J.
4.1.2.8 The P-hub location problem
Hub location problems are used in designing logistics networks. They differ significantly
from all of the models described thus far. The following terminology is used:
1. “Nodes” refers to all of the discrete points that make up the network (similar to
the towns, cities and road intersections that exist on a map). In a hub location
problem, the “demand” that exists at certain nodes in the network refers to the
number of units of material that need to be transported from that node to a
specific destination node;
2. “Arcs” refers to the routes connecting all of the nodes in the network (similar to
the roads that connect the towns, cities and intersections on the map);
3. The “network” is formed by the system of nodes and arcs (similar to the manner
in which the towns, cities, intersections and roads that connect them on a map
form a network). There is a cost associated with transporting a unit of material
along each arc in the network; and
4. “Hubs” can be viewed as the equivalent of the “facilities” that are placed by every
other basic location model that has been discussed thus far and represent trans-
port hubs. A hub is therefore a special kind of node. A key concept underpinning
the P-hub location model is that inter-hub transport is more cost-effective than
normal inter-node transport or transport between a normal node and a hub.
The decisions that need to be made include where to locate hubs and how to route the
deliveries through the network.
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The model is based on the following assumptions:
1. Facilities (hubs) can only be located on the nodes of the network;
2. The “demand” is located at the nodes of the network (i.e. the origin nodes);
3. The facility (hub) capacities are unlimited;
4. The arc capacities are unlimited;
5. All of the demand must be covered; and
6. The objective is to minimise the total cost of transporting all of the units of
material in the network from their respective origin nodes through the network
to their respective destination nodes.
The inputs required by the model are:
1. The list of “demand” sites (origin nodes);
2. The “demand” at each site;
3. The list of potential facility (hub) sites;
4. The number of hubs to locate;
5. The transport cost per unit of material for every arc in the network;
6. The inter-site travel distances; and
7. The discount factor for transport between hubs.
The model generates the following outputs:
1. The location of each facility (hub); and
2. The delivery route for all of the demand in the network.
Mathematical notation: (Current et al., 2002).
The definitions for the variables i, j and P are taken from the mathematical nota-
tion for the standard set covering problem and the maximal covering model given in
Subsections 4.1.2.1 to 4.1.2.2.
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Let
gij : the number of units of flow between nodes i and j
γij : the transportation cost per unit of demand between nodes i and j
β: the discount factor for transportation between hubs.
The definitions of the decision variables xj and yij (given in Subsections 4.1.2.1 and
4.1.2.3 respectively) are adjusted only slightly so that they denote the location of a hub
rather than the location of a facility
xj =
1 if a hub is to be located at candidate site j0 otherwise,
yij =
1 if demand node i are assigned to a hub at node j0 otherwise.
The objective is to minimise
N∑
i=1
N∑
j=1
gij
(
N∑
k=1
γikyik +
N∑
l=1
γjlyjl +
N∑
k=1
N∑
l=1
γklyikyjl
)
(4.27)
subject to
N∑
j=1
yij = 1 i ∈ I, (4.28)
J∑
j=1
xj = P , (4.29)
yij − xj ≤ 0 i ∈ I, j ∈ J, (4.30)
xj ∈ {0, 1} j ∈ J,
yij ∈ {0, 1} i ∈ I, j ∈ J.
4.2 Selection of base model for adaptation
Eight basic model types for location science problems were introduced in the previous
section. According to Daskin & Dean (2004), the most common basic model types for
healthcare applications are the: (i) set covering problem, (ii) maximal covering model,
(iii) P-center model, (iv) P-median model and (v) uncapacitated fixed-charge location
model. The concept of discrete models versus continuous models was briefly introduced
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in Subsection 3.1.1, Daskin & Dean (2004) state that discrete location models are
used more extensively than continuous models in healthcare applications. In discrete
location models, it is assumed that the demand in a region can be aggregated to a
finite number of discrete points. It is also assumed that facilities can be located at a
finite number of discrete points. In contrast to this, continuous models assume that
demand is distributed across a region. (Often the assumption is that the demand is
distributed evenly across the region although this is not a requirement for continuous
location modelling.) Similarly, it is assumed that facilities can be located anywhere in
the region. The eight basic model types that have been discussed in this thesis are all
discrete.
The details of the real-world problem that are to be investigated in this study were
described in Subsection 2.3.4. Section 3.3 described how the real-world problem can
be interpreted so that it can be modelled using a location science model structure. No
detailed analysis of the available input data for modelling the real-world problem has
been performed yet. The mathematical formulation and the input data are mutually
dependent upon each other. The mathematical formulation determines the input data
requirements whilst the availability of input data determines the possible mathematical
formulations that can be applied. In this project, the most suitable mathematical
formulation for application to the real-world problem will be selected based on (i) the
conceptual investigation of the characteristics of the real-world problem presented in
Section 2.3, and (ii) two assumptions regarding characteristics of the input data. The
available input data will then be analysed in detail to (i) verify the two assumptions that
have been made, and (ii) determine whether the required input data sets are available
(refer to Section 5.1). Finally, the selected standardised mathematical formulation will
be adapted based on the analysis of the input data (refer to Section 5.2).
None of the eight basic model types described in this thesis has the capability to
depict the real-world problem with a satisfactory level of accuracy. However, when one
recalls the application-specific nature of location science models as well as the descrip-
tion of the difficulties associated with fitting complex, strategic, real-world problems that
often involve multiple objectives into theoretical models, given in Subsection 3.3.1, this
is not surprising.
In the absence of a basic model that can accomodate the real-world problem in its
standard formulation, the characteristics of the real-world problem will be compared
with those of the eight basic models in order to select the most appropriate mathemat-
ical formulation to use as a basis for the development of a customised model to solve
the real-world problem.
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The maxisum model, P-dispersion model and P-hub location model can be removed
from consideration without more detailed analysis:
1. P-dispersion model: The real-world problem is not concerned solely with siting
new facilities that are as dispersed from one another as possible and the pres-
ence of demand is a key component of the real-world problem. Thus the model
structure is fundamentally unsuitable as a mechanism to represent the real-world
problem;
2. P-hub location model: The real-world problem is not concerned with the design
of a logistical network, it does not contain demand that needs to be transported
from origin nodes to destination nodes within a network. Therefore this model
structure is unsuitable as a mechanism to represent the real-world problem; and
3. Maxisum model: The real-world problem is not concerned with the location of
undesirable facilities. Though the rest of this problem formulation does show
some promise as a method for representing the real-world problem, it is identical
to the P-median problem that will be considered in the detailed analysis. Thus
the maxisum model can be safely removed from consideration.
4.2.1 Assumptions regarding the real-world problem
As stated in the previous subsection, the selection of the most appropriate mathematical
formulation will be based on two assumptions regarding the real-world problem. These
assumptions will be verified as part of the detailed input data analysis in Chapter 5.
4.2.1.1 Assumption on the relationship between loss to follow-up and travel
distance
The concept of loss to follow-up was introduced in Subsection 2.3.2. It is a complex
phenomenon and it is reasonable to assume that a large number of factors including
the psychology of each individual patient, the conduct of the specific healthcare worker
that treats the individual patient, the treatment and other conditions at each clinic,
the travel time and costs for each patient to reach their healthcare facility, etc. play
a role. However, when all of these factors can be assumed to remain approximately
constant, and the only difference is in whether the CD4 count is determined using
conventional testing or POC testing, it is reasonable to conclude that it is the reduced
time delay between when the CD4 sample is taken and when the result of the CD4 test
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is available that causes the loss to follow-up rate to decrease when POC testing rather
than conventional testing is used.
One component of the time delay between when a CD4 sample is taken and when
the result is available (using laboratory-based testing), is the time that it takes to
transport the specimen to the closest CD4 testing laboratory. From the above, one could
hypothesise that, facilities that are located further away from their testing laboratory,
have a higher loss to follow-up rate.
This hypothesis will be investigated during the input data analysis in Chapter 5.
For now however, the following assumption will be made: The loss to follow-up at each
primary healthcare facility is a function of both the demand at the site and the distance
between that site and the closest laboratory.
4.2.1.2 Assumption on testing cost
A detailed investigation of the available costing data will be presented in Chapter 5.
For the time being, the following assumption on testing cost will be made: Economies
of scale (in terms of the cost per test performed) exist within the laboratory network
and for POC testing. Therefore, it is more cost-effective to test a higher volume of
CD4 samples than a lower volume of CD4 samples (whether through POC testing or
laboratory-based testing) at any one site.
4.2.2 Selection based on model objective
As discussed in Subsection 2.3.4, the real-world problem requires that a number of
scenarios for CD4 testing service delivery be investigated based on their (i) financial
impact; and (ii) health impact. A safe assumption is that the country would want to
maximise the health benefit whilst minimising the cost.
As discussed in Subsection 2.3.2.2, the use of POC CD4 testing (rather than tra-
ditional laboratory-based CD4 testing) is expected to result in a reduced number of
HIV positive patients being lost to follow-up before ART initiation. Therefore it is log-
ical to conclude that a scenario that relies entirely on POC CD4 testing (rather than
laboratory-based CD4 testing) would result in the largest possible health benefit for the
country. However, as mentioned in Subsection 2.3.3.2, POC CD4 testing is more ex-
pensive than laboratory-based CD4 testing, therefore it is reasonable to conclude that
this same scenario would result in the largest possible cost for CD4 testing provision
in the country.
From the above, it is clear that the real-world problem involves two conflicting
objectives:
80
Stellenbosch University  https://scholar.sun.ac.za
4.2 Selection of base model for adaptation
1. Maximise the health impact: in terms of the problem being investigated
here, the health impact can be defined as the number of additional patients being
initiated onto ART (i.e. not being lost to follow-up) due to the use of POC CD4
testing; and
2. Minimise the cost: for the problem under investigation, the cost will be defined
as the total cost of providing CD4 testing to public healthcare facilities in the
country, using either laboratory-based or POC technology, or a combination of
the two.
The real-world problem is therefore a multi-objective optimisation problem with two
objectives. All of the eight basic model structures that have been investigated are single-
objective. Literature does contain an increasing number of articles on multi-objective
location science applications. In a comprehensive review, Current et al. (1990) identified
45 papers that described multi-objective location science applications. Twenty years
later, Farahani et al. (2010) conducted a review with a slightly wider scope and found
approximately 730 articles describing multi-criteria location problems (multi-objective
location problems are defined as a subset of multi-criteria location problems). Both
studies defined the types of objectives found in the literature:
1. Cost, including fixed and variable costs (identified by both Current et al. (1990)
and Farahani et al. (2010));
2. Coverage and other demand-related objectives (identified by both Current et al.
(1990) and Farahani et al. (2010));
3. Profit (identified by both Current et al. (1990) and Farahani et al. (2010));
4. Environmental concerns (identified by both Current et al. (1990) and Farahani
et al. (2010));
5. Service level and effectiveness (identified by Farahani et al. (2010)); and
6. Other criteria, e.g. resource accessibility and social or political risks (identified
by Farahani et al. (2010))).
Current et al. (1990) found that, from a structural point of view, the multi-objective
problems are similar to “the general population of single-objective location models”.
Farahani et al. (2010) echo this conclusion by stating that bi-objective location problems
are essentially an extension of the classic, single-objective location science problems.
Against this background, it is valid to proceed with selecting a model for adaptation
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to the real-world problem from the set of eight basic, single-objective location science
problems introduced earlier in this chapter. Table 4.1 summarises the objective of each
of the model structures being considered for application to the real-world problem.
Table 4.1: Summarised basic model objectives.
Set covering problem
The standard set covering model seeks to minimise the total cost of locating the selected facilities.
The location set covering model aims to minimise the total number of facilities that are located.
Maximal covering model
The objective is to maximise the total amount of demand that is covered.
P-center model
The goal is to relax the coverage distance only as much as is required to cover all of the demand
with the given number of facilities.
P-median model
The objective is to minimise the total demand-weighted travel distance between each demand
node and the facility to which it is assigned.
The fixed charge location model
The objective is to minimise the total combined travel cost and fixed facility location cost.
The maximal covering model’s objective seeks to maximise the demand that is
covered. In the real-world problem, it is a requirement that all of the demand must be
covered, therefore this model’s objective is incompatible with the real-world problem.
Both the P-center model and the P-median model are primarily concerned with
minimising the distance between the demand nodes and the facilities. The maximum
health impact is achieved through the use of POC technology (where the facility is sited
at the demand node itself), therefore, minimising the distance between the demand node
and the facility would maximise the health impact. These objectives have the potential
to be adapted to represent the health impact objective. Neither of the models include
a cost consideration.
The two versions of the set covering problem seek to minimise the total cost by
minimising either the operating cost or the fixed facility cost. Both of these objectives
show potential for being developed into the cost objective to represent the real-world
problem.
The fixed charge location model seeks to minimise the combined travel and fixed
facility cost. Minimising the travel cost, would seem equivalent to minimising the
distance between the demand and the facilities. If this portion of the objective function
could be isolated and set as a separate objective, it would have the potential to be
adapted to represent the health impact (similar to the suggestion made for the P-center
and P-median model). This would then leave the minimisation of the fixed facility
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cost as a separate objective. Similar to the discussion of the set covering problem
objective, this objective shows potential for representing the cost objective of the real-
world problem.
4.2.3 Selection based on model assumptions
In the description of the eight basic models in Subsection 4.1.2, the key assumptions
fo each model as well as the input data that is required and the output data that is
produced, were summarised. Table 4.2 summarises the assumptions for the five models
under consideration.
Table 4.2: Summarised basic model assumptions.
Set covering Maximal P-center P-median Fixed charge
problem covering model model location
model model
Facility location At nodes At nodes At nodes At nodes At nodes
Demand location At nodes At nodes At nodes At nodes At nodes
Facility capacities Unlimited Unlimited Unlimited Unlimited Limited[1] or
Unlimited[2]
Demand node weighting Unweighted Weighted Unweighted Weighted Weighted
Coverage distance Fixed[3] Fixed Not fixed Not fixed Not fixed
Demand coverage Complete Potentially Complete Complete Complete
partial
[1] Only applicable to the capacitated model.
[2] Only applicable to the uncapacitated model.
[3] Though the coverage distance is fixed, it is not necessarily standardised across the model.
As discussed in the introduction to Section 4.2, all of the models that are under
consideration are discrete. Thus, all of the models assume that facilities can be located
only at the nodes of the network and that demand is sited at the nodes of the network.
This is compatible with the real-world problem where demand (in the form of CD4
testing requests) is sited only at each of the approximately 3 600 ART initiation facilities
and the facilities that are to be sited by the model (in the form of POC CD4 testing
capability) can only be sited at one of these ART initiation facilities or at one of the
61 CD4 laboratories (see Subsection 2.3.4).
The real-world problem does not place a limit on facility capacity. One single facility
could potentially process all of the CD4 tests that are requested in the country. (This
may be viewed as a controversial statement, but, from a purely theoretical point of
view, it is true.) Thus, with the exception of the capacitated version of the fixed charge
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location model, all of the basic model types under consideration have the capability to
adequately depict the real-world problem in terms of facility capacities.
The demand node weighting assumption refers to whether a model takes the size
of the demand at each node into consideration. Both the set covering problem and
the P-center model are unweighted, therefore, the models do not give higher priority
to nodes with a larger demand. When considering the two objectives of the real-
world problem, it becomes apparent that demand nodes must be weighted in order
to model the problem. The health impact objective seeks to maximise the number of
additional patients being initiated onto ART. Therefore, when calculating the impact
of providing POC CD4 testing capability at a patient-serving healthcare facility, it
would be necessary to include an indication of the number of HIV positive patients
that have not yet been initiated onto ART but are undergoing CD4 testing at this
facility. Similarly, when calculating the cost premium for providing CD4 testing at this
facility, it would be necessary to have an indication of the number of CD4 tests that
would be performed at the facility. In terms of demand node weighting, the set covering
problem and the P-center model are incompatible with the real-world problem, whilst
the maximal covering problem, the P-median problem and the fixed charge location
model are compatible with the real-world problem.
The real-world problem does not stipulate a required coverage distance. It is as-
sumed that that the health impact objective would favour solutions that site CD4 test-
ing capability closer to the patient-serving facilities (refer to the assumption regarding
the relationship between loss to follow-up and distance given in Subsection 4.2.1.1).
However, there is no limit on the maximum distance between a patient-serving facil-
ity and the laboratory that processes the CD4 test requests that are generated there.
Thus, all of the model types under consideration have the ability to depict the real-world
problem in terms of coverage distance.
It is an absolute requirement of the real-world problem that all of the CD4 test
requests that are generated must be tested, either via POC technology or laboratory-
based technology. The maximal covering model is therefore incompatible with the
real-world problem in terms of demand coverage, whilst the other four models are all
compatible.
4.2.4 Selection based on model inputs
The model inputs given in Subsection 4.1.2 are summarised in Table 4.3.
The requirements for a list of potential facility sites and a list of demand sites as
inputs are in line with the discrete nature of the models as described under the facility
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location and demand location assumptions in Subsection 4.2.3. Similarly, the maximum
facility capacity input relates to the facility capacities assumption and the demand
input relates to the demand node weighting assumption, also discussed in Subsection
4.2.3.
Table 4.3: Summarised basic model inputs.
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The list of potential facility sites
√ √ √ √ √
The list of demand sites
√ √ √ √ √
The maximum capacity of each facility
√ [1]
The demand at each site
√ √ √
The coverage distance
√ √
The inter-site travel distances
√ √ √
The number of facilities to locate
√ [2] √ √ √
The cost of a facility
√ [3] √ [4]
[1] Only applicable to the capacitated fixed charge location model.
[2] Only applicable to the standard set covering model.
[3] Either the operating cost of a facility (for the standardised set covering model) or, the
fixed location cost of a facility (for the location set covering model).
[4] The fixed location cost of a facility.
The coverage distance input relates to the assumption (of the same name). The
inter-site travel distance input replaces the coverage distance input for models that
incorporate more complexity when dealing with distance. (Models that make use of a
coverage distance are, generally, not concerned with optimising the distance between
a demand node and a facility beyond the point of ensuring that this distance does
not exceed the coverage distance. The P-center model, which requires inter-site travel
distances as an input and then proceeds to specify the minimum required coverage
distance, is an exception to this statement.) As discussed in Subsection 4.2.3, siting a
testing facility closer to a patient-serving facility improves the performance in terms of
the health impact objective. Thus, the P-center model, the P-median model and the
fixed charge location model that have the capability to take inter-site travel distances
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into consideration are more suited to representing the real-world problem.
The maximal covering model, P-center model, P-median model and one version of
the set covering problem require that the number of facilities that are to be located be
specified as part of the model inputs. As described in Subsection 2.3.4, the real-world
problem requires the evaluation of a number of scenarios for the provision of CD4
testing capability. These scenarios range from a solution where all CD4 testing is done
via POC technology to a solution where all CD4 testing is done via laboratory-based
testing, as well as a number of hybrid solutions that rely on both technologies.
There are various ways to approach the generation of such scenarios, one of which
would be to specify different numbers of POC CD4 facilities to locate. If the model
had a single objective, so that one optimum answer was produced every time the
model was solved, this would be a good approach to scenario generation. However, as
discussed in Subsection 4.2.2, the model is multi-objective. According to the description
in Subsection 3.1.1, a range of solutions (that form the Pareto set) are produced when a
multi-objective model is solved. When one considers the two opposing objectives in the
real-world problem (health impact and cost), it becomes clear that the various solutions
in the Pareto set will be differentiated from one another by the extent to which POC
testing is used. (The solution that uses POC testing the most extensively will have
the best performance in terms of health impact and the worst performance in terms of
cost, and vice versa.) From the above, it can be concluded that, model formulations
that determine the number of facilities that are to be placed endogenously (i.e. the
fixed charge location model and the location set covering problem), are more suited to
represent the real-world problem.
Lastly, it is necessary to take the cost of CD4 testing provision into consideration
when modelling the real-world problem. The set covering model and the fixed charge
location model have mechanisms for incorporating either the fixed cost or the operating
cost of a facility into the problem formulation. The maximal covering model, P-center
model and P-median model are incompatible with the real-world problem in terms of
this requirement.
4.2.5 Selection based on model outputs
The model outputs for each of the five models (first introduced in Subsection 4.1.2) are
summarised in Table 4.4. Subsection 4.2.3 described why coverage distance is not a
necessary consideration when formulating a model to represent the real word problem.
The discussion in Subsection 4.2.4 motivated why a model that determines the number
of facilities to locate (rather than requiring this information as a model input) is more
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suited to modelling the multi-objective real-world problem. It is essential that the
model that is used to represent the real-world problem stipulate both the location of
each facility as well as the referral pattern (i.e. the facility responsible for serving each
demand site) as part of the model outputs.
Table 4.4: Summarised basic model outputs.
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The coverage distance that was achieved
√
The number of facilities to locate
√ [1] √
The location of each facility
√ √ √ √ √
The referral pattern
√ √ √ √ √
[1] Only applicable to the location set covering model.
4.2.6 Conclusion: model selection
The five models under consideration have been evaluated for their compatibility with
the real-world problem in terms of four categories: (i) objectives; (ii) assumptions;
(iii) inputs; and (iv) outputs. The evaluation is summarised in Table 4.5. For each
criterium that was considered, a value of “1” indicates that the model is compatible
with the real-world problem, a “-1” indicates that the model is incompatible with the
real-world problem, and a “0” indicates a neutral impact on compatibility. Each model
is given an overall score.
From the discussion in Subsections 4.2.2 to 4.2.5, as well as from the summarised
compatibility evaluation in Table 4.5, it is clear that the uncapacitated fixed charge
location model (UFL) is most suited to addressing the problem at hand. The UFL
determines three key outputs: (i) the number of facilities to locate; (ii) the optimum
location of the facilities; and (iii) the optimum referral patterns. All three of these need
to be determined as part of the solution to the real-world problem. The UFL covers all
of the demand in the system – this is a key requirement of the real-world problem. The
UFL takes inter-site distances and costs into consideration and prioritises sites with
higher demand, all of these capabilities are required for solving the real-world problem.
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Table 4.5: Summarised basic model compatibility evaluation.
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Model objective
As set out in Subsection 4.1.2 1 1 -1 1 1 1 1
Model assumptions
Facility location 1 1 1 1 1 1 1
Demand location 1 1 1 1 1 1 1
Facility capacities 1 1 1 1 1 -1 1
Demand node weighting -1 -1 1 -1 1 1 1
Coverage distance 0 0 0 0 0 0 0
Demand coverage 1 1 -1 1 1 1 1
Model inputs
List of potential facility sites[1] 0 0 0 0 0 0 0
List of demand sites[2] 0 0 0 0 0 0 0
Maximum facility capacity[3] 0 0 0 0 0 0 0
Demand at each site[4] 0 0 0 0 0 0 0
Coverage distance 0 0 0 0 0 0 0
Inter-site travel distances -1 -1 -1 1 1 1 1
Number of facilities to locate -1 1 -1 -1 -1 1 1
Cost of a facility 1 1 -1 -1 -1 1 1
Model outputs
Coverage distance 0 0 0 0 0 0 0
Number of facilities to locate[5] 0 0 0 0 0 0 0
Location of each facility 1 1 1 1 1 1 1
Referral pattern 1 1 1 1 1 1 1
Total compatibility score 5 7 1 5 7 9 11
[1] Compatibility in terms of this criteria was already evaluated under the “facility location”
category in the list of model assumptions.
[2] Compatibility in terms of this criteria was already evaluated under the “demand location”
category in the list of model assumptions.
[3] Compatibility in terms of this criteria was already evaluated under the “facility capacities”
category in the list of model assumptions.
[4] Compatibility in terms of this criteria was already evaluated under the “demand node
weighting” category in the list of model assumptions.
[5] Compatibility in terms of this criteria was already evaluated under the “number of
facilities to locate” category in the list of model inputs.
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4.3 Conclusion: Mathematical models
This chapter introduced different standard mathematical formulations of location prob-
lems and compared the characteristics of these standard formulations with the real-
world problem to identify the most suitable model for application in this study.
Although the standard formulation of the UFL model was found to be the most
suitable of the eight formulations considered, it is still not directly suited for application
to the real-world problem, for the following reasons:
1. The case study has certain unique characteristics which would cause the optimi-
sation mechanism to not function as intended if the standard formulation of the
UFL model were applied;
2. The standard formulation of the UFL model does not have the capability to
consider all of the factors which need to be considered in order to adequately
model the real-world problem; and
3. The formulation of the real-world problem is constrained by the availablity of
public healthcare data.
The UFL thus requires modification for this study, and Chapter 5 will describe how
the UFL model has been adjusted and applied to the real-world problem.
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Modelling the real-world problem
In the previous chapter, the basic mathematical model that is most suited to the real-
world problem was selected based on the general characteristics of the real-world prob-
lem. This chapter will describe the modelling and solution of the real-world problem.
The following topics will be discussed:
1. Input data analysis;
2. Tailored mathematical model;
3. Model validation;
4. Solution methodology; and
5. Solution methodology verification.
5.1 Input data
In Subsection 3.3.1, reference was made to the difficulties associated with applying the
theoretical location science models that have been developed to solve real-world prob-
lems. In the South African public healthcare context under investigation, the largest
challenge associated with modelling the real-world problem has been the availability of
relevant, representative and accurate data.
Two key assumptions regarding the real-world problem were made when selecting
the most appropriate mathematical formulation (Subsection 4.2.1). These assumptions
need to be verified by analysing the available input data. This section starts with an
explanation of the role these two assumptions play in the functioning of the optimisation
mechanism of the proposed model formulation.
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The input data requirements of the real-world problem were introduced in Subsec-
tion 4.2.4. The remainder of this section discusses how each of the input data sets were
formulated by describing the raw data sets that were sourced as well as how these data
sets were processed and analysed.
5.1.1 Input data assumption verification
Two assumptions regarding the real-world problem were used when selecting the most
appropriate mathematical formulation. These assumptions were stated in Subsections
4.2.1.1 and 4.2.1.2, and are repeated here:
1. The loss to follow-up at each primary healthcare site is a function of both the
demand at the site and the distance between that site and the closest laboratory;
and
2. Economies of scale (in terms of the cost per test performed) exist within the
laboratory network and for POC testing. Therefore, it is more cost-effective
to test a higher volume of CD4 samples than a lower volume of CD4 samples
(whether through POC testing or laboratory-based testing) at any one site.
These two assumptions will be investigated during the input data analysis in Sub-
sections 5.1.4 and 5.1.7. In order to provide the reader with an understanding of the
importance of these assumptions, the remainder of this section will describe: (i) how it
is proposed that the standard UFL model’s objective should be transformed in order
to model the real-world problem; and (ii) what role each of these assumptions fulfill in
the optimisation mechanism of the transformed model objectives.
5.1.1.1 The need for two objectives
The most important requirement of the case study not addressed by the standard
formulation of the UFL is the ability to consider the health impact as part of the
model objective. In the case study, an improved health impact would necessarily cost
more. Therefore, an improvement in health impact weakens the performance in terms
of the standard model’s primary (and only objective), cost. Due to this relationship
between health impact and cost, combining the cost and the inverse of the health impact
into a single objective that needs to be minimised will not produce a satisfactory result.
Therefore the standard UFL model is adapted by:
1. Transforming it to a multi-objective optimisation (MOO) model; and
2. Setting the second objective as the health impact.
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5.1.1.2 Proposed changes to the cost objective
In the standard formulation, the primary (and only) objective is cost. This objective
has two components: (i) the total cost of locating the selected facilities; and (ii) the
total demand-weighted travel time. The cost objective is adjusted in two ways in order
to make it suitable for application to the study:
1. The location cost component is transformed to the total testing cost (for the
combination of conventional testing and POC testing that is used) for one year.
This total testing cost includes the reagents and consumables that are used, as
well as the equipment costs and the labour costs; and
2. The demand-weighted travel component is removed from the cost calculation.
In the real-world problem being investigated, the allocation of POC CD4 test-
ing capability to a patient-serving healthcare facility has no impact on the total
amount of transport required to deliver the diagnostic service in the country.
This is because the specimen transport service of the NHLS collects specimens
for a wide variety of diagnostic tests, including CD4, in a single collection round.
Removing CD4 testing from the batch of specimens that need to be transported
does not reduce the urgency or the required collection frequency of the batch of
specimens. The inclusion of both the demand and either the travel distance or
travel time in the model’s objective(s) is key in ensuring that both the location
of the facilities and the referral pattern is optimised. The possibility of using an
arbitrary weighting factor for the “cost” of the demand-weigthed travel time and
still including this in the cost objective was considered. If this approach were
followed, the ratio between the travel costs and the total testing costs could be
adjusted by adjusting the weighting factor. However, this approach is not ideal
as the model would show great sensitivity to the ratio between the travel costs
and the total testing costs and this ratio would be arbitrary.
In its adjusted form, the cost objective must perform the following function within
the optimisation mechanism: it must ensure that, for a given health impact, an optimal
number of POC facilities and laboratory facilities is located. This can be achieved if
one can assume that economies of scale exist (i.e. that it is more cost-effective to test
a higher volume of samples at a site). This assumption was introduced in Subsection
4.2.1.2. It was repeated in Subsection 5.1.1, and, as mentioned, it will be evaluated by
analysing the available costing data in Subsection 5.1.4.
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5.1.1.3 The proposed health impact objective
Health impact (the second objective) is defined as the number of additional people
that are initiated onto ART in a year due to the changes that have been made to the
diagnostic service provision model.
The following hypothesis relating to the relationship between loss to follow-up and
distance was introduced in Subsection 4.2.1.1: facilities that are located further away
from their testing laboratory, have a higher loss to follow-up rate.
If this hypothesis is correct, the health impact objective will serve to optimise the
referral patterns by minimising the total demand-weighted distance between the pri-
mary healthcare facilities and the laboratories that they are assigned to. Furthermore,
if the hypothesis is correct, then the assumption regarding the relationship between the
loss to follow-up at each primary healthcare facility and the demand at the site as well
as the distance between that site and the closest laboratory (introduced in Subsection
4.2.1.2 and repeated in Subsection 5.1.1) would be proven valid.
From the above, the calculation of the health impact objective will have two com-
ponents:
1. For primary healthcare facilities that are assigned to laboratory-based testing, the
facility’s loss to follow-up rate will be determined based on the distance between
that facility and the CD4 laboratory it is assigned to.
2. For facilities that are assigned to POC testing, the facility’s loss to follow-up will
be determined by applying the odds ratio associated with POC testing (the Wyn-
berg et al. (2014) odds ratio introduced in Subsection 2.3.2.) to the laboratory-
based loss to follow-up rate determined based on the distance between the facility
and the closest existing CD4 laboratory.
5.1.2 Input data set: List of primary healthcare facilities offering ART
initiation
The raw data sets numbers two and three listed in Table 5.1 were used to determine
the list of primary healthcare facilities that offer ART initiation to be included in
the model. All primary healthcare facilities that offer ART initiation should report
ART statistics via the District Health Information System (DHIS). The DHIS data
set that contains the ART initiation statistics does, however, not contain any facility
co-ordinates. There is no unique identifier that can be used to match the records in the
two DHIS data sets that were used, however, the facility naming convention used in the
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Table 5.1: Raw input data sets.
1 Master list of DOH facilities DHIS[1]
2 List of DOH facility co-ordinates DHIS[2]
3 ART statistics reported during the 2013/2014 finan-
cial year
DHIS[3]
4 CD4 testing volumes for the financial year 2012/2013 NHLS[4]
5 List of NHLS CD4 laboratories and their co-ordinates NHLS[6]
6 List of NHLS non-CD4 laboratories and their co-
ordinates
NHLS[5]
7 Post-ART initiation LTFU data tier.net[7]
[1] Via a data request submitted to the National Health Laboratory Service on 14 June 2013.
Data supplied via email on 14 June 2013.
[2] Via a data request submitted to the Department of Health on 24 April 2014. Data
received via email on 8 May 2014.
[3] Data set provided by the Clinton Health Access Initiative, received via email on 2 May
2014.
[4] Via a data request submitted to the National Health Laboratory Service on 4 March 2014.
Data supplied via email on 10 April 2014.
[5] Via a data request submitted to the National Health Laboratory Service on 6 May 2014.
Data supplied via email on 6 May 2014.
[6] Via a data request submitted to the National Health Laboratory Service on 14 May 2014.
Data supplied via email on 16 May 2014.
[7] Data set provided by the Clinton Health Access Initiative, received via email on 16 May
2014.
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two data sets is similar. Co-ordinate data was matched to the list of facilities offering
ART initiation, based on the facility name. According to the DHIS ART data set,
3 633 primary healthcare facilities were offering ART initiation in January 2014. DHIS
co-ordinate data was available for 3 587 of these facilities. The 46 facilities for which no
co-ordinate data is available represent 0.3% of the total number of ART patients in SA
(based on the January 2014 data). These 46 sites have been excluded from the study.
5.1.3 Input data set: Demand per primary healthcare facility
Raw input data sets numbers one to four listed in Table 5.1 were used in the calculation
of the demand per primary healthcare facility. The following data processing steps were
executed:
1. The CD4 testing volumes for the 2012/2013 financial year (data set number four)
were matched to the master list of DOH facilities. The data sets did not contain
a unique identifier for the facilities that could be used to match the records. The
naming convention used in the two data sets did not allow for the use of any
automated methods in matching the records, therefore the records were matched
manually. It is interesting to note that certain primary healthcare facilities appear
to be duplicated up to six times in the NHLS data set. CD4 testing volumes were
successfully matched to 4 041 primary healthcare facilities. 4.7% of the total CD4
testing volume could not be matched to a facility.
2. Unique identifiers were used to match the data set above to the set of 3 587 pri-
mary healthcare facilities that report ART statistics and for which co-ordinate
data is available (refer to Subsection 5.1.2). No CD4 testing data could be
matched for 308 of the 3 587 facilities. These 308 facilities account for 7.2%
of the total number of newly initiated ART patients in the 2013/2014 financial
year. Initially, these facilities were included in the model. However, following the
presentation of preliminary results to the NHLS, a decision was made in collab-
oration with subject matter experts from the NHLS1 to exclude these sites from
the modelling exercise (Stevens et al., 2014).
1Prof. Wendy Stevens (Head of the NHLS’ National Priority Programme and Head of Molecular
Medicine and Haematology at the University of the Witwatersrand), Prof. Debbie Glencross (Director
of the NHLS’ CD4 National Priority Programme and the Pathologist in Charge of the Charlotte Max-
eke Johannesburg Academic Hospital’s CD4, Leukaemia, Immunohaematology and HIV Immunology
Laboratory), Dr Lindi Coetzee (CD4 Co-ordinator of the NHLS’ National Priority Programme), and
Naseem Cassim (NHLS National Priority Programme staff member).
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This data gives the total number of CD4 tests that were performed for determining
ART initiation eligibility and for monitoring patients that are receiving ART. There is
no reputable data set available that would allow one to distinguish between the tests
that have been requested for the purpose of determining eligibility and those that have
been requested for the purpose of monitoring ART patients. The fact that this data is
not available has been confirmed by the NHLS subject matter experts (Stevens et al.,
2014). However, it is the recommendation of various subject matter experts from the
Clinton Health Access Initiative1 (CHAI), WITS University’s Health Economics and
Epidemiology Research Office2 (HEERO) and the NHLS that it would not be practically
feasible to exercise the required control within clinics and hospitals to ensure that POC
CD4 devices are only used for determining eligibility for ART initiation3 and not for
monitoring ART patients4 (Lehe et al., 2014). For these reasons, the modelling of the
real-world problem will include the cost of all CD4 testing in the country (thus the
cost of CD4 testing for determining eligibility for ART initiation as well as the cost
of CD4 testing for monitoring ART patients.) Furthermore, the model will work on
the assumption that, if POC CD4 testing capability is installed at a facility, both the
eligibility testing and the monitoring testing will be performed using POC.
5.1.4 Input data set: Cost per test
Costing data was taken from Cassim et al. (2014). This study is currently in the
peer review process of the Plos ONE journal. The study was conducted using data
from the NHLS in South Africa. A tiered service delivery model for the provision of
CD4 tests was proposed. The tiers were defined based on the testing method (either
laboratory-based or POC) and the volume of samples that are tested per day. The
study calculated a cost per test that is inclusive of reagent, consumable, staffing and
equipment costs. Test error rates (published rates for POC testing and in-house NHLS
rates for laboratory-based testing) were taken into account to ensure that the cost
per test provides for tests that would need to be executed more than once. Sample
1Jonathan Lehe (Senior Manager: Point of Care Diagnostics) and Damian Fuller (Lesotho Country
Support Associate for MDR-TB).
2Kate Schnippel (Senior Researcher)
3POC CD4 tests offer a positive health impact (in terms of the number of eligible individuals that
are initiated onto ART) when used for determining eligibility for ART initiation.
4It is possible that using POC CD4 testing for monitoring ART patients may offer positive health
impacts. However, for the purpose of this study a positive health impact is defined as reducing the loss
to follow-up prior to ART initiation. When POC CD4 testing is used for monitoring ART patients, it
has no effect on the loss to follow-up prior to ART initiaiton.
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transportation costs, laboratory management costs, facility rental and maintenance
costs, etc. were excluded from the study. The five testing tiers, with the type of testing
used, the maximum / minimum testing volume and the cost per test is summarised in
Table 5.2. This data supports the economies of scale assumptions listed in Subsection
5.1.1.
Table 5.2: Cost per test data. (As calculated by Cassim et al. (2014).)
Tier Type of testing Daily testing volume Cost per test (US$)[1]
1 POC ≤5 35.46
2 POC ≤40 19.02
3 Conventional ≤100 10.56
4 Conventional ≤394 9.38
5 Conventional >394 8.51
[1] Because the paper by Cassim et al. (2014) is still in the peer review process, this
is a hidden cost. However, both the order of magnitude of the values and the ratios
between the values are accurate.
5.1.5 List of potential POC testing sites
Raw input data sets numbers one to four listed in Table 5.1 were processed as described
in Subsection 5.1.3 to generate the list of 3 279 facilities that were to be included in the
final model. In accordance with the maximum daily testing volume for POC sites as
defined by Cassim et al. (2014), only sites that request a maximum of 9 600 CD4 tests
per year were considered eligible for POC testing. (The testing threshold of 9 600 is
calculated based on the assumption of 20 working days per month given in the Cassim
et al. (2014) study.)
5.1.6 Input data set: List of CD4 laboratory sites
Raw input data set number five in Table 5.1 contains a list of the NHLS laboratories
that currently offer CD4 testing, together with the facility co-ordinates. This data was
not processed in any way.
5.1.7 Analysis of relationship between distance and LTFU
Subsection 4.2.1.1 stated that a key assumption that was made when selecting the most
appropriate mathematical formulation for the real-world problem was that the loss to
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follow-up rate at each primary healthcare facility is a function of both the demand at
the site and the distance between that site and the closest laboratory. This assumption
was examined in Subsection 5.1.1.3 and it is concluded that if the following hypothesis
is true, the assumption can be assumed to be valid: facilities that are located further
away from their testing laboratory, have a higher loss to follow-up. This hypothesis was
tested using data sets seven and eight listed in Table 5.1.
As discussed in Subsection 2.3.2.2, the use of POC CD4 testing is expected to impact
the pre ART initiation loss to follow-up rate. Unfortunately there is no representative
data set of pre ART initiation loss to follow-up data available for the country. However,
at present, 648 public healthcare facilities in the country report post ART initiation loss
to follow-up statistics (data set seven in Table 5.1). In the absence of representative
pre ART initiation LTFU data for the country, a decision was made to investigate a
relationship between post ART initiation LTFU data and the distance between each
of the healthcare facilities and the closest CD4 testing laboratory (data set eight from
Table 5.1).
A Pearson test and a Spearman rank test were performed and neither test showed
evidence of a correlation between the two data sets. The Pearson test result was
r=-0.0718, p=0.0764 and the Spearman rank test result was ρ(622)=-0.0365, p=0.3000.
The data was analysed to determine whether other factors (such as the urban vs. rural
classification of a site, or the size of the site in terms of patient numbers) impacted
the loss to follow-up rate at the site. Stellenbosch University’s Centre for Statistical
Consultation was also consulted to verify that the data analysis methodology that
was applied was correct. These subject matter experts agreeed that, even when one
controlled for specific factors (such as those listed earlier in this paragraph), there was
still no evidence of a correlation between the two variables.
From the results of the correlation analysis above, we reject the hypothesis that
facilities that are located further away from their testing laboratory, have a higher loss to
follow-up. From this it follows that the assumption regarding the relationship between
the health impact objective and the demand at the site as well as the distance between
that site and the closest laboratory, has not been proven correct.
The proposed formulation of the health impact objective as well as the functions
that would be performed by this objective was introduced in Subsection 5.1.1.3. Since
no evidence of a relationship between distance and the LTFU rate could be established,
the health impact objective must be adjusted so that it no longer takes the distance
between a site and its closest laboratory into consideration. Therefore, this objective
will no longer serve to minimise the total demand-weighted distance between primary
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healthcare facilities and the laboratories to which they refer their work. It is therefore
necessary to control this in another way. The use of a coverage distance is proposed,
this will be discussed in Subsection 5.1.9.
5.1.8 Health impact of locating a POC facility
In view of the fact that the assumption that the health impact is a function of both
the demand at a facility and the distance between that facility and the closest labora-
tory could not be confirmed as correct, the proposed formulation of the health impact
objective must be adjusted.
In Section 5.1 it was stated that the availability of relevant, representative and
accurate data has been the largest challenge associated with modelling the real-world.
This is particularly applicable to data regarding the likely health impact of different
CD4 testing service delivery models.
A large number of studies on the LTFU rate prior to ART initiation (based on
laboratory-based CD4 testing) has been conducted. A systematic review by Mugglin
et al. (2012) was used to introduce the concept of loss to follow-up in Subsection 2.3.2.1.
Though Mugglin et al. (2012) set out the concept very clearly, a systematic review by
Rosen & Fox (2011) has been cited significantly more frequently than Mugglin et al.
(2012)1. For this reason, the Rosen & Fox (2011) study will be used when calculating
the health impact of locating a POC facility. More recently, a large number of studies
has been conducted to determine the impact of POC CD4 testing on the LTFU rate
prior to ART initiation, Wynberg et al. (2014) systematically reviewed this literature.
The results of these systematic reviews are summarised in Table 5.3. The use of the
Rosen & Fox (2011) and Wynberg et al. (2014) data in this study was approved by the
subject matter experts from HEERO and those from CHAI.
Data set number three listed in Table 5.1 indicates the total number of patients that
were newly initiated onto ART at each facility each month (using laboratory-based CD4
testing). This number includes: patients that were eligible for immediate treatment
initiation based on their CD4 results, patients that had been enrolled in pre-ART care
(based on their CD4 result) before becoming eligible for ART; and patients that were
eligible for ART initiation regardless of their CD4 count (e.g. pregnant patients and
those with active TB). If it were possible to extract from this data (i) the number of
patients that were initiated onto ART immediately (δ); and (ii) the number of patients
that were initiated onto ART after having been enrolled in pre-ART care (κ), it would
1On 04/10/2014, Scopus reported that Rosen & Fox (2011) had been cited 169 times whilst Mugglin
et al. (2012) had been cited 10 times.
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Table 5.3: Summary of literature findings on pre-ART initiation LTFU rate.
Treatment stage
LTFU rate
based on
labora-
tory CD4
testing[1]
Odds ratio
based on
POC CD4
testing[2]
LTFU rate
based on
POC CD4
testing[3]
HIV testing to CD4 testing
41%
4.1
14% to 20%[4]
CD4 testing to receipt of result 2.8
CD4 result receipt to ART initiation
(patients that are not eligible for immediate
ART initiation, and are therefore enrolled in
pre-ART care until they become eligible)
54% 1.8 39%
CD4 result receipt to ART initiation
(patients that are eligible for immediate ART
initiation, based on their CD4 results)
32% 0.98 32%
[1] According to Rosen & Fox (2011) systematic review.
[2] According to Wynberg et al. (2014) systematic review.
[3] Calculated by applying Wynberg et al. (2014) odds ratio to Rosen & Fox (2011) LTFU rate.
[4] The Rosen & Fox (2011) review reports a single LTFU rate for the treatment stage from
HIV testing to receipt of CD testing result, while the Wynberg et al. (2014) review breaks this
up into two separate treatment steps and reports a unique odds ratio for each step.
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be possible to use the LTFU rates given in Table 5.3 to determine the number of
patients that would have been initiated onto treatment if POC testing had been used
at each site(ζ) using the following expression
ζ =
[
1− 0.32
1− 0.32δ +
1− 0.39
1− 0.54κ
] [
1− 0.2
1− 0.41
]
ζ = 1.36δ + 1.79κ.
This formula follows a conservative approach, the POC LTFU rate for the stage from
HIV testing to receipt of CD4 result has been set to the upper limit of 20%.
Data set number four in Table 5.1 indicates the number of CD4 test results that
fell within each of the following bands during the year: r≤50; 50<r≤100; 100<r≤200;
200<r≤350; 350<r≤500; r<50. However, this level of detail is not sufficient to allow
one to determine what percentage of patients were eligible for treament immediately
after their first CD4 test and what percentage were enrolled in pre-ART care first:
1. As stated in Subsection 5.1.3, no data is available on the proportion of the re-
ported CD4 tests that were conducted for the purpose of determining eligibility
for ART initiation versus those that were conducted for the purpose of monitoring
patients that were already on ART therapy; and
2. A large number of factors influences a patient’s CD4 count. Therefore, though
one would expect an individual’s CD4 count to increase after initiating ART,
it is incorrect to assume that all CD4 tests with a result of less than 350 were
conducted for the purpose of determining eligibility for ART initiation.
As described, it was not possible to distinguish between the number of patients that
were initiated onto ART immediately, those that were enrolled in pre-ART care first,
and those that were initiated onto treatment regardless of their CD4 count. Therefore,
a decision was taken to apply the most conservative factor (1.36) to the available data
at each facility (i.e. the total number of patients initiated onto ART at the facility per
year) in order to calculate the likely impact of using POC testing at a specific site.
5.1.9 The need for a coverage distance
Subsection 5.1.7 concluded by proposing that a coverage distance should be incorpo-
rated into the model in order to control the distance between the primary healthcare
facilties and the CD4 testing laboratories that they refer to. Two recent South African-
based studies propose a coverage distance for public healthcare laboratories providing
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CD4 testing. Cassim et al. (2014) propose that the tier three laboratories (described
in Subsection 5.1.4) should serve facilities that lie within a 100km radius1. The study
also states that, the tier three laboratories in the Pixley ka Seme district in the North-
ern Cape were serving primary healthcare facilities within a radius of 50km to 250km2.
Furthermore, Cassim et al. (2014) suggests that a distance of more than 150km between
the primary healthcare facility and the CD4 testing laboratory may negatively affect
both the specimen integrity and the turnaround time of the CD4 test result delivery
to the primary healthcare facility. Glencross et al. (2014) in their investigation of the
establishment of a tiered laboratory network for CD4 service provision, suggested CD4
laboratory coverage radiuses of between 50km and 200km. This study states that facili-
ties that fall outside a 100km radius of a CD4 testing laboratory, “largely coincide with
districts with poorer turnaround time (of laboratory testing)”. Literature therefore
does not agree on a specific acceptable coverage radius for CD4 testing laboratories,
although radii of between 50km and 200km are suggested (and radiuses of up to 250km
are observed in practice). There also is no clear consensus on the distance at which
turnaround performance starts being affected, though both 100km and 150km are pro-
posed. In view of the lack of a clear consensus on coverage distance in literature, a
CD4 laboratory coverage distance of 150km is used in the model. Because this distance
is not supported by clear evidence, sensitivity analysis is performed on this variable
by also testing the impact of setting the coverage distance to 100km and to 200km
respectively.
5.1.10 Input data set: Inter-site travel distances
The euclidian distance between each of the ART initiation healthcare facilities and each
of the potential CD4 testing sites was calculated based on data sets numbers two, five
and six in Table 5.1. As discussed in the previous subsection, a coverage radius will
be used in the model, therefore it is appropriate to use the euclidian distance between
facilities rather than the actual travel distance via the road network.
1The draft paper proposes that these laboratories should serve an area of 100km2. However when
one reads the context in which this statement is made, it is reasonable to conclude that the authors
meant to suggest a coverage radius of 100km. This conclusion was verified during a meeting with three
of the authors (Mr N. Cassim, Dr L. Coetzee and Prof. D. Glencross) on 10 June 2014.
2In the draft article, the unit of this radius is given as “km2”, however, the value is clearly labelled
“radius of referrals” therefore this unit can be assumed to be an oversight.
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5.1.11 Summarised final input data set
The input data sets that have been included in the final model are summarised in Table
5.4.
Table 5.4: Summarised final input data set.
A list of 3 279[1] ART initiation facilities with the following attributes:
The total number of CD4 tests requested by the facility during the 2012/2013 financial
year (refer to Subsection 5.1.3).
The number of additional patients that would have been initiated onto ART at the facility
during the 2013/2014 financial year if POC CD4 testing had been used at the facility (refer
to Subsection 5.1.8).
A cost per test for each of the five tiers defined by Cassim et al. (2014) (refer to Subsection 5.1.4).
A list of 61 CD4 laboratories (refer to Subsection 5.1.6)
An inter-site travel distance matrix (refer to Subsection 5.1.10)
[1] Refer to Subsections 5.1.2 and 5.1.3 for an explanation of the number of ART initiation
facilities that are included in the model.
5.2 Tailored mathematical model
The next four subsections describe how the standard formulation has been adjusted in
order to model the real-world problem with the available public healthcare data. The
mathematical formulation of the real-world problem is given in Subsection 5.2.5.
5.2.1 Adjustments to the model objectives
The proposed adjustments to the model objectives were discussed in Subsections 5.1.1.1
to 5.1.1.3. The assumption on which the proposed changes to the cost objective were
based, has been proven correct, therefore this objective has been adjusted as described
in Subsection 5.1.1.2. The assumption on which the proposed changes to the health im-
pact objective were based has not been proven correct, therefore the changes proposed
in Subsection 5.1.1.3 will not be implemented. Instead, the health impact objective
will be adjusted as described below.
The health impact is defined as the number of additional people that are initiated
onto ART (over and above the number of patients that are currently initiated, using
laboratory-based CD4 testing). Therefore:
1. The calculation of the health impact objective will have only one component. For
facilities where POC CD4 testing is allocated, the factor derived in Subsection
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5.1.8 will be applied to data on the number of patients initiated at the facility
during the 2013/2014 financial year to calculate the number of additional patients
that will be initiated onto treatment due to the use of POC. Facilities that make
use of conventional testing will be assumed to have no incremental health impact;
and
2. The health impact objective will not serve to minimise the total demand-weighted
travel time between healthcare facilities and the CD4 laboratories that they have
been assigned to. Instead, as proposed in Subsection 5.1.7, this will be controlled
through the use of a coverage distance.
5.2.2 Adjustments to the model assumptions
With the exception of the assumption regarding the need for a coverage distance, all
of the assumptions that the UFL is based on, are applicable to the real-world problem.
The need for a coverage distance was introduced in Subsection 5.1.7. Please refer to
Subsection 4.2.3 for a detailed discussion of the applicability of each of the remaining
assumptions.
5.2.3 Adjustments to the model inputs
The availability of input data, the processing of the available data and the summarised
final input data set for the real-world problem have been summarised in Section 5.1.
This input data set differs from the UFL input data requirements in only two ways: (i)
the need for a coverage distance as input to the model, refer to Subsection 5.1.9; and
(ii) the nature of the cost data that is required as an input, refer to Subsections 5.1.1.2
and 5.1.4.
5.2.4 Adjustments to the model outputs
The outputs of the UFL model are appropriate for modelling the real-world problem,
this was discussed in more detail in Subsection 4.2.5.
5.2.5 Mathematical formulation of real-world problem
The mathematical formulation of the real-world problem given here incorporates the
required changes to the standard UFL model’s objectives, assumptions and inputs.
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Let
I: set of ART initiation facilities, i ∈ {1, 2, . . . , i, . . . , I}
J: set of CD4 testing facilities, j ∈ {1, 2, . . . , j, . . . , J}
where j = 1 represents POC testing and
j = 2, 3, . . . , J represent laboratory sites
S: the maximum acceptable distance between an ART initiation
facility and the laboratory facility that it is assigned to
ni: the number of additional patients that would have been initiated
onto ART at site i if POC testing had been used at the site
dij : the distance between ART initiation site i and laboratory facility j
vi: the number of CD4 tests requested by ART initiation site i
wj : the total CD4 testing volume assigned to laboratory j
qj : the cost of performing the CD4 tests assigned to laboratory j
ri: the cost of performing the POC tests assigned to ART initiation
site i.
The decision variable is
yij =

1 if the CD4 testing for ART initiation facility i is assigned to
testing facility j
0 otherwise.
The objectives are to maximise
I∑
i=1
yi1ni (5.1)
and minimise
I∑
i=1
ri +
J∑
j=2
qj (5.2)
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subject to
J∑
j=1
yij = 1 i ∈ I, (5.3)
yijdij ≤ S j ∈ J, i ∈ I, (5.4)
wj =
I∑
i=1
yijvi j = 2, 3, . . . , J , (5.5)
qj =

10, 56wj if wj ≤ 24 000
9, 38wj if wj ≤ 94 560
8, 51wj if wj > 94 560
j = 2, 3, . . . , J , (5.6)
ri =
35, 46xi1vi if yi1vi ≤ 120019, 02xi1vi if yi1vi > 1200 i ∈ I, (5.7)
yi1vi ≤ 9 600 i ∈ I, (5.8)
yij is binary.
The coefficients in (5.6) and (5.7) are equivalent to the cost per test data in Table 5.2.
The constants in these two equations represent the annual testing volume thresholds
for each costing tier. These annual volumes were calculated based on an assumption of
20 working days per month, this is the same assumption that was used by Cassim et al.
(2014) when defining the daily testing volume thresholds for each tier in Table 5.2.
Constraint (5.8) ensures that POC testing is not assigned to sites that process more
than the maximum annual testing volume for POC sites as defined by Cassim et al.
(2014).
5.3 Validation of the problem formulation
The problem formulation has been validated to confirm that it adequately depicts the
real-world problem through presentation to three sets of subject matter experts:
1. Public healthcare experts from CHAI and a health economist from HEERO were
frequently consulted during the selection of the most appropriate standard math-
ematical formulation, the analysis of the available input data and the develop-
ment of the tailored mathematical formulation. These subject matter experts
were consulted in order to ensure that the assumptions made were reasonable,
that the input data and other literature were interpreted correctly and that the
characteristics of the real-world problem were understood correctly;
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2. The selected standard mathematical formulation and the input data analysis were
presented to the NHLS subject matter experts (Stevens et al., 2014); and
3. The problem formulation and the input data analysis were presented at the trien-
nial conference of the International Federation of Operations Research Societies
in Spain (2014).
5.4 Solution methodology
A number of factors contribute to make this a difficult problem to solve:
1. The decision space is extremely large (a binary matrix of 3 279 rows by 62 columns,
with only one “1” allowed per row);
2. The problem is non-linear (specifically, the tiered cost per test values given in
Table 5.2 create a saw-tooth function); and
3. The problem is multi-objective.
The first approach was to attempt to solve the problem using the commercial pack-
age AIMMS. The reasons for selecting AIMMS were: (i) the software has a very user-
friendly interface; (ii) AIMMS contains a large variety of built-in algorithms; (iii) the
package has been successfully used to solve complex models both by the researcher and
by fellow M.Eng students at Stellenbosch University; and (iv) the researcher is famil-
iar with the software. AIMMS does not have the capability to solve multi-objective
problems, therefore the problem was converted to a single-objective problem by fixing
the available budget and setting this as a constraint, leaving the health impact as the
only objective. This model formulation was tested using a small version of the problem
(i.e. a reduced number of DOH and laboratory sites). AIMMS was unable to solve this
single-objective version of the problem. Further investigation confirmed that this was
due to the non-linear, saw-tooth cost function. (This was confirmed by replacing the
cost function with a linear function, AIMMS was then able to solve the problem.)
As a second attempt at solving the model, a metaheuristic for multi-objective op-
timisation was applied to the problem. The Cross Entropy Method for Multi-objective
Optimisation (the MOO CEM) developed by Bekker (2012) was selected. The reasons
for selecting this metaheuristic were: (i) the MOOCEM has the ability to solve prob-
lems with multiple objectives; and (ii) literature describes that the metaheuristic has
been successfully applied to similar problems (more details are given in the following
subsection). Both the problem formulation and the metaheuristic were adjusted, first
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to enable the metaheuristic to be successfully applied to the problem and second to
improve the efficiency with which the metaheuristic was able to solve the problem. The
application of the MOO CEM to the real-world problem is described in more detail in
the next subsection.
In order to verify the quality of the solution generated by the MOO CEM, at-
tempts were made to apply various built-in algorithms in the Matlab software package
to the real-world problem. A single-objective version of the problem was succesfully
solved with the Matlab Genetic Algorithm. The process of selecting this algorithm and
applying it to the real-world problem is described in more detail in Subsection 5.4.2.
5.4.1 Multi-objective solution via the MOO CEM
The cross-entropy method was developed by Rubinstein (1997) and extended for ap-
plication to single-objective continuous and combinatorial problems by Rubinstein &
Kroese (2004). The cross-entropy method has been adapted for application to both
continuous multi-objective optimisation problems (Bekker & Aldrich, 2011) and to dis-
crete multi-objective optimisation problems (Bekker, 2013). Both Bekker & Aldrich
(2011) and Bekker (2013) found that the MOO CEM generates high-quality results
while requiring relatively few evaluations of the objective functions. Stadler (2012) and
Hauman & Bekker (2014) applied the MOO CEM to real-world problems and found
that the metaheuristic performs well. Scholtz (2014) studied the metaheuristic by com-
paring the performance of the MOO CEM as well as two hybrid algorithms based on
the MOO CEM to the performance of two algorithms that take relationships between
decision variables into account. Importantly, Scholtz (2014) found that on large prob-
lems, the MOO CEM as well as a hybrid algorithm based on the MOO CEM typically
perform better than algorithms that take the relationships between decision variables
into account.
The MOO CEM is a population-based algorithm (as opposed to a single-solution-
based algorithm), as such, during each iteration of the algorithm, a number of solutions
(as opposed to a single solution) are produced. The MOO CEM produces a popula-
tion of N solutions by sampling from a unique probability density function for each
decision variable in the problem N times. Once a full population of solutions have
been generated, the MOO CEM uses a ranking algorithm to evaluate the quality of
the solutions that have been generated, based on their objective function values. The
best ranked solutions are added to a set of solutions known as “Elite”. The probability
density function for each decision variable is updated, based on the probability den-
sity functions for that variable contained in the Elite set, and a new population of N
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solutions (referred to as a new “generation”) is generated. In this way, the algorithm
increases the likelihood of generating solutions of a superior quality (this is referred to
as exploitation). In order to ensure that the algorithm does not become trapped in one
area of the solution space, the MOO CEM introduces new solutions into the Elite set.
This specific mechanism is invoked randomly. The algorithm starts searching in a new
area of the solution space (this is referred to as exploration).
As discussed in the introduction to this section, both the problem formulation and
the metaheuristic were adjusted in order to enable the MOO CEM to be applied to the
real-world problem. This process of problem and algorithm adjustment was executed
in a number of iterative phases described next. Figure 5.1 provides a comparison of the
shape and size of the variable matrices and structures used in each of these iterations.
5.4.1.1 MOO CEM solution phase one
In its original form, the MOO CEM is most commonly applied to continuous rather
than discrete problems. The algorithm also does not have the ability to take constraint
equations into consideration. During the first MOO CEM solution phase, the focus
was on adjusting the problem formulation to eliminate the need for separate constraint
equations, and to adjust the functioning of the MOO CEM so that it is able to generate
solutions to this problem, evaluate these solutions and exploit good solutions.
The mechanism by which the algorithm ensures exploration of the solution space
was also adjusted from the standard mechanism that is invoked randomly (described
in the preceding subsection). The exploration mechanism was adjusted to evaluate
the diversity of the solutions contained in the “Elite” set and to generate a new set
of probability density functions for each decision variable (based on random number
generation) if the diversity fell below a threshold value.
1. The problem was formulated using an allocation matrix with a row for each of
the 3 279 DOH facilities and a column for each of the 61 CD4 laboratories as well
as a column to denote POC testing (depicted in the top section of Figure 5.1).
Constraints were incorporated as desribed next:
(a) The coverage distance constraint was implemented using the concept of a
“big M”. Therefore the health impact goal function was penalised by a
very large amount whenever a DOH facility’s testing was assigned to a CD4
laboratory outside of its coverage distance; and
(b) Each DOH facility must either be assigned to exactly one laboratory or to
POC testing. Therefore each row of the allocation matrix had to contain
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exactly one “1”. As mentioned, the MOO CEM samples from a unique
probability density function to determine the value of each decision vari-
able. Each row of the allocation matrix was set as a decision variable and
the MOO CEM was programmed to sample from unique truncated Poisson
distributions in order to allocate exactly one “1” to one of 62 positions for
each row of the allocation matrix.
2. The metaheuristic now worked as follows:
(a) The algorithm stored a unique λ value for the truncated Poisson distribution
associated with each of the 3 279 decision variables;
(b) It was possible to generate an infeasible solution by allocating a DOH fa-
cility to a laboratory that falls outside its coverage distance. However, as
discussed, the concept of a “big M” was employed to ensure that these solu-
tions generated a weak performance in terms of the health impact objective;
(c) Exploitation of good solutions was ensured by adjusting the λ value of each
decision variable, based on the λ values in the “Elite” set; and
(d) As described in the introduction to the subsection, exploration of the solution
space was implemented by evaluating the diversity of the solutions in the
“Elite” set. This was done by converting each of the 3 279 binary strings
to a binary representative number and then comparing each representative
number for each of the solutions in the “Elite” set.
This model was programmed and implemented in Matlab. The programming and im-
plementation of the mathematical model were verified by running small sets of test
data, writing out interim results at various points in the code, duplicating the manipu-
lation of this data in a Microsoft Excel spreadsheet and comparing the results to those
generated by the Matlab model. Smaller portions of the Matlab code were also isolated
into separate models and tested against an Excel spreadsheet in a similar manner. Af-
ter the programming of the model had been succesfully verified, it was applied to the
full data set and it succesfully generated a Pareto set.
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Decision variable matrix Reference matrix Allocation matrix
Solution phase one:
j ∈ {1, 62}
i
∈
{
1
,
3
2
7
9
}
x1,1 x1,2 · · · x1,62
x2,1 x2,2 · · · x2,62
...
...
. . .
...
x3279,1 x3279,2 · · · x3279,62
Solution phase two, first approach:
j ∈ {1, 18} j ∈ {1, 18} j ∈ {1, 62}
i
∈
{
1
,
3
2
7
9
}
θ1,1 θ1,2 · · · θ1,18
θ2,1 θ2,2 · · · θ2,18
...
...
. . .
...
θ3279,1 θ3279,2 · · · θ3279,18
13 28 · · · 0
4 17 · · · 59
...
...
. . .
...
9 0 · · · 0
x1,1 x1,2 · · · x1,62
x2,1 x2,2 · · · x2,62
...
...
. . .
...
x3279,1 x3279,2 · · · x3279,62
Solution phase two, second approach:
j ∈ {1, ?} j ∈ {1, 61} j ∈ {1, 62}
i
∈
{
1
,
3
2
7
9
}
θ1,1 · · · θ1,8
θ2,1 · · · θ2,8 · · · θ2,17 · · · θ2,23
θ3,1 · · · θ3,8 · · · θ3,17
...
θ3279,1
13 · · · 28 · · · 0 · · · 0
4 · · · 17 · · · 33 · · · 59
2 · · · 36 · · · 51 · · · 0
...
...
...
...
...
. . .
...
9 · · · 0 · · · 0 · · · 0
x1,1 x1,2 · · · x1,62
x2,1 x2,2 · · · x2,62
...
...
. . .
...
x3279,1 x3279,2 · · · x3279,62
Figure 5.1: Decision variable structure in MOO CEM.
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5.4.1.2 MOO CEM solution phase two
In the second MOO CEM solution phase, the focus was on enabling the metaheuristic to
solve the real-world problem more efficiently and to generate better quality results. The
proposal was that the metaheuristic would be able to (i) find feasible solutions and (ii)
exploit these feasible solutions more efficiently if the truncated Poisson distribution used
to generate the value of each decision variable were shorter. (As described in Subsection
5.4.1.1, each truncated Poisson distribution was defined on the range {0, 61} during the
first solution phase). The process of incorporating a reference matrix to shorten each
truncated Poisson distribution is described next.
1. As a first approach, a standard number of options were made available for each
DOH site. In addition to the allocation matrix used in Subsection 5.4.1.1, a deci-
sion variable matrix and a reference matrix were also introduced to the problem.
The decision variable matrix had significantly fewer columns than the allocation
matrix. (Experiments were run with different numbers of standard options for
each DOH site, ranging from two options to 18 options.) The reference matrix
was used to keep track of which laboratory each cell in the decision variable ma-
trix referred to and this was used to convert the decision variable matrix to the
allocation matrix before evaluating the goal functions. (Refer to the middle sec-
tion of Figure 5.1.) This approach was verified using a similar method to that
described in Subsection 5.4.1.1 and a Pareto set was succesfully generated for the
full data set. This approach was not ideal because:
(a) for DOH facilities with a large number of CD4 laboratories within their
coverage distance, all of the feasible options were not being considered; and
(b) for DOH facilities with only a small number of laboratories in their cov-
erage distance, infeasible options were also being considered (the “big M”
approach described in Subsection 5.4.1.1 was used to penalise the health
impact objective in these cases).
2. As a second approach, the algorithm was adjusted so that the exact number of
feasible options that exist for each DOH site1 was made available to that site.
This was achieved by adjusting the decision variable structure (introduced in the
preceding paragraph) so that it had varying row lengths. (This is depicted in
the bottom section of Figure 5.1.) For each of the 3 279 decision variables, the
1The number of CD4 laboratories that fall within the coverage distance of each DOH site as well
as the POC option.
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metaheuristic now kept track of both the length and the λ-value of the trun-
cated Poisson distribution. While the λ-value was adjusted as the metaheuristic
explored good solutions, the length of each truncated Poisson distribution re-
mained fixed. The implementation of this approach was verified using a similar
method to that described in Subsection 5.4.1.1 and a Pareto set was generated
for the full data set. This approach was superior to those implemented previously
because:
(a) all feasible solutions are considered;
(b) no infeasible solutions are considered; and
(c) due to the reduced size of the decision variable structure, the metaheuristic
is able to generate better quality solutions with less computational effort.
5.4.1.3 MOO CEM solution phase three
During the third MOO CEM solution phase, the focus was on ensuring that the meta-
heuristic thoroughly explored the solution space. Specifically, different methods for
generating the initial set of λ values during each main iteration of the metaheuristic
were experimented with. The details of this experimentation will not be covered here
but an important conclusion from this experimentation is that the functioning of the
MOO CEM can be greatly affected by the method used to generate the probability
density function parameters. As an illustration of this point, earlier experimentation
with the generation of probability density function parameters was succesful in direct-
ing the metaheuristic to explore a specific portion of the solution space, but could
not succeed in widening the scope of this exploration. Consequently, an approach was
formulated where the metaheuristic was run 22 times, directed to explore a specific
portion of the solution space during each run. (Due to the stochastic nature of the
metaheuristic, it was challenging to direct the search at a specific portion of the solu-
tion space. The 22 runs were decided on through experimentation, and were selected
with the aim of ensuring that the metaheuristic explores the entire solution space.)
These results were then combined to form a final Pareto set. This was the status quo
for approximately two months until further experimentation with alternative methods
of generating probability density function parameters eventually led to a method that
allowed the metaheuristic to explore the solution space as completely during only one
run as it had previously done over the course of 22 runs.
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5.4.1.4 Other factors considered during the MOO CEM solution
Before concluding the discussion of the MOO CEM, it is important to mention two
parameters that influence the working of the metaheuristic:
1. The  parameter governs the threshold value for an acceptable level of diversity in
the “Elite” set. As discussed in Subsection 5.4.1, this ensures thorough exploration
of the solution space.
2. The α parameter governs the extent to which the probability density function for
each decision variable is updated based on the solutions contained in the “Elite”
set. As discussed in Subsection 5.4.1, this ensures thorough exploitation of good
solutions.
During all three phases of the MOO CEM solution, experiments were conducted with
different combinations of these parameter values in order to determine combinations
that generated good results in a short period of time. Parameter adjustment of this
type is not an exact science and, though this experimentation was documented and
conducted in a systematic manner, it was not the purpose of this research to conduct
exhaustive experiments on these parameters of the MOO CEM. In addition to the 
and α parameters, other settings of the metaheuristic such as the population size and
the maximum number of evaluations that are executed were also experimented with.
5.4.1.5 Results generated by the MOO CEM
Due to the need for sensitivity analysis based on the coverage distance (discussed in
Subsection 5.1.9), three scenarios were solved using the MOO CEM metaheuristic. The
results are displayed in Figure 5.2. As shown, the real-world problem does not seem to
display a significant sensitivity to the different coverage distance values (100km, 150km
and 200km) that are considered. It is therefore recommended that it is reasonable to
proceed with further analysis based on a coverage distance of 150km.
5.4.2 Single-objective solution with a commercial algorithm
As a method to verify the quality of the solutions generated by the MOO CEM, a de-
cision was made to apply a standardised Matlab solver or solvers to a single-objective
version of the problem. (The single-objective version of the problem described in the
introductory paragraphs of Section 5.4 was used, therefore the maximum solution cost
was constrained and the health impact was set as the objective.) The complete set of
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Figure 5.2: The MOO CEM results.
solvers available in both the Matlab Optimisation Tool and the Matlab Global Optimi-
sation Tool are summarised in Table 5.5. As described in the table, four of the solvers
can be applied to a single-objective version of the real-world problem.
The standardised Matlab solvers require that the problem constraints be formulated
using two equations
A.x ≤ b, (5.9)
Aeq.x = beq. (5.10)
Thus all linear inequality constraint equations are grouped into a single matrix (A
and b respectively) for the left and the right hand side of (5.9) and all linear equality
constraint equations are similarly grouped into a single matrix (Aeq and beq) for the
left and the right hand side of (5.10). The objective function as well as any nonlinear
constraint(s) that may exist are defined as functions that are programmed in the normal
Matlab script environment. The solvers also generally allow the user to set a lower and
an upper bound for the variable(s) and to define an initial value for the variable(s).
The first step in solving a single-objective version of the real-world problem using one
of the standardised Matlab solvers, was to convert the mathematical formulation given
in Subsection 5.2.5 to suit the standardised problem format required by the Matlab
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Table 5.5: Suitability of Matlab solvers.
Matlab solver name Suitability for application to real-world
problem
Binary integer programming (“bint-
prog”)
Unsuitable: Unable to handle nonlinear con-
straints
Multi-objective goal attainment
(“fgoalattain”)
Unsuitable: Multi-objective optimisation
Single-variable nonlinear minimisation
with bounds (“fminbind”)
Unsuitable: Unable to handle multiple vari-
ables
Constrained nonlinear minimisation
(“fmincon”)
Suitable
Minimax optimisation (“fminimax”) Suitable
Unconstrained nonlinear minimisation
(“fminsearch”)
Unsuitable: Unable to handle constraints
Unconstrained nonlinear minimisation
(fminunc”)
Unsuitable: Unable to handle constraints
Semi-inifite minimisation (“fseminf”) Unsuitable: the problem does not have semi-
inifinite constraints
Nonlinear equation solving (“fsolve”) Unsuitable: Unable to handle constraints
Single-variable nonlinear equation solv-
ing (“fzero”)
Unsuitable: Unable to handle multiple vari-
ables
Genetic Algorithm (“ga”) Suitable
Multi-objective optimisation using Ge-
netic Algorithm (“gamultiobj”)
Unsuitable: Unable to handle nonlinear con-
straints
Linear programming (“linprog”) Unsuitable: Unable to handle nonlinear con-
straints
Nonlinear curve fitting (“lsqcurvefit”) Unsuitable: Curve fitting is not applicable to
the problem
Constrained linear least squares
(“lsqlin”)
Unsuitable: Unable to handle nonlinear con-
straints
Nonlinear least squares (“lsqnonlin”) Unsuitable: Unable to handle constraints
Nonnegative linear least squares
(“lsqnonneg”)
Unsuitable: Unable to handle constraints
Pattern Search (“patternsearch”) Suitable
Quadratic programming (“quadprog”) Unsuitable: Unable to handle nonlinear con-
straints
Simulated annealing algorithm (“simu-
lannealbnd”)
Unsuitable: Unable to handle constraints
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solvers.
As a first attempt to convert the real-world problem to a suitable format, an alloca-
tion matrix with 3 279 rows and 62 columns was used as the decision variable (x) and
the constraint matrices (A, b, Aeq, and beq) were set up based on this allocation ma-
trix. The accuracy of this model formulation was tested by applying one of the suitable
solvers to smaller versions of the real-world problem. The results that were generated
were written out to Excel files and were analysed to verify that all constraint equations
were functioning correctly. Following this verification step, an attempt was made to
solve the full problem. Unfortunately, Matlab was not able to solve the real-world
problem in this formulation as the size of the constraint matrices that were generated
were larger than Matlab’s memory allows for.
As a second attempt to convert the real-world problem to a suitable format, a
decision variable vector with 3 279 rows and 1 column was used in combination with
a reference matrix. (This is similar to the approach combining a decision variable
and a reference matrix used in Subsection 5.4.1.2, although the decision variable used
in Subsection 5.4.1.2 was a structure with varying numbers of columns rather than
a vector.) The constraint equations were adjusted in accordance with the decision
variable format, in this format, it was possible to formulate the mathematical model
using only a nonlinear constraint function. Therefore no matrices for the linear equality
and inequalities were required. The accuracy of this model formulation was tested using
small data sets and analysis in Excel, similar to the approach used previously. Following
this verification step, an attempt was made to solve the full problem with each of the
four suitable solvers identified in Table 5.5. In each case, an initial feasible solution
was provided as a starting point for the solver:
1. The “fmincon” constrained nonlinear minimisation solver ran for approximately
40 minutes without generating any feasible solutions. The solver then generated
an error message. Therefore, though this solver is suited to all of the character-
istics of the single-objective version of the real-world problem, it was not able to
solve the problem efficiently in the formulation described here;
2. The “fminimax” minimax optimisation solver responded in exactly the same man-
ner as the “fmincon” solver;
3. During the first hour, the Genetic Algorithm solver generated several feasible
results that had a better objective function value than the initial feasible solution.
This confirmed that the solver was suited to all of the characteristics of the single-
objective version of the real-world problem and that it had the potential to solve
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the problem formulation described here efficiently; and
4. The Pattern Search solver ran for an hour without generating any feasible solu-
tions or any error messages. Therefore it is reasonable to conclude that, though
this solver is compatible with all of the characteristics of the real-world problem,
it is not able to solve the problem efficiently in the formulation described here.
From the experimentation above, a decision was made to proceed using only the
Genetic Algorithm solver. The Matlab Genetic Algorithm has various parameters that
can be adjusted in order to improve the performance of the solver. The following
parameters were experimented with: population size, reproduction crossover fraction,
migration fraction, migration interval, stopping criteria time limit, and stopping cri-
teria stall function value tolerance. Similar to the approach used during the MOO
CEM parameter experimentation, though this experimentation was documented and
conducted in a systematic manner, the aim was not to perform exhaustive experiments
on the effects of different combinations of parameter values. The purpose of solving a
single-objective version of the real-world problem using a commercial algorithm, is to
verify the quality of the results generated by the MOO CEM. The verification process
is described in more detail in the next subsection.
5.5 Verification of the solution methodology
Two approaches were followed to verify the quality of the solution generated by the
MOO CEM: (i) the cost of the status quo (where no POC testing is used) as well as the
cost and incremental health impact of a scenario where POC testing is used as widely as
possible were estimated using deterministic methods; and (ii) a single-objective version
of the problem was solved using a commercial algorithm. A coverage distance of 150km
was used during verification.
5.5.1 First verification step
The status quo is equivalent to the scenario with the lowest possible cost and has an
incremental health impact of zero. (As stated in Subsection 5.2.1, facilities that make
use of laboratory-based testing are assumed to have no incremental health impact.)
The scenario where POC testing is used as widely as possible, is the scenario with
the highest possible cost and incremental health impact. The objective function values
for these scenarios were estimated to establish whether the MOO CEM explored the
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full range of options for the incorporation of POC testing into the diagnostic service
delivery model.
The costing of the status quo scenario is based on the most conservative estimate of
the current annual cost of delivering CD4 testing to the South African public healthcare
sector. Two approaches were considered, both approaches used the number of CD4 tests
performed by the NHLS in the 2012/2013 financial year (refer to Subsection 5.1.3) as
part of the calculation:
1. Use the average cost per test for the laboratory tiers (tiers 3, 4 and 5) as given in
Table 5.2. This results in a cost per test of US$6.34, which translates to a total
annual testing cost of US$21 291 280; or
2. Use the average number of tests per facility to determine which laboratory tier’s
cost per test amount to use in the calculation. The average number of tests per
facility per day is 229, this falls within the tier 4 laboratory classification (as given
in Table 5.2). A total annual testing cost of US$20 955 455 was estimated, based
on the tier 4 cost per test of US$6.24.
The second approach was selected as it generated the lowest estimate of the status quo
cost. (As this cost will be used to determine the lowest cost in the solution space, this
is the most conservative approach.)
The estimates for the scenario where POC testing is used as widely as possible were
developed by asigning POC testing to all ART initiation facilities where the total annual
testing volume is less than the threshold for POC testing defined in Table 5.2. The
remaining 20 ART initiation facilities were allocated to one of three CD4 laboratories.
This approach generated an estimated testing cost of US$71 215 960 and an incremental
health impact of 186 013 people.
These two scenarios are compared to the results generated by the MOO CEM in
Figure 5.3. Though it is clear that the MOO CEM does not explore the most extreme
reaches of the solution space, it does appear to explore a sufficiently wide range of
options from very limited use of POC (at a cost of US$23 825 197) to widespread use
of POC (at a cost of US$67 656 318).
5.5.2 Second verification step
In the second verification step, the Matlab Genetic Algorithm was used to solve a
single-objective version of the real-world problem. The incremental health impact was
set as the only objective and the cost function was converted to an inequality constraint.
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Figure 5.3: Comparison of MOO CEM and Matlab Genetic Algorithm solution quality.
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In order to generate several points that could be compared with the Pareto set, the
optimisation was run 10 times with the maximum allowable testing cost set to a different
value each time. (The maximum cost was varied from US$25 million to US$70 million
at intervals of US$5 million.) The Matlab solver was set to terminate either after eight
hours or if all of the solutions in 15 consecutive generations had failed to improve on
the objective function value.
The points generated by the Matlab Genetic Algorithm solver are compared to the
Pareto set generated by the MOO CEM in Figure 5.3. From the figure, it is evident
that the Matlab Genetic Algorithm struggles to explore both the low cost, low health
impact and the high cost, high health impact portions of the solution space. However,
as shown, the quality of the results generated by the MOO CEM compare well with
that of the results generated by the commercial algorithm. The figure also clearly shows
that the MOO CEM struggles to explore the portion of the solution space with a cost
of approximately US$50 million. However, the Matlab Genetic Algorithm results show
that solutions do exist in this portion of the solution space. An important conclusion
that can be made from this is that one could generate a more complete set of solutions
to the real-world problem by combining solutions that have been generated by both the
MOO CEM and the commercial algorithm into a single data set and then generating a
Pareto set from this combined data set.
5.6 Final solution set
With reference to the conclusion made in the previous subsection, the solutions pre-
sented here have been drawn from a Pareto set that was formed based on both the
MOO CEM and the commercial algorithm’s results. As stated in Section 1.2, the aim
of this research is to provide decision-makers with information on a range of scenarios
for the use of POC CD4 testing in South Africa. To accomplish this, the details on a set
of nine solutions ranging from a budget of US$25 million to US$65 million at intervals
of US$5 million are given. (US dollars was selected as the currency for the modelling as
it is the currency that was used in the Cassim et al. (2014) study on which the costing
in the model is based.)
Figure 5.4 contains both the MOO CEM Pareto set solutions with a system cost that
is closest to the defined budget as well as the Matlab Genetic Algorithm results for each
of the defined budgets. The budgets were not intended as absolute constraints, therefore
the Matlab Genetic Algorithm was set up to generate solutions with a total system cost
that did not exceed the budget amount by more than a tolerance amount. Similarly,
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Figure 5.4: Final MOO CEM and Matlab Genetic Algorithm solution sets.
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the MOO CEM solution with a total testing cost that was closest to the budget amount
was selected, provided the testing cost did not exceed the budget amount by more than
US$1 million. The MOO CEM Pareto set did not contain a solution with a total testing
cost of between US$49 million and US$51 million.
Table 5.6 gives the summarised final solution set that will be discussed in more
detail in Chapter 6. For a budget of US$50 million, the Matlab Genetic Algorithm
solution was selected. The MOO CEM solutions were selected for the remainder of the
budget options being explored.
Table 5.6: Final solution set.
Total Incremental
Scenario Budget system cost health impact Solution method
1 $25 million $25 071 516 15 603 people MOO CEM
2 $30 million $30 108 463 33 433 people MOO CEM
3 $35 million $35 150 572 55 040 people MOO CEM
4 $40 million $39 993 712 73 708 people MOO CEM
5 $45 million $45 195 168 91 149 people MOO CEM
6 $50 million $49 322 233 104 678 people Matlab GA
7 $55 million $54 930 000 132 954 people MOO CEM
8 $60 million $60 025 574 150 032 people MOO CEM
9 $65 million $64 643 600 166 558 people MOO CEM
5.7 Conclusion: Modelling the real-world problem
This chapter discussed the modelling of the real-world problem by describing the input
data analysis, presenting the mathematical formulation and describing the solution
methodology. The next chapter will discuss the results that have been generated.
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Analysis of results
The previous chapter detailed the modelling of the real-world problem. This chapter
provides an analysis of the results obtained for the real-world problem and discusses
the implication of these results in terms of the healthcare delivery system.
6.1 Presentation of results
Arguably the most important contribution of this research is to provide decision-makers
within the SA public healthcare sector with an indication of where the optimal trade-
off points between an improved healthcare outcome and increased healthcare spending
lie. This information better equips individuals involved in managing diagnostic service
delivery and those responsible for managing the allocation of public funds by providing
an indication of the alternative scenarios that should be considered.
The final solution set was presented in Table 5.6. When comparing these scenarios,
there are a number of factors other than the total testing cost and the incremental
health impact of the solution that decision-makers should take into account:
1. The number of ART initiation sites where POC is implemented;
2. The number of CD4 laboratories that are required;
3. The percentage of the total testing workload that is executed on POC testing
devices; and
4. The incremental cost per additional person initiated onto treatment.
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Table 6.1 gives the complete data set for each of the nine selected scenarios as well
as the status quo (scenario 0) and a scenario where POC testing is implemented as
widely as possible (scenario 10). The calculation of the cost and the incremental health
impact for these two scenarios was described in Subsection 5.5.1.
Table 6.1: Summarised results to the real-world problem.
Annual Incremental Number Number % of testing Incremental
S
c
e
n
a
ri
o
CD4 health of POC of CD4 volume cost per
testing impact sites laboratories performed additional
cost using POC person
initiated
0 $20 955 455 0 0 61 0% $0
1 $25 071 516 15 603 453 61 7% $264
2 $30 108 463 33 433 739 61 16% $274
3 $35 150 572 55 040 1 215 57 25% $257
4 $39 993 712 73 708 1 480 54 34% $258
5 $45 195 168 91 149 1 757 54 43% $266
6 $49 322 233 104 678 1 743 33 55% $271
7 $54 930 000 132 954 2 236 47 64% $256
8 $60 025 574 150 032 2 618 44 71% $260
9 $64 643 600 166 558 2 827 35 81% $262
10 $71 251 960 186 013 3 259 4 91% $270
From an operational perspective, the number of ART initiation sites where POC
testing will be utilised is an important metric as it would be reasonable to conclude that
the operational management of the healthcare system would become more complex as
testing is executed at a larger number of facilities. Similarly, the number of CD4 labora-
tories that are required for each scenario is an important operational consideration. It
is logical that, as the use of POC increases, a reduced number of CD4 laboratories will
be required to deliver diagnostic services. This would simplify the operational manage-
ment of the laboratory network by reducing the number of laboratory sites that require
staff with specialist skills to perform CD4 testing, reducing the number of laboratory
sites where specialist CD4 testing equipment needs to be maintained, etc.
The interpretation of the incremental cost per person initiated is discussed in more
detail in Section 6.2. This value was calculated by subtracting the total testing cost
of the status quo from the total testing cost of each scenario. This amount was then
divided by the total number of additional people initiated onto ART in each scenario
(ni in (5.1)) in order to determine the incremental CD4 testing cost associated with
initiating each of these additional people.
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Figure 6.1: Scenario 1 – Location of POC ART initiation sites, non-POC ART initiation
sites and NHLS CD4 laboratories.
Figures 6.1 to 6.3 visually depict the distribution of POC sites for scenarios 1, 5
and 9. One can clearly see how the number of POC sites increase from scenario 1 to
scenario 9.
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Figure 6.2: Scenario 5 – Location of POC ART initiation sites, non-POC ART initiation
sites and NHLS CD4 laboratories.
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Figure 6.3: Scenario 9 – Location of POC ART initiation sites, non-POC ART initiation
sites and NHLS CD4 laboratories.
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6.2 Analysis of results
It would be reasonable to conclude that the available healthcare budget in the country
would play a large role when decision-makers evaluate these alternative scenarios. How-
ever, in addition to the available budget, it would be important to also consider (i) the
cost effectiveness of each scenario; as well as (ii) the total public healthcare expenditure
on HIV.
6.2.1 Cost effectiveness of the scenarios
The incremental cost per additional person initiated is an indication of the cost effec-
tiveness of each scenario. As shown in Table 5.6 the low cost scenarios have a lower
incremental cost per additional person initiated than the high cost scenarios. To pro-
vide some perspective on these costs: based on the most conservative estimate of the
current laboratory-based CD4 testing cost (scenario 0), the status quo CD4 testing cost
per person initiated is US$33.72. Acoording to DHIS data1, 621 379 individuals were
initiated onto ART at this cost during the 2012/2013 financial year.
6.2.2 Total healthcare system cost
Though estimates of the exact amounts vary from one study to another, literature
agrees that the total annual cost to the healthcare system of a patient that is eligible
for ART and that is in fact receiving the treatment is lower than that of a patient
that is eligible but is not receiving the treatment. Therefore, though the expenditure
on CD4 testing in scenarios 1 to 10 would be higher than at present, it is possible
that the total public healthcare expenditure on HIV would be lower. In order to make
a recommendation on the effect of each of these scenarios on the total health system
cost, one would need to (i) systematically review the literature to establish which of the
published healthcare system cost estimates to use; and (ii) use modelling to calculate
the nett year-on-year financial effect of an increased number of patients being initiated
onto ART each year. Such a study falls outside the scope of this thesis, but it would
be valuable as the topic of further research.
6.3 Other considerations
In addition to the quantified financial and healthcare impact characteristics of each
scenario, there are also a number of more practical considerations which one would
1Data set introduced in Subsection 5.1.8.
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need to consider before implementing any of the scenarios presented here. Some of
these practical considerations are listed here in order to give an indication of the types
of factors that should be considered, however, this is by no means a comprehensive list.
1. Is the necessary infrastructure (most importantly a reliable electricity supply)
available at the ART initiation facilities that have been selected for the imple-
mentation of POC testing;
2. A decision on who would take the responsibility for the execution of POC testing:
would DoH staff be responsible for executing this work, or would NHLS staff be
allocated to the ART initiation facilities to execute the work;
3. Other effects that POC testing would have on the workload of clinic staff – for
example, patients will be coming to the clinic at least one less time before being
placed on treatment.;
4. The need to manage the quality of the results generated by POC instruments.
For example, one would need to ensure that analyser calibrations take place as
scheduled and that the necessary corrective actions are taken when calibration
fails. It is reasonable to assume that neither the NHLS nor the DoH would be
willing to take responsibility for signing off the test results if such a system were
not in place as this could have medico-legal implications; and
5. The effect of POC testing on the accuracy of HIV surveilance data in South Africa.
At present, these analysers are not set up to automatically submit the result of
each test to a centralised database. This is something that the laboratory-based
analysers are set up to do.
It is also recommended that decision-makers consider revisiting one of the business
decisions that have informed this study. It is likely that revisiting the decision not to
relocate any of the existing CD4 laboratories may enable one to deliver HIV services to
public healthcare users in the country significantly more cost-effectively. As highlighted
in Figure 2.3, NHLS laboratory sites are not distributed uniformly accross the country.
The maps indicating the location of CD4 laboratories in Figures 6.1 to 6.3 also illustrate
this unbalanced distribution. It is recommended that it would be prudent to consider
relocating some of the existing laboratory-based CD4 testing capability so that a larger
number of ART initiation sites fall within the coverage distance of a laboratory.
Lastly, it is important that decision-makers understand the limits of the modelling
work that has been done here. As discussed in Section 5.4, this is a difficult problem
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to solve. During this study, the problem was solved using a metaheuristic that has
been designed for multi-objective optimisation as well as a commercial algorithm. It is
recommended that, for a problem of this size and nature, one might manage to generate
superior quality results by applying a customised heuristic that has been specifically
designed for application to this real-world problem.
6.4 Conclusion: Analysis of results
This chapter presented an analysis of the results obtained from the modelling of the
real-world problem. The next chapter will provide a summary of the project and serve
as a conclusion to the project report.
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Summary and conclusions
The previous chapter discussed the results obtained from the modelling and solving
of the real-world problem. This chapter provides a summary of the research that has
been done before presenting the research findings and making suggestions for further
research.
7.1 Project summary
The purpose of this research was to apply Operations Research to solve a location
science problem concerned with the provision of HIV diagnostic services in the South
African public healthcare sector. This was done by modifying a standardised mathe-
matical formulation of a location science problem in order to ensure that it was able to
take all of the characteristics of the real-problem into consideration. Both a metaheuris-
tic for multi-objective optimisation and a commercial algorithm for single-objective
optimisation were then applied to solve the real-world problem.
As background to the research, Chapter 2 provided a brief overview of the status
quo of the South African public healthcare sector, the strategic aims and objectives of
the sector, and the current diagnostic service delivery model. The real-world problem
was introduced by describing the role of CD4 testing in the ART initiation pathway
and presenting research on loss to follow-up and the expected impact of POC CD4
testing on this phenomenon.
The discipline of Operations Research as well as the field of location science were in-
troduced in Chapter 3. The need for the application of Operations Research to support
decision-making in healthcare was established. The lack of literature on the applica-
tion of location science to real-world problems was confirmed and the applicability of
location science to the real-world problem was demonstrated.
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Eight standard types of location science models were identified and their mathe-
matical formulations presented in Chapter 4. These standard models were analysed
against the characteristics of the real-world problem and the most compatible model
was selected.
The modelling of the real-world problem was described in Chapter 5. The avail-
able input data was analysed and processed for use in the model; the mathematical
formulation of the standard location science model selected in the previous chapter was
adjusted according to the available input data and other characteristics of the real-
world problem; and the problem was solved using both the MOO CEM metaheuristic
and a commercial Matlab algorithm.
Chapter 6 presented the results obtained from the modelling of the real-world prob-
lem. The results were analysed in terms of their cost-effectiveness. The importance
of evaluating the impact of a decision on the use of POC CD4 testing on the total
healthcare system cost was highlighted. Examples of practical considerations that de-
cision makers would need to take into account when making a decision on the use of
POC CD4 testing were given. Finally, business decisions that informed this modelling,
but that do not necessarily lead to the most effective solution for diagnostic service
provision in SA were outlined.
7.2 Research findings
The research produced the following three findings:
1. It highlighted the importance of collecting accurate healthcare data in order to
allow for informed decision-making on healthcare interventions (specifically in the
public healthcare sector);
2. It demonstrated the challenges associated with applying theoretical model formu-
lations to complex, real-world problems; and
3. It demonstrated that, for multi-objective problems of this size and level of com-
plexity, combining the results from the multi-objective problem with those of
a single-objective version of the problem, may generate a superior set of final
results.
7.3 The contributions of this research
This research contributes to both academic literature and to South African public
healthcare management:
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1. It adds to the location science application literature by applying Operations Re-
search to a novel real-world testing device location problem;
2. It adds to the location science literature by proposing a framework for selecting
the most suitable standard mathematical model for application to a real-world
problem;
3. It adds to the metaheuristic literature by describing a tailored method for apply-
ing the MOO CEM to an allocation problem;
4. It provides healthcare decision makers in South Africa with quantified data on
the optimal trade-off between cost and health impact of the various scenarios for
the implementation of POC CD4 testing that should be considered; and
5. It provides detailed solutions for CD4 testing provision at 3 279 ART initiation
facilities as well as the resulting optimal referral network to 61 CD4 laboratories
for each of the nine proposed scenarios.
7.4 Opportunities for further work
It is proposed that the following opportunities for further work be explored. It is
believed that each of these suggested studies would add value to the quality of decision-
making in the SA public healthcare sector:
1. Revisit the business decision on the relocation of CD4 testing capacity to NHLS
laboratories that do not currently offer it. Generate scenarios that incorporate
a simultaneous use of POC testing and optimal re-allocation of CD4 laboratory
sites;
2. Evaluate the long-term holistic financial impact of each scenario on the healthcare
system. Specifically, take the annual treatment cost of HIV positive individuals
that are eligible for ART and are either receiving the treatment or not into con-
sideration. Also attempt to translate this holistic financial impact to an annual
healthcare provision cost per quality adjusted life year1 (QALY) in order to allow
the options to be evaluated according to a recognised methodology; and
1A measure that is typically used in economic evaluations of different healthcare interventions.
The cost per QALY is compared to the GDP per person to determine how cost-effective a healthcare
intervention is.
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3. Attempt to develop a customised heuristic for solving this real-world problem and
evaluate whether this heuristic is able to generate better quality results than the
MOO CEM and the Matlab GA.
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Appendix A
South African healthcare sector
strategic goals and objectives
This appendix contains more detailed information on the South African public health-
care sector’s strategic goals and objectives. The South African government’s Medium
Term Strategic Framework (MTSF) as well as the National Department of Health’s
set of priorities (the “10 Point Plan”), drawn up in response to the MTSF, were in-
troduced in section 2.1.4. Here the details of how the 10 Point Plan relates to the 20
healthcare outcomes defined in the MTSF are given. The 2014 target for each of the
MTSF healthcare outcomes is also defined.
A.1 The 10 Point Plan and the Medium Term Strategic
Framework
In its strategic plan for the period 2010/11 to 2012/13, the National Department of
Health gives a table that demonstrates how the 10 Point Plan is aligned to the 20
healthcare outcomes listed in the MTSF. This table also outlines the key activities
to be executed for each of the priorities in the 10 Point Plan. This table has been
reproduced here.
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Table A.1: The 10 Point Plan and the Medium Term Strategic Framework. (Reproduced from: Department of Health
(2010).)
Department of Health 10 Point Plan 2009-2014
Deliverables from the
outcome-based MTSF 2009
-2014
Priorities Key activities
1. Provision of Strategic Ensure unified action across the health sector Revitalisation of the
leadership and creation of in pursuit of common goals. Primary Health Care
Social compact for better Mobilize leadership structures of society and approach.
health outcomes communities. Enhanced Operational
Communicate to promote policy and buy in Management of Health
to support government programs. Facilities.
Review of policies to achieve goals.
Impact assessment and program evaluation.
Development of a social compact.
Grassroots mobilization campaign.
2. Implementation of National Finalisation of NHI policies and Improved Health Care
Health Insurance (NHI) implementation plan. Financing.
Immediate implementation of steps to Implementation of NHI.
prepare for the introduction of the NHI, Strengthened Health
e.g. Budgeting, Initiation of the drafting of Information Systems (HIS).
legislation.
Finalise and implement an Information and
Communication Technology (ICT) Strategy.
Continued on next page
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Continued from previous page
Department of Health 10 Point Plan 2009-2014
Deliverables from the
outcome-based MTSF 2009
-2014
Priorities Key activities
3. Improving the Quality of Improve service delivery in all 52 districts, Improved Patient Care and
Health Services with a special emphasis on 18 priority districts. Satisfaction.
Refine and scale up the detailed plan on Accreditation of health
the improvement of Quality of services and facilities for quality.
directing its immediate implementation.
Consolidate and expand the implementation
of the Health Facilities Improvement Plans.
Establish a National Quality Management and
Accreditation Body.
4. Overhauling the health care
system and improving its
management
4.1 Refocus the Health System Develop and implement a national model for Revitalisation of the Primary
on Primary Health Care the delivery of health services based on the Health Care approach.
(PHC) PHC approach. Enhanced Operational
Scale up community-based promotive and Management of Health
preventive health service, and massively Facilities.
expand immunisation programmes:
antenatal care post.
4.2 Improve the functionality Assess the qualification, skills and Revitalisation of the Primary
and management of the competencies of Hospital CEOs; Hospital Health Care approach.
Health System Senior Managers and District Managers. Enhanced Operational
Training managers in leadership, Management of Health
management and governance. Facilities.
Decentralization of management.
Development and implementation of an
accountability framework for the public and
private sectors.
Establish a management and leadership
Continued on next page
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Continued from previous page
Department of Health 10 Point Plan 2009-2014
Deliverables from the
outcome-based MTSF 2009
-2014
Priorities Key activities
academy for health managers.
5. Improved Human Refinement of the HR plan for health. Improved access to Human
Resources Planning, Re-opening of nursing schools and colleges. Resources for Health.
Development and Recruitment and retention of professionals,
Management including urgent collaboration with countries
that have excess of these professionals.
Focus on training of PHC personnel and midlevel
health workers.
Make an assessment of and also review
the role of the Health Professional Training
and Development Grant (HPTDG) and the
National Tertiary Services Grant (NTSG).
Manage the coherent integration and
standardisation of all categories of Community
Health Workers.
Continued on next page
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Continued from previous page
Department of Health 10 Point Plan 2009-2014
Deliverables from the
outcome-based MTSF 2009
-2014
Priorities Key activities
6. Revitalization of physical Improved Physical Infrastructure
infrastructure for Healthcare
Delivery.
6.1 Accelerate the delivery Establish Public Private Partnerships,
of health infrastructure particularly for the construction and
through Public Private refurbishment of Tertiary Hospitals.
Partnerships (PPPs) Accept 13 new projects annually for delivery
through the revised Hospital Revitalisation
Project.
Implement refurbishment and preventative
maintenance of all hospitals.
6.2 Revitalise Primary level Complete the Audit of PHC infrastructure
facilities and services.
Accelerate the delivery of infrastructure for
primary level facilities.
Implement refurbishment and preventative
maintenance of all hospitals.
6.3 Accelerate the delivery Finalise and implement the Health
of Health Technology Technology Strategy.
and Information Finalise and implement the ICT Strategy for
Communication the Health Sector.
Technology (ICT)
Infrastructure
7. Accelerated implementation Implement new HIV and AIDS policies and Managing HIV Prevalence.
of the HIV and AIDS strategic strategies announced on World AIDS Day, 01 Reduced HIV Incidence.
plan and the increased focus December 2009. Expanded PMTCT Programme.
on TB and other communicable Urgently strengthen programs against TB, Improved TB Case Finding.
diseases MDR-TB and XDR-TB. Improved TB outcomes.
Implement new PMTCT Guidelines. Improved access to Antiretroviral
Continued on next page
151
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
A
.1
T
h
e
1
0
P
o
in
t
P
la
n
a
n
d
th
e
M
e
d
iu
m
T
e
rm
S
tra
te
g
ic
F
ra
m
e
w
o
rk
Continued from previous page
Department of Health 10 Point Plan 2009-2014
Deliverables from the
outcome-based MTSF 2009
-2014
Priorities Key activities
Treatment for HIV-TB
co-infected patients.
Decreased prevalence of
MDR-TB.
Expanded access to Home
Based Care and Community
Health Workers.
8. Mass mobilisation for the Place more focus on the programs to attain Increased Life Expectancy
better health for the population the Millennium Development Goals (MDGs). at Birth.
Intensify health promotion programs. Reduced Child Mortality.
Place more focus on Maternal, Child and Decreased Maternal
Womens Health. Mortality Ratio.
Place more focus on non-communicable Improved health services for
diseases and patients rights, quality and the Youth.
provide accountability. Expanded access to Home
Based Care and Community
Health Workers.
9. Review of drug policy: Complete and submit proposals and a Improved Patient Care and
strategy, with the involvement of various Satisfaction.
stakeholders. Accreditation of health
Draft plans for the establishment of a Stateowned facilities for quality.
drug manufacturing entity. Enhanced Operational
Management of Health
Facilities.
10. Strengthen Research and Commission research to accurately quantify Enhanced Operational
Development Infant mortality. Management of Health
Commission research into the impact of Facilities.
social determinants of health and nutrition. Strengthened Health
Support research studies to promote Information Systems (HIS).
indigenous knowledge systems and the use
of appropriate traditional medicines.
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A.2 Quantified 2009 performance and 2014 target for the MTSF
healthcare outcomes
A.2 Quantified 2009 performance and 2014 target for the
MTSF healthcare outcomes
In its strategic plan for the period 2010/11 to 2012/13, the National Department of
Health gives a table that:
1. Quantifies the country’s performance in terms of each of the 20 healthcare out-
comes listed in the MTSF; and
2. More clearly defines the target for each of these 20 healthcare outcomes.
This table is reproduced here.
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Table A.2: 2009 performance and 2014 target for the MTSF healthcare outcomes. (Reproduced from: Department of Health
(2010).)
Indicator Baseline 2009 Target 2014/2015
Life Expectancy at Birth 53.9 years for males. 58-60 years.
57,2 years for females.
Child Mortality 69 per 1,000 live births. 30 - 45 per 1,000 live births.
Maternal Mortality Ratio 400 - 625 per 100,000 100 per 100,00 live births.
live births.
HIV Prevalence (amongst 15-24 year old 21,7% Not Applicable.
pregnant women)
HIV Incidence 1,3% 0,6%
Mother to child transmission rate of HIV 10% 0% - ¡ 5%
Percentage of eligible HIV positive women 37% All eligible pregnant women
initiated on ART to be initiated on ART at a
CD4 count of ¡350 or WHO
stage III or IV.
TB cases notified 341, 165 175,000
TB Cure Rate 64% 85%
Percentage of HIV-TB co-infected patients who 30% 100%
are on ART
PHC service delivery model completed Strategy for accelerating Health service delivery model
progress towards health based on the PHC approach
related MDGs through developed.
strengthening PHC
developed.
Percentage of health facilities accredited for None. 25% of health facilities
quality accredited annually.
Continued on next page
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Continued from previous page
Indicator Baseline 2009 Target 2014/2015
Improved access to Human Resources for Health Human Resources Revised HRH Plan
for Health (HRH) Plan produced, which
produced. reflects an appropriate
balance between health
professionals and
administrative personnel; reintroduces
key PHC workers
such as Infection Control
Officers; Environmental
Health Practitioners.
Monitor vacancy rates
in the public sector on a
quarterly basis.
Improved Health Care Financing Creation of national Health NHI policy finalised and
Insurance comenced. implemented.
Strengthened Health information systems (HIS) Draft e-Health Strategy Finalise e-Health Strategy
produced. finalised and implemented.
National Indicator Dataset Finalise new NIDS.
(NIDS) revised.
Improved health services for the Youth Strategy to improve Strategy finalised.
health levels of the youth 70% of PHC facilities
population segments implementing Youth Friendly
developed. Services by 2014/15.
Expanded access to Home Based Care and Draft policy on Community Strategy for Home and
Community Health Workers Health Workers produced. Community-based Care
(HCBC) developed.
Policy on Community
Health Workers finalised.
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